Development of a novel, clinically-relevant model for investigating factors that stimulate human hair growth by Miranda, Benjamin H.
 University of Bradford eThesis 
This thesis is hosted in Bradford Scholars – The University of Bradford Open Access 
repository. Visit the repository for full metadata or to contact the repository team 
  
© University of Bradford. This work is licenced for reuse under a Creative Commons 
Licence. 
 
DEVELOPMENT OF A NOVEL, CLINICALLY-RELEVANT 
MODEL FOR INVESTIGATING FACTORS THAT
STIMULATE HUMAN HAIR GROWTH
BENJAMIN H MIRANDA
PhD THESIS
2011
1DEVELOPMENT OF A NOVEL, CLINICALLY-RELEVANT 
MODEL FOR INVESTIGATING FACTORS THAT
STIMULATE HUMAN HAIR GROWTH
A comparison of the morphological differences, behaviour in organ culture 
and response to androgens, of pre-auricular intermediate 
and terminal hair follicles using morphometry, immunohistochemistry, 
PCR and gene microarray methods.
BENJAMIN H MIRANDA
Principal Supervisor: Professor V.A. Randall
Associate Supervisor: Professor D.J. Tobin
Plastic Surgery and Burns Research Unit
Director: Professor D.T. Sharpe
Department of Biomedical Sciences
Centre for Skin Sciences
University of Bradford
2011
2ACKNOWLEDGMENTS
I would like to thank Professor David Sharpe and the Plastic Surgery and Burns Research Unit, 
for giving me the opportunity to undertake this research; you have been a real inspiration. This 
research is dedicated to the hundreds of lives that were affected by the Bradford FC Fire 
Disaster in 1985. 
I would like to give a special thanks to my principal supervisor, Professor Val Randall, for her 
support and guidance throughout this research. Without her input, completion of this project 
would not have been possible. I would also like to thank my second supervisor, Professor Des 
Tobin, for his support and guidance. 
I thank my fellow research colleagues for their help throughout my learning period in 
mastering the techniques used to complete this project. I also thank the technical staff of the 
Biomedical Sciences Department, for all of their help and assistance. 
A special thank you to my parents. You have supported and encouraged me to work hard and 
to achieve throughout my life. I love you both, I am very grateful and I know that I would not 
be where I am today without your help. I will remember this always. 
Finally, to anyone that I have mistakenly forgotten, thank you for your help and support.
3ABSTRACT
Lack of hair due to alopecia or skin grafting procedures causes significant distress due to hair’s 
role in social and sexual communication. Only limited pharmacological agents are currently 
available to stimulate hair growth; their development is hampered by inappropriate model 
systems. Most research involves large terminal scalp follicles rather than the clinical targets of 
tiny vellus or intermediate follicles.
The overall aim of this thesis was to develop a novel model system based on intermediate hair 
follicles. Initially, intermediate follicles from female pre-auricular skin were characterised and 
compared to matched terminal follicles. Intermediate follicles were smaller, less pigmented, 
shorter and possessed a more 'tubular' bulb morphology than their more 'bulbous' terminal 
counterparts. Significant correlations were demonstrated between various hair follicle 
measurements and corresponding dermal papilla diameters.
Isolated terminal follicles grew significantly more than intermediate hair follicles in organ
culture for 9 days. Testosterone (10nM), the major regulator of human hair growth, increased 
only intermediate follicle growth; the anti-androgen, cyproterone acetate (1μM), prevented 
this stimulation, unlike the 5α-reductase type 2 inhibitor finasteride (40ng/ml).
Immunohistochemistry demonstrated androgen receptor and 5α-reductase type 2 proteins in 
both follicle types, while quantitative real-time PCR and gene microarray analysis detected
their increased gene expression in intermediate follicles. 
Thus, smaller intermediate follicles showed major morphological and gene expression 
differences to terminal follicles in vivo and retained significant, biologically-relevant 
differences in vitro in organ culture including androgen-responsiveness. Therefore, 
4intermediate hair follicles offer a novel, exciting, more clinically relevant, albeit technically 
difficult, model for future investigations into hair growth. 
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SECTION 1
INTRODUCTION
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1. INTRODUCTION
1.1 Functions of hair
A particular characteristic of mammalian skin is that it is covered in a variety of subtypes of 
hair. Certain body areas of skin are glabrous and therefore devoid of hair such as the lips, 
palms and soles in human beings. 
Hair plays an important part in mammalian survival. It contributes to mammalian 
thermoregulation, primarily through an insulator role with pockets of air being trapped 
between hairs next to the skin. These air pockets minimise heat loss through radiation. This 
relationship has previously been demonstrated in animal models such as mice (Minakami et 
al., 1986). Thermoregulation is a less important function in human beings compared with other 
mammals as evident from a relative lack of terminal body hair. This is probably due to the 
importance of the human evaporative cooling mechanism of sweat produced from eccrine 
glands (Ebling, 1985).
Camouflage is important in protecting animals from detection by predators and hair 
contributes to this in many mammals. An example of this is the spotting pattern on the coat of 
a leopard. The disruptive coloration theory (Thayer, 1909), later extended and formalised by 
Cott (Cott, 1940), explains that adjacent contrasting markings near the edge of the body break 
up the outline of the animal, thus giving the impression of a collection of unrelated objects. 
Hair is also involved in sexual and social communication. As an example, the presence of a dark 
mane in the male lion has been associated with a longer reproductive life-span and higher 
20
offspring survival (West and Packer, 2002). Furthermore, hair may function as a 
mechanoreceptor such as a whisker on the face of a cat (Oliver and Jahoda, 1989).
The main functions of hair in human beings are social and sexual communication and 
protection. Two landmark studies have depicted and described differences in both male and 
female hair growth patterns from childhood, through puberty until adulthood (Marshall and 
Tanner, 1969, 1970). Such differences are important in contributing to clear identification 
between the sexes. Interestingly, hair also contributes to individuality between same sex 
members and its removal may therefore have strong depersonalising effects. This is illustrated 
by the characteristically short hair of members of the armed forces and the ritual religious 
shaving of the heads of Buddhist or Christian monks. On the other hand, long hair may be 
encouraged within certain groups due to its positive associations such as with members of the 
Sikh religion (Randall, 2007). 
Seasonal variations in hair growth have also been well documented and may contribute to 
survival, camouflage and hunting success. An example of such variation would be in Scottish 
mountain hares (Lepus timidus scotius) where winter coats are white and are replaced with 
brown coats during the summer months to fit in with their environment (Flux, 1970). Seasonal 
variation is present, though less marked, in human beings. One particular study of 14 healthy 
Caucasian males demonstrated that scalp hair has a single annual cycle (Randall and Ebling, 
1991). During the spring months, more than 90% of scalp hair follicles were in anagen and this 
dropped to approximately 80% in autumn. Furthermore, facial and thigh hair grew significantly 
faster during the summer months than in the winter months. What is even more interesting is 
that this relationship was demonstrated even when the men had indoor occupations. 
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With respect to its protective role, scalp hair assists as a barrier against potentially harmful 
ultraviolet radiation that is implicated in various forms of skin cancer. Furthermore, eyelashes 
and eyebrows are an important protective mechanism against foreign body contact with the 
delicate cornea in children and adults of both sexes (Martini, 1998).
With all this in mind it is clear that the implications of conditions affecting human hair growth 
may be distressing to affected individuals, who may experience psychological trauma, loss in 
confidence, bullying, low self-esteem and relationship difficulties (McKillop, 2010). In a study 
of 103 balding males and 42 nonbalding male controls, balding males were found to have less 
body image satisfaction (Cash, 1992). Furthermore, males who suffer with greater hair loss 
have been shown to be more ‘bothered’ and more concerned about ageing than males who 
suffer with less hair loss (Girman et al., 1998); this study also demonstrated that males with 
greater hair loss felt that they were more noticeable to others. Females affected by hair loss 
have been shown to suffer substantially more detrimental psychological effects than males
(Cash et al., 1993). It has been noted that unwanted facial hair may affect over 40% of the 
general female population and that its presence may have a negative psychological and 
psychosomatic impact that should not be underestimated (Blume-Peytavi et al., 2007). 
Currently, hair growth disorders are not particularly well controlled. Further understanding of 
the complex interactions of biophysiological processes contributing to hair follicle function and 
growth is therefore required in order to help generate new treatments for related disorders in 
human beings. Furthermore, there are potential surgical issues regarding skin grafting 
procedures to areas that previously were ‘hairy’ in burns patients or after skin cancer excision. 
The idea of being able to harvest skin from an area that harbours intermediate hair follicles 
e.g. from the pre-auricular region, and then stimulating their growth to that of terminal 
follicles, may provide a better cosmetic and psychological outcome from patients.
22
1.2 Morphology.
The hair follicle produces a flexible tube composed of completely keratinised epithelial cells, 
recognisable as a hair fibre protruding from the skin. Hair may broadly be classified as lanugo, 
vellus, intermediate or terminal and can be differentiated by the structure and shape of the 
hair fibre, outward body appearance and dimensions (Table 1.1) (Vogt et al., 2008). Many non-
vellus hair fibres have three specific layers: a central medulla, surrounding cortex and outer 
cuticle. When present, the medulla may either be discontinuous or continuous and if 
continuous, will result in a hair with a stiffer character, as seen in an eyelash (Forslind, 2000). 
Table 1.1: Table of different hair type dimension guidelines, according to Vogt et al (2008).
Hair Type Typical Diameter Typical Length
Lanugo <30μm >2mm
Vellus <30μm <2mm
Intermediate 30-60μm >2mm
Terminal >60μm >2mm
Lanugo hairs are soft, fine, mildly pigmented and without a central medulla; they are produced 
by the foetus in utero and are the first hairs to be produced by the developing hair follicle 
during embryogenesis. Vellus hairs are small and so fine that they are often located on areas of 
the body classically termed as ‘hairless’. Furthermore, they may constitute up to 25% of the 
hair present in areas classically considered to be terminal hair bearing areas, such as the scalp 
(Vogt et al., 2008). Vellus hairs are without a medulla, in contrast to terminal hairs that may 
have a central medulla when large (Randall, 1994a). Intermediate hairs are first seen in the 
postnatal period where they replace the lanugo hairs of the scalp. Intermediate hairs possess 
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characteristics of both terminal and vellus hairs as they are only partially pigmented and their 
medulla may be fragmented or absent. Terminal hairs are relatively thick and pigmented 
(unless affected by canities or greying), possessing the largest cross sectional diameter of all 
the above hair types. 
Hair follicles are part of pilosebaceous units. Each pilosebaceous unit represents a hair follicle 
in association with one or more sebaceous glands. The sebaceous gland and associated duct 
produces a waxy secretion which coats and waterproofs the hair fibre. Also attached to the 
hair follicle, at the anatomical structure known as the hair bulge, is the smooth muscle known 
as arrector pili. This muscle has its origin in the superior dermis and is implicated in the 
manoeuvring of the hair follicle and associated hair fibre during thermoregulation, such as 
during cold conditions where erection of the hair fibre is desirable (Harding and Rogers, 1999). 
In certain regions of the human body, such as the axillae and genitals, hair follicles also possess 
apocrine sweat glands that are located superiorly to the sebaceous ducts (Hurley, 2001). These 
apocrine sweat glands, amongst other functions, discharge secretions such as odour binding 
proteins (Spielman et al., 1995) and volatile steroids (Rothardt and Beier, 2001), that 
contribute to the pheromone phenomenon. 
The hair follicle and its associated hair fibre both have a complex microanatomy (Fig 1.1). The 
tubular hair follicle extends from the epidermis into the dermis and in many species, such as 
human beings, into the subcutaneous adipose tissue. The hair follicle may be divided into four 
sections: the infundibulum and isthmus, together comprising the upper follicle, under which 
lies the lower follicle and hair root (Whiting, 2004). Furthermore within the hair root, towards 
its base, the follicle enlarges into the hair bulb which surrounds the vascularised dermal papilla 
that is of mesenchyme origin (Montagna and Van Scott, 1958). 
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Figure 1.1: Isometric diagram illustrating the components and structure of the human hair follicle 
(Richard J. Dew).  
Reproduced from Randall (1994), with permission from the author.
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The dermal papilla is ‘inverted strawberry shaped’ and comprises relatively few specialised 
fibroblastic dermal papilla cells that are associated with mucopolysaccharides (Montagna et 
al., 1952) and basement membrane proteins contained within a relatively large amount of 
extracellular matrix (Couchman, 1993; Messenger et al., 1991). Melanocytes are often located 
at the apex of the dermal papilla. The dermal papilla is surrounded, almost in total, by the 
matrix of the hair follicle and is separated efficiently from this structure by a trilaminar 
basement membrane (Nutbrown and Randall, 1995).
Within the hair follicle, the central medulla of the hair fibre is immediately surrounded by the 
hair cortex and cuticle. Three sheaths surround these structures. The inner root sheath 
structure is formed by the cuticle, Huxley’s layer and Henle’s layer. The cells of the inner root 
sheath cuticle are elongated. These cells interdigitate with the cuticle of the hair fibre and this 
is present from the bulb to the level of the sebaceous gland, hence providing elasticity to the 
hair fibre (Forslind, 2000). Huxley’s layer is comprised of 3-4 layers of cuboidal cells, while 
Henle’s layer is comprised of a single layer of elongated cells. Several layers of cells of the 
outer root sheath, or trichilemma, surround the inner root sheath. A potential space lies 
between these two sheaths and provides a smooth, unobstructed plane for growth. A 
connective tissue sheath with an underlying vitreous membrane surrounds the outer root 
sheath (Whiting, 2004).
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Morphological studies on human hair follicles have examined some relationships between 
structures within the follicle and between different hair follicle types. In a study of histological 
sections of scalp and retroauricular biopsies from 39 healthy individuals, measurements were 
made between terminal and vellus hair follicles (Vogt et al., 2007; Vogt et al., 2008). Terminal 
hair follicles (3865µm) penetrated significantly further below the skin surface than vellus hair 
follicles (580µm). Mean terminal hair follicle (172µm) infundibulum diameter at the skin 
surface was also significantly greater than vellus hair follicles (86µm). Other statistically 
significant differences in morphometry between terminal and intermediate hairs included 
infundibulum length, position of the bulge region and length of the bulge region, all of which 
were greater in terminal hair follicles. Although such comparative studies exist for vellus and 
terminal hair follicles, formal data about the differences between intermediate and terminal 
hiar follicles, the first part of this PhD thesis, was only published recently (Miranda et al., 2010)
(appendix). 
In an earlier stereologic study of 235 human facial and scalp hair follicles, a  correlation 
between hair cortex area and dermal papilla volume was demonstrated (Elliott et al., 1999). A 
further correlation between hair cortex area and the number of dermal papilla cells was also 
shown. With respect to the differences between large male facial hair follicles and female 
vellus hair follicles, dermal papilla volume was nearly 40 times greater in the large male facial 
hair follicle group. This difference was associated with a 2.4 times greater volume per dermal 
papilla cell and 17 times greater number of dermal papilla cells. 
The relationships between dermal papilla sizes and hair follicle dimensions have been a topic 
of interest for some time (Elliott et al., 1999; Tobin et al., 2003; Van Scott and Ekel, 1958). A 
previous  histo-geometric study, examined 84 anagen hair follicles taken from scalp biopsies of 
8 women and 3 men (Van Scott et al., 1963). Direct measurements were taken, including 
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dermal papilla and corresponding hair follicle diameter, from cross sections at different levels 
of the dermal papilla. These data were used to create scale drawings of hair follicles with 
different heights of dermal papilla that show a relationship between dermal papilla and hair 
follicle bulb size. Furthermore, the total number of dermal papilla cells and mitotic matrix cells 
were also determined by direct counting. It was found that larger hair follicles had taller 
dermal papillae and these were associated with a greater volume of matrix cells. Finally of 
interest is that this study demonstrated that approximately 2/3 of mitoses occur below the 
critical level at Auber’s line, with 1/3 occurring above this level. Therefore below Auber’s line, 
a line drawn through the widest part of the papilla at the critical level of the hair bulb, matrix 
cells are poorly differentiated and highly proliferative via increased mitotic activity (Auber, 
1952; Lorenz et al., 2007; Van Scott et al., 1963). Above Auber’s line however, a low 
proliferation zone exists, with well differentiated matrix cells with decreased mitotic activity. 
1.3 Hair follicle embryology.
Human hair development begins due to an interaction between epidermal and mesenchymal 
tissue during the 8th week of gestation in the regions of the eyebrow, upper lip and chin 
(Whiting, 2004) and completes by the 6th foetal month (Gorpinich and Nozdrin, 2007). This 
development is traditionally described in five stages: pre-germ, hair germ, hair peg, bulbous 
hair peg and hair follicle (Fig 1.2). 
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Figure 1.2: Diagram illustrating hair follicle embryogenesis. 
Reproduced from Randall (1994), with permission from the author.
Initially, epidermal thickenings or placodes will form in the epidermal basal layer above dermal 
aggregates of mesothelial cells, hence forming the pre-germ (Fuchs, 2007; Holbrook and 
Minami, 1991; Pinkus, 1958). These aggregates continue to grow down in an oblique manner 
to form the hair germ which subsequently elongates, penetrating deeper into the dermis to 
form the hair peg. At this stage the hair peg is represented by a cluster of mesenchymal cells at 
the base of a column of epithelial cells. The deepest part of the hair peg or epithelial column 
changes in shape to become more concave and begins to engulf mesoderm which eventually 
forms the dermal papilla. This relationship represents the bulbous hair peg. Epidermal cells 
superior to the primitive dermal papilla differentiate to eventually form the hair matrix. 
Further differentiation of these cells results in formation of the hair fibre and inner root 
sheath. The outer root sheath of the hair follicle is formed by differentiation of epithelial cells 
connecting the interfollicular epidermis and matrix and the connective tissue sheath is formed 
by differentiation of surrounding mesenchymal cells. 
At 12-15 weeks gestation, foetal hair follicles develop two posteriorly placed epidermal 
swellings. A superior swelling differentiates to form the sebaceous gland and an inferior 
swelling differentiates to become the point of eventual attachment of the arrector pili muscle 
known as the hair bulge. Areas such as the axillae and genitals, which have hair follicles 
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associated with apocrine sweat glands (Hurley, 2001), develop a third, more superior 
epidermal swelling from which these glands differentiate. 
The innermost cells of the bulbous hair peg degenerate to form the hair canal at around 15 
weeks gestation. Furthermore, keratinisation of the hair canal and hair fibre ensues. By this 
time, the dermal papilla will be completely engulfed by epithelial cells and the first sebocytes
are visible. In association with further differentiation of the hair follicle components, the first 
hair fibre is able to grow out towards the external environment. Whilst the hair follicle 
continues to extend deeper into the skin, at 19 weeks gestation, the first lanugo hair fibres will 
be visible as they protrude through the epidermis (Gorpinich and Nozdrin, 2007; Hardy, 1992; 
Holbrook and Minami, 1991; Pinkus, 1958; Wu-Kuo and Chuong, 2000). Interestingly, in a study 
of 6 healthy volunteers aged 27-41 years, average forehead hair follicle density was found to 
be 292 follicles/cm2 and this was significantly higher than other body areas including thorax, 
upper arm, lower arm, back, thigh and calf (Otberg et al., 2004). The maximum number of hair 
follicles present on the scalp of a human is seen at birth. At this point, scalp follicle density is at 
its greatest. As the neonate progresses through childhood to adolescence, the density of scalp 
hair follicles decreases until it reaches a plateau during adulthood. The density of scalp hair 
follicles at this time is in the region of 250-350 follicles/cm2 (Whiting, 2004).
1.4 The hair follicle growth cycle.
The human hair follicle possesses a unique, cyclical growth mechanism that enables the type of 
hair produced to vary according to stimuli such as seasonal variation and sexual development 
(Kligman, 1959). This cycle allows for degeneration of the previous hair follicle and 
regeneration of a new hair follicle that may be of a different type to the previous one. This 
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property is exploited during puberty and in such medical conditions as androgenetic alopecia. 
The cycle is comprised of 3 stages: anagen (growth phase), catagen (transitional phase) and 
telogen (resting phase). Figure 1.3 is an illustration of the stages of the hair follicle growth 
cycle.  
Anagen, the growth phase, may be further divided into 6 stages (Chase, 1954; Chase et al., 
1951). Anagen stages I-V describe the regeneration of the new follicle and during stage VI, 
most hair fibre growth takes place. During anagen stage I, keratinocytes below the bulge 
region of the follicle, known as the germ, become mitotically active and proliferate rapidly, 
hence adding cells to the growing hair fibre. The germ also begins downward growth and 
envelopes the cells of the dermal papilla during this stage. During anagen stage II, matrix 
epithelial cells form an inverted cone around the developing dermal papilla and above this, a 
layer of keratinocytes appear which ultimately give rise to the inner root sheath. During 
anagen stage III, the inner root sheath keratinocytes continue to divide and grow toward the 
superior aspect of the follicle. Also during this stage, matrix melanocytes above the dermal 
papilla become activated and commence melanin synthesis. By anagen stage IV, the tip of the 
hair fibre will be at the level of the sebaceous gland and will also still be enveloped by the 
superiorly growing inner root sheath cone. 
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Figure 1.3: Diagram illustrating the stages of the hair growth cycle.
Reproduced from Randall (2008), with permission from the author.
During anagen stage V, the new hair fibre penetrates through the inner root sheath cone and 
may dislodge the old, telogen club hair that is shed in a process known as exogen (Stenn et al., 
1998; Whiting, 2004). At this point, the hair follicle is at its widest diameter. Current evidence 
suggests that exogen may be an active process involving the breakdown of adhesion between 
the telogen club hair and its associated epithelial sac (Higgins et al., 2009). This is based on 
observations of empty human telogen follicles with absent club hairs on phototrichograms, a 
phase known as kenogen (Courtois et al., 1994; Rebora and Guarrera, 2002). Mouse studies 
have pointed to a number of mechanisms by which kenogen may be achieved; these include 
involvement of proteolytic enzymes and loss of cell adhesion molecules, which allow the club 
hair to be released in a process known as teloptosis (Hayashi et al., 2004; Roth et al., 2000). 
During anagen stage VI, the new hair shaft emerges from the surface of the skin and continues 
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to grow until the follicle re-enters catagen. At this point, the follicle is at its greatest depth 
within the subcutaneous tissue and the dermal papilla is fully enlarged. 
The duration in which the hair follicle remains in anagen, which generally depends on the area 
of the body in which the hair follicle is located, determines the length of the resulting hair 
fibre. With respect to the duration of anagen, stages I-V may remain relatively constant 
between hair follicles despite their different locations on the body; however, the duration in 
which the follicle remains in anagen stage VI may vary and it is this stage that primarily 
influences the final shaft length (Saitoh et al., 1970; Trotter, 1924; Whiting, 2001). With 
respect to location differences, hair follicles in the region of the eyebrow may remain in 
anagen for 2-3 weeks and consequently produce short hair fibres, however, hair follicles in the 
region of the scalp may remain in anagen for 2-8 years and consequently produce long hair 
fibres (Kligman, 1959; Paus and Cotsarelis, 1999; Saitoh et al., 1970). 
Human scalp follicles remain in the catagen phase of the hair growth cycle for approximately 2 
weeks (Kligman, 1959). Initially, the melanocytes of the follicle resorb their dendritic processes 
and stop synthesising melanin. The keratinocytes of the hair bulb matrix cease mitotic division 
and consequently do not enter the hair fibre any more. The outcome of these processes is that 
the hair fibre no longer grows, rather its base becomes ‘clubbed’ and degenerates, via 
apoptosis, towards the level of the sebaceous gland where it finally comes to rest (Botchkareva 
et al., 2006; Weedon and Strutton, 1981). The dermal papilla condenses and become a small 
aggregation of cells that must reach the level of the bulge during catagen in order for the hair 
not to be lost and the cycle to continue (Paus and Cotsarelis, 1999).  
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1.5 Mesenchymal & epithelial interactions of the hair follicle.
The hair follicle is composed of structures derived from both ectoderm and mesenchyme as 
described in section 1.4. Signal interactions between these epithelial and dermal structures are 
important for both hair follicle development and hair cycling. Initially, aggregated dermal cells 
of the hair germ (Fig 1.2) send signals to the overlying epidermis, resulting in formation of the 
cutaneous appendage. Tissue recombination experiments between the embryonic skin of 
differing species have illustrated this point, an example of which would be the development of 
feather follicles in chick foot epidermis by mouse dermis (Ferraris et al., 2000; Hardy, 1992; 
Sengel, 1983).
  
The next signals are generated from the epidermis and result in dermal papilla development 
from a cluster of dermal cells. This appears to be a class specific response and is probably due 
to the fact that populations of specific stem cells are retained for this purpose, hence only 
mouse dermis will respond to a mouse hair peg (Fuchs, 2007; Niemann and Watt, 2002). A 
subsequent message, transmitted from the dermal papilla, stimulates rapid division of 
adjacent epithelial cells which results in the formation of a class specific appendage. It is 
therefore apparent that a complex series of mesenchymal-epithelial signals are responsible for 
hair follicle embryogenesis (Fuchs, 2007; Niemann and Watt, 2002)
The dermal papilla persists throughout the hair growth cycle and is responsible for regulating 
mesenchymal-epithelial interactions in the post-embryonic stage. The importance of the 
dermal papilla in the hair growth cycle is highlighted by the fact that if the dermal papilla is 
removed from anagen vibrissae follicles in rats, cessation of hair growth is observed (Link et 
al., 1990; Oliver, 1966). Furthermore, implantation studies have demonstrated that when 
dermal papillae, which contain a specialised and discrete population of fibroblasts, are 
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implanted into follicles without the potential for growth, induction of hair growth is observed 
(Jahoda et al., 1984). Interestingly, the type of hair that grows after transplantation of the 
dermal papilla, is governed by the papilla itself and not the donor site. For example, adult rat 
vibrissae dermal papillae induce vibrissae-type hair fibres after transplantation to small 
wounds on rat ear pinnae (Jahoda, 1992). In a more recent experiment, human dermal papillae 
were implanted into rat footpads which lack follicles and sebaceous glands (Lin et al., 2008). 
Histological examination demonstrated the development of hair follicles and sebaceous glands 
between 6-10 weeks, with hair fibre production occurring after 10 weeks.    
Cells of the dermal sheath cup, which surrounds the hair bulb, have been shown to possess 
similar properties to cells of the dermal papilla with respect to hair follicle growth induction 
(McElwee et al., 2003). In this experiment, green fluorescent protein expressing wild-type, and 
nontransgenic mouse vibrissa follicle cells were cultured and implanted into mouse ears and 
footpads. Implanted dermal sheath cup cells were found to induce the growth in both ears and 
footpads, whilst cells from other locations of the dermal sheath did not. These findings have 
previously been demonstrated in human beings (Reynolds et al., 1999). In this small study, 
scalp biopsy dermal sheath tissue from an adult male was microdissected and transplanted 
into shallow inner arm skin wounds of a genetically unrelated and immunologically 
incompatible adult female. New hair follicles and hair fibres were produced at all sites, 3-5 
weeks following transplantation. After further biopsy, histology and PCR techniques confirmed 
production of normal hair follicles, originating from the male donor.    
Dermal sheath and germinative epithelium have also been shown to play an important part in 
follicular growth. Germinative epithelial cells, previously referred to as hair follicle stem cells, 
in the lower bulb area of anagen hair follicles, have been shown to give rise to hair fibres via 
complex differentiation and rapid proliferation (Reynolds and Jahoda, 1991). Furthermore, 
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these cells have been shown to be morphologically and behaviourally distinct from 
comparative epithelial cells. When cultured in growth conditions suitable for epithelial cell 
growth, germinative epithelial cells did not display differentiation or division. In contrast, when 
cultured with hair follicle dermal papilla cells, germinative epithelial cells were stimulated to 
proliferate and aggregate, forming organotypic-like structures. In another study, dermal 
sheath cells and germinative epithelium cells were implanted into small rat ear skin wounds 
(Reynolds and Jahoda, 1996). When implanted alone, no hair growth was observed, however, 
when implanted in combination, hair follicle formation was induced. These studies suggest the 
importance of signal interactions between germinative epidermal cells, dermal sheath cells 
and cells of the dermal papilla in hair cycling and growth.
As hair follicles grow extensively and change their morphology throughout their cycle, it is 
highly likely that they possess stem cells. In an important study of newborn SENCAR mice, 
twice daily injections of tritiated thymidine were administered over 7 days (Cotsarelis et al., 
1990). Autoradiography after tissue sectioning revealed labelling of nearly 100% of nuclei in 
the skin epidermis, hair follicles and associated sebaceous glands. At 4 weeks however, 
labelling was still observed in the outer root sheath at the region of the hair bulb, but not in 
other structures such as the matrix and sebaceous glands. Furthermore, after painting the skin 
and hair of these mice with tissue plasminogen activator, a potent tumour promoter, 
significantly higher proportions of nuclear staining were observed. This evidence is supportive 
of the concept that slow-growing cells are present in the hair bulge and that these cells may be 
stimulated to proliferate. Both of these properties are characteristic of stem cells. More recent 
studies have confirmed the self-renewal and multipotency potential of murine bulge cells 
(Blanpain et al., 2004; Claudinot et al., 2005). Using rat whiskers as an experimental model, 
Claudinot et al (2005) demonstrated a number of important properties of bulge cells. When 
transplanted to the dermo-epidermal junction of the skin of newborn mice, these cells formed 
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part or all of the subsequent developing hair follicles. It was also demonstrated that these cells 
could generate all lineages of the hair follicle and associated sebaceous gland. Furthermore, a 
single cultivated cell was able to give rise to thousands of hair follicles and cultured cells 
expressed the self-renewal genes Bmi1 and Zfp145;(vi). This evidence is highly supportive of 
the stem cell properties of keratinocyte bulge cells at the hair bulge of the outer root sheath of 
the hair follicle. 
         
1.6 Hormonal regulation of human hair growth.
Aside from seasonal changes (Section 1.1), normal hormonal mechanisms during pregnancy 
and those that involve androgens may significantly affect hair growth (Randall, 2007). Under 
certain abnormal circumstances, such as in poor nutritional states or with abnormal thyroid 
function, normal mechanisms may be overridden. 
It has been shown that throughout the 2nd and 3rd trimesters of pregnancy, until 1 week post 
partum, 95% of scalp hair follicles may be in the anagen phase (Lynfield, 1960). After this point 
only 76% of hair follicles remain in anagen, with the remainder entering catagen or telogen 
phases. Furthermore, a wave of hair shedding occurs a few weeks after birth (Pecoraro, 1968). 
These phenomena are probably due to changes in levels of circulating pregnancy hormones. 
Studies, involving the reverse transcription polymerase chain reaction and 
immunohistochemistry, have shown that both prolactin and 17β-oestradiol receptors are 
present in the human hair follicle (Foitzik et al., 2006; Thornton et al., 2003). An example of the 
effects of such hormones on cultured human hair follicles includes the inhibition of growth by 
prolactin, an effect that supports its role in post-partum hair loss.
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Androgens exert paradoxical effects on hair growth. After puberty, vellus follicles are replaced 
by terminal follicles on areas such as the beard, pubic diamond, chest and limbs of males 
(Hamilton, 1958). Females also display post-pubertal hair growth in areas such as the pubic 
triangle and axillae. These post-pubertal changes parallel a rise in circulating androgens and 
occur earlier in girls than in boys (Winter and Faiman, 1972, 1973). In contrast, the same 
individual may have the exact opposite response to androgens in later life during the male 
scalp balding process (Hamilton, 1951). Furthermore, androgens have no effect on body areas 
such as the eyebrows and eyelashes, so it seems that the response of a hair follicle to 
androgenic stimulation is dependent on body site (Figure 1.4). Hair transplantation procedures 
further confirm these site-dependent or site-independent androgenic properties, as the 
transplanted hair follicle retains the characteristics of the donor site; in fact it is these exact 
properties that are exploited in order to achieve a good cosmetic outcome (Orentreich and 
Durr, 1982). The duration and intensity of response of hair follicles to androgenic stimulation 
may vary greatly. As an example, beard density increases rapidly during puberty until the mid-
thirties, however terminal hairs may only be visible on the chest or within the ear canal, years 
after puberty has occurred (Hamilton, 1958).  
The main circulating androgen is testosterone, which is a lipophilic, cholesterol-derived 
steroid. Over 95% of testosterone is produced and secreted by testicular Leydig cells, with the 
remainder being produced by the adrenal cortex. Androgens may be transported within the 
circulation, either bound to plasma proteins such as sex-hormone-binding globulin and 
albumin, or as free molecules (Rommerts, 2004). Androgens are delivered to the hair follicle 
via its capillary network, hence reaching the dermal sheath and dermal papilla. Androgens 
diffuse through cell membranes, passing through cytoplasm and entering cell nuclei.
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Figure 1.4: Diagram illustrating the paradoxical effects of androgens on human hair growth depending 
on follicular body site.
During and after puberty, androgens stimulate the gradual transformation of vellus hairs to terminal 
follicles in the beard region (upper panel). Many follicles in the scalp and eyelashes simultaneously 
continue to produce the same type of hairs, unaffected by androgenic stimulation (middle panel). In 
contrast, androgens may inhibit and reverse follicular growth in certain body areas such as the scalp, 
resulting in the replacement of terminal follicles with vellus follicles (lower panel). Reproduced from 
Randall (2008), with permission from the author.
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Once within the cell nucleus, androgens may bind to their corresponding receptor, resulting in 
a receptor complex conformational change that exposes DNA binding sites. Dimerisation of 
androgen-receptor complexes occurs and these bind to the regulatory DNA sequence either 
close to or at the site of the target gene, known as a hormone response element  
(Handelsman, 2001). The outcome of these events is the expression of corresponding 
hormone-dependent genes via initial DNA transcription. Furthermore, 5α-reductase may 
intracellularly metabolise testosterone to 5α-dihydrotestosterone, which is a more potent 
androgen than testosterone (Hoffmann et al., 2001; Randall, 1994a). This process may occur in 
many tissues, such as prostate, so that the more potent form binds preferentially and in a 
stronger manner to induce gene expression (Fig 1.5). Although binding with the androgen 
receptor and activating gene transcription is the classical mechanism through which androgen 
action occurs, alternative pathways have been proposed including via the action of other 
androgen metabolites, such as 5α-androstane, 3β, 17β-diol on the stress response mediated 
by the hypothalamo-pituitary-adrenal (Handa et al., 2008)., or after aromatisation to 17β-
oestradiol through oestrogen receptors and via rapid non-classical testosterone signalling 
pathways (Rahman and Christian, 2007). Furthermore, recent evidence suggests that the 
classical androgen receptor pathway may be modulated by interaction with other signalling 
pathways such as Wnt (Terry et al., 2006). Also of note, is that hair follicles seem to utilise 
testosterone or 5α-dihydrotestosterone, depending on their body site. Individuals with 5α-
reductase type 2 deficiency produce female patterns of axillary and pubic hair growth, 
although their body shape is distinctly masculine (Fig 1.6) (Wilson et al., 1993). This led to the 
concept that 5α-dihydrotestosterone is a requirement for male-specific hair follicles such as 
those found in the beard, chest and pubic diamond, while testosterone has the capacity to 
stimulate hair follicle growth in the axilla and pubic triangle in both males and females. 
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Figure 1.5: Diagram illustrating the general intracellular mechanisms of androgen metabolism and 
action. 
Testosterone, the primary circulating androgen, diffuses across the cell membrane into the cell, enters 
the cell nucleus and binds to its corresponding receptor which undergoes a conformational change. 
Dimerisation of androgen-receptor complexes and further binding to the DNA hormone response 
element results in upregulation of gene expression. The presence of 5α-reductase converts testosterone 
to its more potent form 5α-dihydrotestosterone, hence augmenting this process. Reproduced from 
Randall (2008), with permission from the author.
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Figure 1.6: Variations in patterns of hair growth due to different medical conditions.
Reproduced from Randall (2000), with the author’s permission.
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It is not yet known for certain why some hair follicles require testosterone, while others 
require 5α-dihydrotestosterone, in order to alter gene expression and induce subsequent 
biophysiological responses that lead to hair fibre growth. Hair follicles and skin do contain a 
number of enzymes that metabolise weak androgens, such as dehydroepiandrosterone from 
the adrenal glands, to more potent androgens such as testosterone and 5α-
dihydrotestosterone, to oestrogens such as oestradiol and oestrone (Fig 1.7) (Randall, 2008). 
Studies of individuals with pseudohermaphroditism confirm the role of 5α-
dihydrotestosterone in hair growth (Akgun et al., 1986; Imperato-McGinley, 1991; Imperato-
McGinley et al., 1991). These individuals inherit a deficiency of the enzyme 5α-reductase which 
results in decreased conversion of testosterone to 5α-dihydrotestosterone. They may have 
normal or high levels of testosterone, but low levels of 5α-dihydrotestosterone. Affected 
males are born with a rudimentary clitoral-like penis and pseudovaginal perineoscrotal 
hypospadias. During puberty there is significant muscular development, with rudimentary 
penis enlargement, however there is decreased facial and body hair in comparison to their 
normal male counterparts. Furthermore, body hair distribution tends towards a female 
pattern, located primarily around the axillae and pubic triangle. Despite this, the lack of hair on 
individuals with complete androgen insufficiency syndrome is supportive of the fact that the 
androgen receptor is vital for such hair growth. It therefore follows that those androgens that 
bind to the androgen receptor with the highest affinity, specifically testosterone and 5α-
dihydrotestosterone, are the most important with respect to hair growth. 
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Figure 1.7: Diagram illustrating the pathways by which androgens may be converted to either weaker 
or stronger forms, or converted to oestrogens. 
Hair follicles and skin contain a number of enzymes that metabolise weak androgens, such as 
dehydroepiandrosterone from the adrenal glands, to more potent androgens such as testosterone, or 
potent androgens such as testosterone and 5α-dihydrotestosterone, to oestrogens such as oestradiol 
and oestrone. Reproduced from Randall (2008), with the author’s permission.
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Current thinking is that androgen action commences at the dermal papilla of the hair follicle 
(Randall, 2008). After being delivered to the dermal papilla via its capillary network, androgens 
eventually bind to their corresponding androgen receptors within the cells of the dermal 
papilla, altering gene expression and thus production of paracrine regulatory factors that may 
influence other target cells (Fig 1.8). To date, the exact nature of these paracrine factors is 
unknown, however a number of growth factors and cytokines have been proposed that seem 
to be soluble substances with a mitogenic capacity. The targets of these paracrine factors 
include follicular melanocytes (resulting in pigmentary change), keratinocytes (resulting in hair 
fibre growth), outer root sheath and endothelial cells (Randall, 2007). The dermal papilla must 
also be a target of androgens as it varies its size in concordance with changes in overall hair 
dimensions (Elliott et al., 1999; Van Scott and Ekel, 1958). This effect may be direct or indirect 
via involvement of paracrine factors (Hamada and Randall, 2006). 
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Figure 1.8: Diagram illustrating the action of androgens at the hair bulb.
Androgens, such as testosterone (T), are delivered to the dermal papilla via its capillary network. After 
binding to corresponding androgen receptors within the cells of the dermal papilla, regulatory changes in 
paracrine factors (?) occur which result in altered activity of dermal papilla cells, follicular keratinocytes 
and melanocytes. Reproduced from Randall (2008), with permission from the author. 
46
1.7 Paracrine factors involved in hair growth control.
It is probable that androgens stimulate paracrine factors that are released from the dermal 
papilla, resulting in cell-specific behaviours within the hair follicle (Section 1.6). Some of these 
potential paracrine factors will be discussed in more detail. 
Insulin-like growth factor
Insulin-like growth factor-I (IGF-I) has been proposed as a paracrine factor involved in hair 
growth. It has been shown, in the absence of insulin, to result in dose-dependent hair growth 
with greater effect than both insulin and insulin like growth factor-II (IGF-II) in cultured human 
scalp hair follicles (Philpott et al., 1994b). Furthermore, the same study showed that IGF-I 
maintained hair follicles in anagen phase with greater efficacy than insulin and IGF-II. 
Androgens have been shown to stimulate IGF-I expression in beard dermal papilla cells co-
cultured with outer root sheath cells, resulting in the proliferation of outer root sheath cells 
(Itami et al., 1995). Neutralizing antibody against IGF-I antagonised these stimulatory effects,
resulting in cessation of outer root sheath cell growth even with androgen stimulation. 
Hepatocyte growth factor
Hepatocyte growth factor (HGF) has been shown to possess mitogenic properties on epithelial 
cells in vitro (Sonnenberg et al., 1993). Immunohistochemistry studies of anagen mouse hair 
follicles have located its presence in dermal papilla cells and the presence of its corresponding 
receptor, c-Met, in the hair keratinocytes (Lindner et al., 2000). HGF has been shown to 
stimulate both hair length and DNA synthesis in hair follicle, bulb-derived keratinocytes and 
whole organ culture systems in a dose-dependent manner (Shimaoka et al., 1995). HGF mRNA 
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has also been shown to be expressed by human hair follicle dermal papilla cells (Merrick, 2000; 
Shimaoka et al., 1994). In a study of cultured dermal papilla cells from beard, balding and non-
balding scalp in the presence of testosterone, it was demonstrated that balding scalp dermal 
papilla cells expressed less HGF than non-balding scalp dermal papilla cells. In turn, non-
balding scalp dermal papilla cells expressed less HGF than beard dermal papilla cells (Merrick 
et al., 2000). This difference in HGF expression suggests that HGF may play a role in 
maintaining large follicles and that androgens may exert some effect on HGF expression in 
androgen-dependent follicles (Randall et al., 2001).
Stem Cell Factor      
Stem cell factor (SCF) and its receptor, c-kit, are known to play a part in the pigmentation of 
epidermis (Grichnik et al., 1998; Williams et al., 1992) and hair (Fleischman et al., 1991; 
Geissler et al., 1988). In a study of beard and non-balding scalp dermal papilla and fibroblast 
cells in the presence or absence of testosterone, enzyme linked immunosorbent assay (ELISA) 
was undertaken in order to quantify SCF production (Hibberts et al., 1996). It was found that 
after 24h, beard and scalp fibroblasts produced significantly less SCF than either beard or scalp 
dermal papilla cells. Furthermore, darker beard follicle cells secreted more SCF than scalp 
follicles. During androgenetic alopecia, scalp hairs become paler, in contrast to the increased 
pigmentation of beard hairs stimulated by androgens. Balding dermal papilla cells secreted less 
SCF than normal scalp cells although the density of melanocytes in the follicles remained the 
same (Randall et al., 2008). In both experiments, testosterone had little effect on SCF secretion 
in vitro, suggesting that androgens probably only alter SCF production at specific points of the 
hair cycle (Hibberts et al., 1996; Randall et al., 2008).
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Vascular endothelial growth factor
Vascular endothelial growth factor (VEGF) modulates angiogenesis and vascular permeability. 
As anagen hair follicles are well vascularised, microvascular angiogenesis probably occurs 
during early anagen phase (Montagna and Van Scott, 1958). Furthermore the relative size of 
the vasculature adapts as androgen-sensitive hair follicles alter in size, for example during 
puberty (Montagna and Ellis, 1958). VEGF has been shown to be expressed by cultured dermal 
papilla cells (Lachgar et al., 1996; Merrick et al., 1999). Lachgar et al (1996) characterised an 
angiogenic growth factor that was indistinguishable from vascular endothelial growth factor, 
based on biochemical and immunologic criteria. They identified 2 binding sites on dermal 
papilla cells for this growth factor and found that these cells proliferated or migrated in its 
presence. Furthermore, neutralising antibodies inhibited these effects, hence suggesting that 
vascular endothelial growth factor may contribute to hair growth either by direct action on 
dermal papilla cells, or by stimulating local vascularisation. In a study of 20 previously biopsied 
patients with prostate cancer who underwent transurethral prostatectomy after androgen 
deprivation therapy for at least 3 months, prostate specimens were investigated 
immunohistochemically for the expression of VEGF (Aslan et al., 2005). Androgen deprivation 
therapy was associated with significantly lower positive staining for VEGF, hence supporting 
the idea that VEGF expression is downregulated in the absence of androgenic stimulation.
Transforming growth factor
Transforming growth factor-β1 (TGF-β1) has been shown to inhibit hair growth in in vitro organ 
culture studies and thus it may be a negative regulator of hair follicle growth in vivo (Philpott 
et al., 1990). A particular study using an in vitro co-culture system of human dermal papilla 
cells and keratinocytes from individuals with androgenetic alopecia, demonstrated an 
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interesting relationship between these cells, androgens and TGF-β1 (Inui et al., 2002). Initially, 
androgenic stimulation had no effect on dermal papilla cells, however during the culturing 
process, mRNA expression of the androgen receptor decreased. In a modified co-culture 
environment, after transfecting the androgen receptor expression vector into dermal papilla 
cells, androgens significantly suppressed the growth of keratinocytes by approximately 50%. 
This indicated restoration of the responsiveness of dermal papilla cells to androgens in vitro. 
Additionally, androgenic stimulation was found to increase the expression of TGF-β1 mRNA in 
co-cultured dermal papilla cells. ELISA assays further demonstrated that androgenic 
stimulation increased the secretion of TGF-β1. After introducing anti-TGF-β1 antibody, 
androgenic growth inhibition of keratinocytes was reversed in a dose-dependent manner. 
These findings suggest that androgen-dependent TGF-β1 from dermal papilla cells may result 
in suppressive effects on hair follicle growth in vitro. 
Paracrine factors involved in hair growth control are likely to be numerous and their cellular 
mechanisms of action are complicated. Better understanding is required in order to help 
develop more efficacious treatments for hair growth disorders. It is for this reason that 
paracrine factors are the subject of much current research. 
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1.8 Disorders of hair growth.
The distressing implications to individuals affected by conditions that affect human hair growth 
have been discussed in section 1.1. The three most common disorders of hair growth are
androgenetic alopecia, alopecia areata and hirsutism.
Androgenetic Alopecia 
Androgenetic alopecia affects the scalp of male and female individuals, however males are 
more commonly affected (Hamilton, 1951). Alternative terminology for this condition includes 
male pattern baldness and common baldness. The pattern and progression of hair loss in male 
pattern baldness was first described by Hamilton and then later revised by Norwood (Fig 1.9)
(Hamilton, 1951; Norwood, 1975; Randall, 2005). The pattern progresses from the pre-
pubertal distribution of scalp hair (type I), through fronto-temporal recession and by hair loss 
from the vertex of the scalp, finally resulting in hair only being present at the most inferior 
aspects of the back and sides of the scalp (type VII). In the most classic cases, thick, terminal 
hairs are slowly replaced by shorter, non-pigmented, vellus hairs, starting at some stage after 
puberty has occurred. Females may also be affected by androgenetic alopecia, however 
classically, there is progressive hair loss from the vertex, with frontal hair line preservation (Fig 
1.10) (Ludwig, 1977; Randall, 2000).  
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Figure 1.9: Norwood’s revision of Hamilton’s classification of male pattern baldness. 
.
Figure 1.10: Diagram illustrating Ludwig’s description of the progression of female pattern baldness.
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Androgens and genetic predisposition are the two major factors that contribute to the 
pathogenesis of androgenetic alopecia. With respect to androgens, androgenetic alopecia will 
not affect males who have been castrated prior to puberty and in post-pubertal males with 
androgenetic alopecia, castration results in cessation of progression of baldness (Hamilton, 
1960). In males who have been castrated after puberty, testosterone replacement therapy 
may induce hair loss, hence further illustrating the requirement of androgens for disease 
progression (Hamilton, 1958). Adults with complete androgen insensitivity syndrome lack 
androgen receptors and have an absence of body hair, hence only displaying child-like patterns 
of hair growth (Figure 1.6) (McPhaul, 2005). This is supportive of the concept that body hair 
growth is reliant on androgen stimulation. 
A genetic predisposition for androgenetic alopecia is implicated by numerous studies. For 
example, a study of  1st degree relatives in 572 males, found a significantly increased risk of 
balding in young males with a balding father over those with a non-balding father, although 
this risk fell to insignificant levels with increasing age (Birch and Messenger, 2001; Ellis and 
Harrap, 2001). In another study of 135 pairs of adult twins over the age of 50, intrapair 
differences in hair loss were negligible in 92% of monozygotic twins (Hayakawa et al., 1992). 
Furthermore, this study also showed significantly higher concordance rates in monozygotic 
twins over dizygotic twins. In a genome-wide association study of 1125 males, a locus at 
chromosome 20p11.22 was identified in association with androgenetic alopecia (Richards et 
al., 2008). They reported that 1 in 7 males have alleles at both 20p11.22 and AR, the region 
responsible for coding the androgen receptor. These individuals displayed 7 times the odds of 
developing androgenetic alopecia. Despite the presence of only a small volume of studies 
confirming specific gene associations, the aetiology of androgenetic alopecia is likely to be 
multifactorial with a polygenic basis (Küster and Happle, 1984; Randall, 2005; Smith and Wells, 
1964). 
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Alopecia Areata
Alopecia areata is a chronic inflammatory condition causing nonscarring hair loss (Garg and 
Messenger, 2009). The lifetime risk of developing alopecia areata incidence of alopecia areata 
is reported to be in the region of 1.4-1.7% (Safavi et al., 1995; Tazi-Ahnini et al., 2002). 
Although both males and females may be affected, there is a slightly increased prevalence 
amongst females, the ratio of which has been reported to be around 1.3:1 (Tan et al., 2002). 
Although alopecia areata may affect individuals of all ages, studies have reported that over 
80% of individuals are under the age of 40 years old (Tan et al., 2002; Yang et al., 2004). 
Affected individuals experience hair loss in well circumscribed patches that often affects the 
scalp, although any hair bearing skin may be affected (Delamere et al., 2008). Interestingly, 
affected hairs are usually referred to as ‘exclamation mark’ hairs due to their tapered 
appearance as they ‘enter’ the skin. In some patients, patchy hair loss from the scalp may 
progress to total scalp hair loss (alopecia areata totalis), or total body hair loss (alopecia 
universalis), both of which in females are more prevalent in the pre-menopausal years (Chen 
et al., 2010). Although an autoimmune component is likely to be present, the exact cause of 
alopecia areata is unknown (Randall, 2001). Furthermore, genetic predisposition and 
environmental triggers are also commonly thought to play an important part in the disease 
process (Yang et al., 2004). 
The autoimmune component of this condition is supported by the findings of lymphocytic 
infiltrates in and around hair follicles (Wasserman et al., 2007). Additionally, as with other 
autoimmune diseases, there is a strong association with co-existing autoimmune disease in 
individuals affected by alopecia areata; 7-27% of affected patients may suffer with 
autoimmune thyroid disease (Puavilai et al., 1994; Shellow et al., 1992). Vitiligo has also been 
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reported to co-exist in 4-9% of affected individuals and autoimmune diseases such as diabetes 
and myasthenia gravis have also been reported in patients with alopecia areata (Muller and 
Winkelmann, 1963).
With respect to environmental factors: infections, vaccines, chemical exposure and emotional 
stress have all been associated with disease onset (Madani and Shapiro, 2000). In a study of 
173 Chinese, 35 Indian, and 11 Malaysian individuals affected by alopecia areata, 9.8% of 
individuals reported stressful life events prior to disease onset (Tan et al., 2002). With respect 
to genetics, alopecia areata may be passed on in an autosomal dominant manner with variable 
penetrance (Sinclair et al., 1999). In a study of 202 patients affected by alopecia areata 
matched with 175 controls, genotyping for the autoimmune regulator (AIRE) gene on 
chromosome 21q22.3 was carried out (Tazi-Ahnini et al., 2002). It was found that the 
frequency of the rare allele, 961G, was 0.08 in the control group. In the most severe form of 
disease and in alopecia areata overall, there was a significant increase in frequency of this 
allele to 0.2 and 0.13 respectively. Furthermore, possession of the AIRE 961G allele was shown 
to increase the risk of the most severe form of alopecia areata, and of early disease onset at 
the age of 30, by a factor of 3. A more recent genome-wide association study of 1054 cases 
and 3278 controls has identified 139 single nucleotide polymorphisms significantly associated 
with alopecia areata (Petukhova et al., 2010).
Hirsutism
Hirsutism refers to excessive growth of hair, on the body of a woman, in the normal post-
pubertal male pattern (Fig 1.6) (Azziz, 2003). This should not be confused with hypertrichosis 
which simply refers to the excess of hair, in males or females, in a normal pattern of 
distribution. Cultural interpretations of excess hair greatly differ and reports of hirsutism 
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consequently vary between around 1.2% and 9% (Dawber and Sinclair, 2001; Lowenstein, 
2006). 
Although hirsutism may be idiopathic, conditions involving excessive hair growth are 
associated with excess androgen production (Simpson and Barth, 1997). With respect to 
androgenetic alopecia, the effect of androgens is paradoxical as in hirsutism, they result in the 
transformation of vellus hairs to terminal hairs.  The most common condition associated with 
excess androgen production resulting in hirsutism is polycystic ovarian syndrome (Bardin and 
Lipsett, 1967; Ehrmann, 2005; Franks, 1989; Rosenfield, 2005). 
1.9 Treatment of disorders of hair growth.
Treatment of all medical conditions may be broadly classified as conservative, medical or 
surgical. Conservative treatment strategies may include hair style modification, hair pieces or 
wigs where scalp hair is sparce, or bleaching, regular shaving or cutting, waxing, electrolysis or 
the more recent approach of laser treatment of hair where it is over prevalent (Martin et al., 
2008; Tanzi et al., 2003). Furthermore, patients who are psychologically affected by their 
appearance may benefit from hypnosis (Willemsen et al., 2010), counselling or from joining 
support groups or societies where they may share their experience with others who suffer 
with a similar condition (alopecia UK - www.alopeciaonline.org.uk, national alopecia areata 
foundation - www.naaf.org, polycystic ovarian syndrome UK - www.pcos-uk.org.uk).  Current 
pharmacological treatments do not achieve ideal control of hair loss even in common 
conditions like androgenetic alopecia or alopecia areata (Garg and Messenger, 2009; Rogers 
and Avram, 2008). The development of novel therapies is hampered by the lack of suitable hair 
loss model systems in animals or human beings (Randall et al., 2003). The most common 
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medical treatment for hair loss is minoxidil (Messenger and Rundegren, 2004), which can 
affect all intermediate hair follicles, further suggesting that these follicles would be a useful 
model for further study. 
Androgenetic Alopecia
There are currently 2 medical treatments widely used in androgenetic alopecia. Although some 
hair regrowth may occur with use, they may be of more benefit in prevention of disease 
progression. Minoxidil is a non-hormonal treatment, initially used as an antihypertensive agent 
in the early 1970s, but was unacceptable due to its side effect of stimulating unwanted 
hypertrichosis. It was found to reverse the balding process amongst users (Zappacosta, 1980). 
The mechanism of action of minoxidil on hair growth was unclear, however it possesses 
vasorelaxant properties via the opening of adenosine triphosphate sensitive potassium 
channels (Messenger, 2008). Potassium channels have regulatory sulfonylurea receptors (SUR) 
and pore-forming subunits (Kir) (Nichols, 2006). In a study of human hair follicles in organ 
culture in the absence of insulin, minoxidil stimulated the proportion of cultured hair follicles 
remaining in anagen over the course of 9 days, an effect inhibited by the potassium channel 
blocker tolbutamide (Shorter et al., 2008). Furthermore, molecular biology and 
immunohistochemical approaches illustrated that the SUR2B and Kir6.1 genes and proteins 
were expressed in the dermal papilla and dermal sheath, whilst SUR1 and Kir6.2 genes and 
proteins were expressed in the hair matrix. This evidence is supportive of the action of 
minoxidil on potassium channels directly within the hair follicle. Although well tolerated, side 
effects of minoxidil may include skin irritation, hair overgrowth, nausea, vomiting and weight 
gain, although systemic side effects are limited due to its use as a topical application. 
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Finasteride is a competitive, 5α-reductase type 2 inhibitor that prevents the conversion of 
testosterone to its more active metabolite 5α-dihydrotestosterone. This results in decreasing 
the progression of hair loss and promoting hair regrowth, particularly in males under the age 
of 42 suffering with stage II to V hair loss (Fig 1.9) (Kaufman et al., 1998). A more recent study 
of 416 males examined the efficacy of dutasteride, which inhibits both type 1 and 2 5α-
reductases, against finasteride and placebo (Olsen et al., 2006). Dutasteride increased hair 
numbers after treatment, compared to both finasteride and placebo, particularly between 12-
24 weeks. Clinical trials examining the side effects of finasteride in the treatment of 
androgenetic alopecia in males have demonstrated an increased risk of sexual dysfunction by a 
factor of almost 2 (Drake et al., 1999; Kaufman et al., 1998). In a study of 3 large randomised 
placebo-controlled trials examining the effects of dutasteride on benign prostatic hyperplasia, 
the incidence of side effects were minimally increased by <5% with respect to impotence, 
ejaculation disorders, decreased libido and gynaecomastia (Andriole et al., 2004). Surgical 
treatments have evolved from more invasive procedures such as scalp reduction (excising bald 
areas) and rotational flaps, to more specialist procedures such as individual follicle 
transplantation from occipital scalp to balding areas (Salanitri et al., 2009; Toscani et al., 2009).
Alopecia areata
There is no recommended definitive treatment for alopecia areata and strategies employed 
vary (Epstein, 2001), however a recent review of current evidence-base for treatments has 
been published (Garg and Messenger, 2009). Minoxidil is also used, however very few papers 
exist to support this. An early modified cross over study of 30 patients with alopecia areata 
and totalis, found that 21 of 26 patients who received topical minoxidil responded with some 
hair regrowth, however only in 15 patients was this response cosmetically acceptable (Fenton 
and Wilkinson, 1983). In a later study of 66 patients with alopecia areata, 1% minoxidil and 5% 
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minoxidil topical treatments were compared (Fiedler-Weiss, 1987). In patients with extensive 
(≥75%) hair loss, terminal hair regrowth was observed in 81% of patients using the 5% 
preparation, versus 38% of patients using the 1% preparation. Despite these results, many 
other studies around the same time did not show any significant benefit of minoxidil 
treatment for alopecia areata (Fransway and Muller, 1988; Tosti et al., 1986; Vestey and Savin, 
1986). 
The British Association of Dermatologists published guidelines in 2003 that addressed the 
quality of evidence supporting various treatments (MacDonald Hull et al., 2003). Evidence in 
support of treatment was graded A (good in favour), B (fair in favour), C (poor in favour), D 
(fair against) and E (good against). Intralesional corticosteroids and contact sensitisation 
treatment using immunomodulators such as dinitrochlorobenzene and 
diphenylcyclopropenone were graded B. Topical corticosteroids, systemic corticosteroids, 
minoxidil and psoralen ultraviolet A therapy (PUVA) were graded C. Despite this, most 
treatments are confounded by side effects and consequently none is ideal (Freyschmidt-Paul 
et al., 2008). Intralesional injection of corticosteroids may be both painful and result in skin 
atrophy. Mild eczema, pruritis, vesicular or bullous reactions, urticaria, erythema multiforme 
and skin pigmentary changes have all been described with use of immunomodulators, 
however these are usually well tolerated in all but 2-5% of patients (Freyschmidt-Paul et al., 
2003; Freyschmidt-Paul et al., 2001). Long term use of systemic corticosteroids are associated 
with Cushing’s syndrome and PUVA therapy increases the risk of skin malignancies. 
Hirsutism
Treatment of hirsutism will largely depend on the cause of the disease, however iatrogenic 
causes will require more conservative approaches as discussed earlier in this section. Adrenal, 
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ovarian and pituitary causes of hirsutism rely on the use of both corticosteroids, to suppress 
adrenal activity, and anti-androgens, to block the effects of androgens on target hair follicles
(Camacho-Martinez, 2008). Glucocorticoids such as dexamethasone may be taken orally in 
order to suppress testosterone production, the adrenal production of dehydroepiandrosterone 
and to suppress production of Δ-4-androstenedione in ovarian tumours (Camacho, 2001). 
Eflornithine 13.9% may be used as a topical treatment for hirsutism as it irreversibly inhibits 
the enzyme ornithine decarboxylase that is involved in hair growth (Azziz, 2003; Shapiro and 
Lui, 2001). It may be particularly useful as an adjunct for hirsutism when used with systemic 
medications, laser therapy or photoepilation (Blume-Peytavi and Hahn, 2008).
Cyproterone acetate and spironolactone are commonly used drugs with anti-androgen 
properties (Barth et al., 1989; Shapiro and Lui, 2005). Cyproterone acetate is an anti-androgen 
that prevents binding of 5α-dihydrotestosterone to its corresponding androgen receptor. 
Reported side effects include fatigue, decreased libido, weight gain and mood disturbances 
(Camacho-Martinez, 2008). Spironolactone is a potassium sparing diuretic that acts by 
antagonising aldosterone, however it also possesses anti-androgen properties. Side effects 
include lethargy, nausea, vomiting, gynaecomastia, menorrhagia, headaches and 
hyperkalaemia (Spritzer et al., 2000). As a treatment modality, anti-androgens are further 
confounded by the fact that they may take months to have an effect on hair growth, there may 
only be partial improvement and there is a risk of feminisation in the male foetus (Hughes and 
Cunliffe, 1988). 
Finasteride may also be used in the treatment of hirsutism and it has been addressed in a 
recent systematic review and meta-analysis of anti-androgen therapy randomised controlled 
trials (Swiglo et al., 2008). It was found that evidence was weak in support of the use of anti-
androgens in hirsutism, although combination therapy of either spironolactone or finasteride 
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in combination with oral contraceptives was superior to that of monotherapy with oral 
contraceptives or metformin. The Endocrine Society has recently published clinical guidelines 
for the treatment of hirsutism in pre-menopausal females (Martin et al., 2008). Based on a 
systematic review of available evidence, recommendations include the initial testing of 
patients for elevated androgen levels and the implementation of cosmetic therapy. Where 
cosmetic therapy has been unacceptable, oral contraceptives are recommended, adding an 
anti-androgen after 6 months if a suboptimal response is observed. With respect to hair 
removal treatments, laser therapy & photoepilation are recommended. A final point of note is 
that as with all medical treatments used for androgen dependent hair disorders, treatment 
must be continued in order to maintain a satisfactory outcome (Sinclair et al., 1999).
Despite the widespread psychological distress experienced by patients with disorders of hair 
growth, no pharmacological treatment is particularly effective. There is real potential to 
discover a highly effective treatment, however our understanding of hair follicle biology and 
the actions of androgens on it is limited. This, in combination with the additional issue of 
accounting for the differences between androgen sensitive and insensitive hair follicles, 
confounds our ability to study specific models of hair growth. Furthermore, changes in the 
legislation of human tissue harvesting and processing (Human Tissue Act 2004 –
www.hta.gov.uk) have lead to stricter protocols being implemented by institutions prior to 
collection of skin samples, thus decreasing their availability. These protocols include stricter 
collection processes and auditing of consent forms that must be filled in by the donor prior to 
tissue donation.   
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1.10 Investigative methodology of hair follicle function.
Specific examples of methodologies employed to investigate hair follicle function, have been 
discussed throughout sections 1.1 to 1.9. These studies may be broadly classified as human or 
animal, in vivo or in vitro. The pros and cons of these methodologies will be discussed below.  
Human versus animal studies
Clearly, when investigating human hair follicles, the ideal study model will involve human
subjects or harvested human tissue. There are however, a number of issues surrounding the 
use of human subjects in research. Ethical issues regarding this methodology are governed by 
the Human Tissue Act 2004. The fundamental principles of this act include respectful and 
dignified treatment of all bodies, body parts and tissue, such that dignity and respect are 
maintained throughout the research process. Furthermore, beneficence, non-malfeasance, 
informed consent and confidentiality must be adhered to, throughout all human research 
studies. 
The principles of beneficence and non-malfeasance (do good and do no harm), encompass 
many important issues relating to human research. The research should be scientifically sound, 
focused and with a beneficial question to be answered. Careful assessment of benefits and 
risks of the research must be undertaken prior to the start of the study, such that any potential 
hazards to the human participant are predictable and not unacceptable. Finally, the research 
should be undertaken by a professional body of investigators, within a professional 
environment with adequate facilities. Once these issues have been addressed in the research 
design, obtaining human tissue is the next key step.
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Section 32 of the Human Tissue Act 2004 outlines that it is an imprisonable offence to obtain 
any human transplant tissue, by commercial means. This limits the availability of human tissue, 
as it may only be obtained from willing anonymised patients that have been specifically 
consented for a particular area of research participation, in an informed manner. Although 
these guidelines are fundamental with respect to ethical research on human tissue, they 
present a wealth of practical difficulties with respect to obtaining human samples. For 
example, within the National Health Service, operating lists are often over-booked, thus 
limiting time availability to obtain patient consent for research. Furthermore, patients may 
consider it to be inappropriate for a surgeon to obtain consent for research, prior to 
undergoing a procedure that may have a serious impact on morbidity or mortality. 
Animal studies have a number of benefits over human studies, although there are                  
still ethical issues to consider which are governed by The Home Office 
(http://www.homeoffice.gov.uk/science-research). There are currently 3 licenses that may be 
obtained with respect to animal research. A Personal Licence may be issued to an 
appropriately trained individual, with the expertise to look after the research animals properly. 
A Project Licence may be issued to a researcher who is able to justify the use of animal models, 
over any other experimental models, for a particular area of research, where the methodology 
has been fully refined and optimised. A Certificate of Designation may be issued to an 
individual who is then responsible for ensuring that all aspects of the research and research 
environment are properly maintained. The holder must also ensure that all staff are 
appropriately trained and that unauthorised procedures are not undertaken. 
Once these ethical issues have been addressed, animals may provide a large volume of 
research material for research groups. Animals with genetic abnormalities may be selectively 
bread and those without genetic abnormalities may be manipulated by radiation or chemical 
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mutagenesis in order to answer specific research questions. For example, studies of mice with 
genetic hair abnormalities have been employed for years (Gaskoin, 1856; Kiso et al., 2009; 
Sundberg et al., 1999). Finally, the use of transgenic technology in animal study models, has 
allowed for targeted mutagenesis resulting in predictable phenotypes that may be rapidly 
compared with specific human genes, hence furthering our understanding of the genetic basis 
of hair growth and disorders (Randall et al., 2003). 
Despite their uses, the drawbacks of animal studies include an inability to directly apply 
findings to human beings. This is due to the fact that animal biophysiology is distinct from 
human biophysiology. Furthermore, human beings have lost a primary function of hair that 
other mammals still retain. We refer to human beings as ‘naked apes’ as human hair no longer 
has major thermoregulatory properties (Randall et al., 2003). These inter-species differences 
are typified by the fact that androgens have a vastly different effect on human hair follicles at 
different body sites, an aspect that is limited to only a few other mammals e.g. a lion’s mane, 
and no laboratory animals (Sections 1.6 & 1.8).
In vivo versus in vitro studies 
Human in vivo studies of hair follicles, their cells and associated functions, would require 
manipulation and observation within a living subject. These studies are therefore either 
impractical or limited by ethical constraints as discussed earlier in this section. Only non-
invasive observational study designs, such as those relating to seasonal changes in hair follicle 
growth, will be appropriate (Randall and Ebling, 1991). For this reason, animal models, 
particularly involving mice and rats, are a predominant feature of invasive in vivo study designs 
(Amoh et al., 2009; Jahoda et al., 1984; Nakayama et al., 2009).
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One might consider in vivo studies to be ‘better’ than in vitro studies, owing to the fact that 
any responses are within an almost normal biophysiological environment. For example, pelage 
development has been observed in adult spiny mice, after injection with a course of oestrogen 
or testosterone (Martin-Dennis and Peitz, 1981). After injection, steroid hormones will be 
absorbed and metabolised by pathways that are native to these mice, after which a response 
may be seen. In this early experiment, it was demonstrated that males completed their adult 
pelage faster than males after injection with both hormones, whilst female pelage 
development was delayed after injection with testosterone. Although animal in vitro models 
may offer a greater indication of what natural responses occur within a particular experimental 
design, they do not resolve the issues relating to inter-species differences. 
Human in vitro models resolve the issues relating to inter-species differences, however they 
may at best only offer an indication of what happens in vivo. There are several key 
methodologies involved in human in vitro models relating to hair follicles, their cells and 
associated functions. Cell culture experiments may give rise to many primary cultures of a 
variety of cell types that are contained within the hair follicle. These individual cell types may 
then be studied, either with or without manipulation, or even re-implanted in vivo (Lin et al., 
2008; Roh et al., 2008). There are however issues relating to in vitro cell culture experiments 
that may include a short lifespan of populations of cultured cells and removal from an 
environment that allows for normal nutrition, inter-cellular interactions and regulatory factors 
(Randall et al., 2003).
Whole organ culture may overcome a few of the issues posed by cell culture experiments. 
Although in vitro cultured hair follicles also have a relatively short lifespan and are removed 
from their normal environment, they retain all cell types that interact within the hair follicle 
itself and may also synthesise new hair. These properties allow for manipulation of whole 
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organ culture conditions in order to observe effects on the hair follicle, such as after 
supplementation of culture media with IGF-I, TGF-β1 or T3/T4 (Philpott et al., 1990; Philpott et 
al., 1994b; van Beek et al., 2008). Clearly no ethical methodology is ideal with respect to the 
study of hair follicle function and this must be carefully considered when designing or 
interpreting studies. In many cases, functional studies should be supplemented with other 
experimental techniques, such as those that involve the extraction of genetic material, 
immunohistochemistry or histological staining, in order to assist in the understanding of why 
functional outcomes have been observed  (Shorter et al., 2008).      
1.11 Aims and objectives.
The overall aim of this research was to develop a new human hair follicle model which would 
be more clinically-relevant than the current large terminal scalp follicles. Terminal hair follicles 
producing large, pigmented hairs are, except for in hirsutism, not the clinical target, but rather 
the hoped-for end point of treatment. A human model based on smaller follicles would be 
more relevant. Since tiny vellus follicles are both very difficult to study due to their size and 
also may have additional complications involving inflammation, intermediate follicles were 
selected. Intermediate follicles are those midway between tiny vellus follicles and large 
terminal ones and therefore should be able to respond to appropriate stimulation by increased 
growth, at least in vivo.   
Ideally, a practical model should be manipulatable in vitro so the hair follicle organ culture 
approach developed by Philpott et al (1990) seemed appropriate. Since androgens are the key 
regulator of normal human hair growth (Randall, 2007) and are implicated in two of the major 
clinical disorders, androgenetic alopecia and hirsutism (Sections 1.8 & 1.9), an ideal model 
would involve follicles which can respond to androgens. Therefore, intermediate follicles from 
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the preauricular region of adult women were selected as the most promising target. In men, 
these follicles respond to male levels of androgens to form terminal hairs as part of the beard.
To investigate the potential of pre-auricular intermediate hair follicles and characterise the 
model involved five main aims. The first was to establish that there were differences between 
the intermediate and terminal follicles in vivo. This involved two main objectives initially. The 
first objective was to characterise histological differences between matched human female 
Caucasian pre-auricular terminal and intermediate hair follicles. The second objective was to 
investigate morphological differences between both hair follicle types using quantitative 
morphometric analysis, also considering the correlations between dermal papilla size and hair 
follicle length, fibre diameter, connective tissue sheath diameter and bulb diameter.
The second aim was to establish whether the small intermediate follicles could be successfully 
isolated and grown in organ culture and, if so, to establish any differences between terminal 
and intermediate hair follicles over 9 days of organ culture, considering all aspects of growth 
including percentage of follicles remaining in anagen, cumulative growth, daily absolute 
growth and total hair fibre production. 
The third aim was to determine whether intermediate follicles could respond to physiological 
levels of testosterone in organ culture through a receptor-mediated mechanism and if so 
whether this also involved metabolism of testosterone to 5α-dihydrotestosterone. The initial 
objective of this was to investigate the effect of 10nM testosterone on terminal and 
intermediate hair follicle growth in organ culture. The next objective was to investigate 
whether the effects of testosterone involved action via the androgen receptor by blocking the 
androgen receptor during organ culture, using cyproterone acetate. 
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With the aim of supporting any biological effect in culture by establishing the presence of the 
androgen receptor in the intermediate hair follicles and further extending their comparison 
with terminal follicles, the androgen receptor protein was investigated and localised by 
immunohistochemistry techniques, and its gene expression confirmed using both reverse 
transcription polymerase chain reaction (RT-PCR) and quantitative real time polymerase chain 
reaction (qPCR) methodologies in both terminal and intermediate hair follicles. The next 
objective was to investigate whether any effects of testosterone involved metabolism by the 
enzyme 5α-reductase to the more potent androgen, 5α-dihydrotestosterone, in organ culture
by using a 5α-reductase inhibitor, finasteride. Again to support this, the location of 5α-
reductase was also to be investigated by immunohistochemistry, and gene expression by 
qPCR. 
The final aim was to confirm differences in overall gene expression between matched terminal 
and intermediate hair follicles by gene microarray analysis which should reflect further in vivo
differences between the two follicle types. In particular, the keratins, androgen receptor and 
5α-reductase type 2 genes were to be considered to support the morphological and androgen 
responsive differences seen in vivo between the two types of follicles.
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SECTION 2
MATERIALS & METHODS 
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2. MATERIALS & METHODS
2.1 Histological analysis.
2.1.1 Skin sample collection.
Human facelift skin samples were collected from 5 healthy Caucasian females, aged 40-66 
years. Appropriate ethical permission (CSS–E1) and informed consent was obtained prior to 
the procedure (Figs 2.1 & 2.2). Collection, storage and processing of all samples was 
undertaken according to Human Tissue Act guidelines (2004). Terminal and intermediate hair 
bearing skin from the pre-auricular region of the face & scalp was collected at the time of 
elective private surgery (non-NHS) in a 50ml Falcon tube containing 25mls of transport media. 
Transport media consisted of William’s E medium (Sigma-Aldrich Ltd, Dorset, UK) 
supplemented with 10 units/ml penicillin (Sigma-Aldrich Ltd, Dorset, UK), 100ng/ml 
hydrocortisone (Sigma-Aldrich Ltd, Dorset, UK), 10µg/ml insulin (Sigma-Aldrich Ltd, Dorset, UK) 
and 2mM L-glutamine (Gibco, Paisley, UK). The samples were transported to the laboratory at 
4oC and microdissected immediately.
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Fig 2.1: Photograph of freshly harvested human facelift skin (superior view). 
Figure 2.2: Photograph of freshly harvested human pre-auricular facelift skin (vertical cross section). 
The epidermis, dermis & subcutaneous fat layers are clearly visible. Obliquely orientated hair follicles 
and associated fibres can also be seen. Taken at 6.5X magnification under a dissecting microscope.
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2.1.2 Poly-l-lysine coating of slides.
Twin frost glass slides (76 x 26 x 1 mm; BDH, Lutterworth, UK) were initially coated in poly-l-
lysine (Sigma-Aldrich Ltd, Dorset, UK) to help sections adhere to the slides. Slides were placed 
into a slide carrier & cleaned in pyrogen detergent (Diversey Lever Ltd, Northampton, UK) with 
distilled water for 20 minutes. The slides were then thoroughly rinsed in distilled water, to 
remove any remaining detergent, prior to being immersed in absolute ethanol (Sigma-Aldrich 
Ltd, Dorset, UK) for 5 minutes. Following this, the slides were dried in a drying cupboard at 
60oC, prior to being immersed in 10% poly-l-lysine in distilled water for 5 minutes. Finally, the 
slides were allowed to dry overnight in a drying cupboard at 60oC and were then stored at 
room temperature until required.  
2.1.3 Preparation of frozen tissue sections.
Fresh skin samples were cut, with a size 10 scalpel, into small pieces, no larger than 4mm x 
4mm in the intended sectioning plane. This was to minimise tissue shredding throughout the 
sectioning process. These pieces were then submerged in OCT (Raymond A Lamb, USA) and 
stored at -20°C until required. 
Frozen sections were prepared using a cryostat (Leica CM 1800 Cryostat, Germany). OCT was 
applied to the chuck, avoiding air bubbles, in order to create a flat base. The chuck was placed 
in the cryostat at -22°C to allow for the OCT base to freeze. Once frozen, the chuck was placed 
into the sample holder and the OCT base was sliced until perfectly level. Skin samples were 
removed from OCT and carefully mounted on to the chuck to ensure that longitudinal hair 
follicle sections could be obtained. The sample was then covered with OCT and allowed to 
freeze. Sections were cut to a thickness of 5µm and carefully transferred on to poly-l-lysine 
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coated slides. These sections were viewed under a light microscope to ensure good structural 
integrity, then stored at -20°C in a slide holder wrapped in foil.
2.1.4 SACPIC staining.
Mounted frozen sections of human pre-auricular facelift skin, from 5 healthy female Caucasian 
patients (57 ± 2years; Mean ± SEM), were stained with various dyes to highlight different 
components of the hair follicle and skin as described by (Nutbrown and Randall, 1995). Stain 
preparation instructions are listed in the appendix. Slides were removed from -20°C and 
allowed to gradually defrost at room temperature in order to prevent tissue shock. Once 
defrosted, the slides were submerged in cold acetone (Fisher Scientific, Loughborough, UK) for 
15 minutes to fix the proteins. After this, the slides were rinsed twice in distilled water, prior to 
being submerged in celestine blue staining solution for 5 minutes. The slides were then rinsed 
in tap water and submerged in Gill’s haematoxylin for 5 minutes. After a further tap water 
rinse, the slides were submerged in Scott’s tap water for 2 minutes. The slides were then 
rinsed in tap water again and submerged in 2% safranin for 5 minutes. After another tap water 
rinse, the slides were submerged for 1 minute in each of the following: tap water, 70% ethanol 
and 95% ethanol in order to dehydrate the sections. The slides were then submerged in 
absolute picric acid/ethanol for 3 minutes, prior to being submerged in each of the following: 
95% ethanol, 70% ethanol and tap water for 1 minute each, to rehydrate the sections. Next, 
the slides were submerged in picro-indigo carmine for 1 minute and then rinsed in tap water. 
The slides were then submerged in the following: 70% ethanol, 95% ethanol and absolute 
ethanol for 5 minutes each to dehydrate the sections. The sections were then cleared by 
placing the slides in histoclear:ethanol (50:50 v/v), then absolute histoclear (National 
Diagnostices, Hull, UK) for 4 minutes each. Finally the sections were covered using histomount 
(VWR International, Leicester, UK) and coverslips (VWR International, Leicester, UK).  
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2.2 Morphometric analysis.
2.2.1 Skin microdissection & hair follicle isolation.
Individual hair follicles were isolated by microdissection for morphometric analysis. Sterile 
material and equipment were used throughout the microdissection process. Tissue and hair 
follicle manipulation and dissection was performed under a Leica MZ8 dissecting microscope, 
using fibre optic illumination to avoid overheating the tissue. Phosphate buffered saline (PBS) 
in a sterile 60mm diameter plastic Petri dish, kept on ice, was used as the dissecting medium. A 
scalpel with a size 10 blade was used to cut the skin samples into 5mm x 5mm pieces. 
Matched terminal and intermediate hair fibres were identified and differentiated by their 
outward body appearance as discussed in section 1.2. By carefully following the fibre inferiorly 
towards the epidermis, combined with careful dissection of the epidermis, dermis and 
subcutaneous fat using a scalpel with a size 10 blade and fine tipped (size 5) microdissecting 
forceps, terminal and intermediate hair follicles were extracted and placed into separately 
labelled 60mm diameter Petri dishes. Using a second pair of fine tipped (size 5) microdissecting 
forceps, the subcutaneous fat was gently teased away from the hair follicles. The follicles were 
cleaned by gently stripping any remaining dermis or subcutaneous fat away using two, 27.5 
gauge sterile syringe needles (Tyco health care Ltd, Gosport, UK). 
2.2.2 Morphometric analysis.
Two hundred and fifty terminal (25 per sample) and intermediate (25 per sample) hair follicles, 
from 5 healthy Caucasian patients (age range 45-66 years), were measured after isolation. The 
following parameters were obtained: length below the skin surface, bulb diameter at the level 
74
of Auber’s line (Auber, 1952), dermal papilla diameter at the level of Auber’s line, hair fibre 
diameter at the level of the epidermis and connective tissue sheath diameter at the level of 
the dermal-fat junction. Measurements of the hair follicles, still submerged in sterile PBS in the 
60mm diameter Petri dish, were achieved using a Leitz Labovert inverted microscope fitted 
with an eyepiece graticule and set to phase contrast illumination. Measurements relating to 
hair follicle length below the skin surface, were taken in a standardised manner at 50X 
magnification and then converted to µm by comparison with a stage micrometer; 3.5 graticule 
units were equivalent to 1mm. All other measurements were taken in a standardised manner 
at 400X magnification and then converted to µm by comparison with a stage micrometer; 2.8 
graticule units were equivalent to 0.1mm. 
Statistics
Hair follicle morphometry data, for terminal versus intermediate hairs, were analysed using 
the paired t-test analysis option in SPSS. The relationships between dermal papilla size and all 
other measurements, taken at morphometric analysis, for both terminal and intermediate hair 
follicles were also compared by Pearson's correlation coefficient analysis in SPSS. Parametric 
statistical analyses were undertaken after confirming that data were normally distributed, 
using the Kolmogorov-Smirnov test.
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2.3 Organ culture.
2.3.1 Skin sample collection.
Human facelift skin samples were collected from 6 healthy Caucasian females, for each 
experimental question (Table 2.1), according to the methodology outlined in 2.1.1. 
Table 2.1: Age ranges of subjects according to experimental question.
Experimental Question Age of Subjects
(Mean ± SEM)
Do intermediate hair follicles exhibit differences to terminal hair follicles in 
organ culture?
59 ± 3 years
Does testosterone stimulate intermediate or terminal hair follicle growth 
in organ culture at physiological levels? 
59 ± 3 years
Do the effects of testosterone involve the androgen receptor? 57 ± 3 years
Do the effects of testosterone require metabolism of testosterone by 
5α-reductase?
65 ± 2 years
2.3.2 Skin microdissection & hair follicle isolation. 
Matched terminal and intermediate anagen hair follicles were isolated from each skin sample 
under a Leica MZ8 dissecting microscope. Sterile conditions were adhered to throughout the 
microdissection process. PBS in a sterile 60mm diameter plastic Petri dish, kept on ice, was 
used as a dissecting medium. A scalpel with a size 10 blade was used to cut the skin samples 
into 5mm x 5mm pieces. The initial dissection technique involved removal of the epidermis 
and upper dermis with a horizontal, transdermal incision. After this, anagen hair follicles were 
gently teased out from the subcutaneous fat layer, through the dermal layer, using fine tipped 
(size 5) microdissecting forceps, taking special care in ensuring that the follicles remained 
intact to optimise successful culture conditions (Philpott et al., 1990). 
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This methodology was later altered to accommodate for the delicate nature of the 
intermediate hair follicles, which did not grow under culture conditions when teased through 
the dermal layer. Instead, matched terminal and intermediate hair follicles were 
microdissected from the side of the skin sample, holding the sample at the level of the 
epidermis or dermis. This enabled maximum manipulation of the tissue, without causing any 
trauma to the hair follicles below the level of the sebaceous glands. Using a second pair of fine 
tipped (size 5) microdissecting forceps, the subcutaneous fat and dermis were gently teased 
away from the hair follicles. Once the hair follicles were exposed, with satisfactory length to 
allow for growth in culture media, they were cut with a sharp pair of microdissecting scissors. 
Care was taken to resist the urge to microdissect intermediate hair follicles to a level in the 
dermis that approached the sebaceous glands. Doing this invariably resulted in over 
manipulation and damage as evident by unsuccessful culture. Once free, the isolated, 
undamaged anagen hair follicles were transferred into a fresh, sterile Petri dish containing 
sterile PBS, kept on ice. Any remaining dermis or subcutaneous fat was gently stripped from 
the follicle using two, 27.5 gauge sterile syringe needles (Tyco health care Ltd, Gosport, UK). 
2.3.3 Culture medium preparation.
All culture media were prepared under sterile conditions using a laminar flow cabinet. Prior to 
use, to ensure sterility, all culture media was then put through a sterile 0.2µm pore filter 
(Sarstedt, Nümbrecht, Germany). This was achieved by attaching the pore filter to a 50ml 
syringe, pre-filled with media. The media was then flushed through the pore filter and 
collected in a 50ml Falcon tube. After pore filtration, 1ml of sterile culture medium was used 
for each hair follicle and transferred to a 24-well plate (Corning Inc). Culture media preparation 
was according to experimental question as follows:
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Do intermediate hair follicles exhibit differences to terminal hair follicles in organ culture?
Matched terminal and intermediate hair follicles were cultured in normal culture medium to 
compare their growth under standard conditions. Normal culture conditions were achieved 
using William’s E medium (with 10µg/ml phenol red), supplemented with 10units/ml penicillin, 
100ng/ml hydrocortisone, 5µg/ml insulin, 2mM L-glutamine and 0.001% Dimethyl Sulphoxide 
(DMSO; Sigma-Aldrich Ltd, Dorset, UK).
Does testosterone stimulate intermediate or terminal hair follicle growth in organ culture at 
physiological levels?
Matched terminal and intermediate hair follicles were cultured in either ethanol control 
medium to account for the ethanol vehicle required to dissolve the testosterone, or a 
physiologically-relevant level of testosterone-containing medium to determine whether 
testosterone affected growth in organ culture of either intermediate or terminal hair follicles. 
Ethanol control culture conditions were achieved by supplementing normal culture medium 
with 0.0001% ethanol. Testosterone culture conditions were achieved by supplementing 
normal culture medium with 10nM testosterone (Sigma-Aldrich Ltd, Dorset, UK) diluted in 
ethanol. The low testosterone concentration was achieved using a serial dilution technique 
starting with a 5M solution comprising 360.5mg testosterone (FW = 288.42) dissolved in 250ml 
100% ethanol.
Do the effects of testosterone involve the androgen receptor?
Androgens classically act via binding to the androgen receptor (Section 1.6). To confirm 
androgen effects are working via this mechanism, experiments were carried out to determine 
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whether the anti-androgen cyproterone acetate could prevent androgen stimulation or cause 
any effects alone. Matched terminal and intermediate hair follicles were cultured in media 
supplemented by 0.0001% ethanol, 1µM cyproterone acetate, 10nM testosterone or 1µM 
cyproterone acetate + 10nM testosterone. Ethanol and testosterone culture conditions were 
as previously described. Cyproterone acetate culture conditions were achieved by 
supplementing 0.0001% ethanol medium with 1μM cyproterone acetate (Sigma-Aldrich Ltd, 
Dorset, UK) diluted in ethanol. Cyproterone acetate + testosterone culture conditions were 
achieved by supplementing 10nM testosterone culture medium with 1μM cyproterone acetate 
diluted in ethanol. These low concentrations were achieved using a serial dilution technique
starting with a 1mM solution comprising 104.23mg cyproterone acetate (FW = 416.94)
carefully dissolved in 250ml 100% ethanol. 
Do the effects of testosterone require metabolism of testosterone by 5α-reductase?
Since some tissues need to metabolise 5α-dihydrotestosterone for them to have an effect 
(Section 1.6), whether or not this is necessary for terminal and intermediate pre-auricular 
follicles was investigated by adding a 5α-reductase type 2 inhibitor, finasteride, alone and in 
combination with testosterone. Matched terminal and intermediate hair follicles were 
cultured in either0.0001% ethanol (control), 40ng/ml finasteride, 10nM testosterone and 
40ng/ml finasteride + 10nM testosterone. Ethanol and testosterone culture conditions were as 
previously described. Finasteride culture conditions were achieved by supplementing 0.0001% 
ethanol medium with 40ng/ml finasteride (Sigma-Aldrich Ltd, Dorset, UK) diluted in 100% 
DMSO. Finasteride + testosterone culture conditions were achieved by supplementing 10nM 
testosterone culture medium with 1μM finasteride diluted in ethanol. The low finasteride 
concentration, based on therapeutic plasma concentrations reported by Merck 
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(www.merck.com), was achieved using a serial dilution technique starting with a 53.7mM 
solution comprising 20mg finasteride (FW = 372.55) diluted in 1ml 100% DMSO.
2.3.4 Maintaining optimum culture conditions.
Under sterile conditions, each clean, isolated, undamaged, anagen hair follicle was carefully 
transferred to an individual well of the 24-well plate, containing 1ml of appropriate culture 
medium. The hair follicles were incubated in a 5% CO2 and 95% air atmosphere, in a humidified 
incubator at 37°C, for 9 days. To ensure adequate nutrition and antibiotic prophylaxis, media 
were carefully changed every 3 days in a laminar flow cabinet, ensuring that the follicles were 
neither lost nor damaged during the process. 
2.3.5 Culture process & monitoring.
Matched, anagen terminal and intermediate hair follicles were microdissected from human 
pre-auricular facelift skin from healthy Caucasian females. To address each experimental 
question, samples from 6 subjects (Table 2.1) were microdissected to obtain matched terminal 
(20 per sample for each culture condition) and intermediate (15 per sample for each culture 
condition) hair follicles. Therefore, 90 terminal and 120 intermediate hair follicles were 
dissected for each of the culture conditions previously outlined in section 2.3.3. A greater 
number of intermediate hair follicles were dissected in order to compensate for their fragility 
and increased risk of not growing, with respect to their matched terminal counterparts.
Over the course of the culturing process, hair follicles were measured at the same time daily. 
This was necessary to ensure that a daily growth rate could be calculated as accurately as 
possible. Measurements of the hair follicles, still submerged in culture medium in the 24-well 
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plate, were achieved using a Leitz Labovert inverted microscope fitted with an eyepiece 
graticule. Measurements were taken in a standardised manner at 50X magnification and then 
converted to mm by comparison with a stage micrometer, where 3.5 graticule units were 
equivalent to 1mm. Evidence of hair follicle growth and morphology was photographically 
documented daily using a Nikon Coolpix 4500 digital camera. The overall increase in hair 
follicle length over time, was calculated by subtracting the initial length of the follicle from the 
length of the follicle on the subsequent day of measurement. Non-viable follicles were classed 
as those that did not display any increase in length after 3 days incubation in culture medium 
and were discounted from the experiment. Hair follicles that entered catagen, as indicated by 
separation of the dermal papilla from the hair matrix, were recorded and discounted from 
further growth measurements and excluded from cumulative and daily growth analyses, 
however they were included for percentage anagen and total hair fibre production analyses.
Statistics
Data for mean terminal and intermediate hair follicle sample growth within the first 3 days, 
under normal, ethanol control and testosterone culture conditions, were analysed using Chi² 
tests and the statistical software package SPSS. Data for the mean percentage of terminal and 
intermediate hair follicle samples remaining in anagen over 9 days under normal, ethanol 
control and testosterone culture conditions were analysed using the analysis of variance 
(ANOVA) test. Mean hair follicle organ culture data for terminal and intermediate hair follicle 
samples, were analysed using the paired t-test analysis option in SPSS. Parametric statistical 
analyses were undertaken after confirming that data were normally distributed, using the 
Kolmogorov-Smirnov test.
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2.4 Immunohistochemistry.
2.4.1 Sample collection & processing.
Human pre-auricular facelift skin samples were collected from 5 healthy Caucasian females, 
aged (Mean ± SEM) 52 ± 3years (localisation of the androgen receptor) and 53 ± 3years
(localisation of 5α-reductase type 2). Skin sample collection (Section 2.1.1), poly-l-lysine 
coating of slides (Section 2.1.2) and preparation of frozen tissue sections (Section 2.1.3) were 
all undertaken using previously outlined methodology. In addition 3 male Wistar albino rats of 
the species Rattus norvegicus were dissected and processed for use as positive controls for 
androgen receptor localisation by immunohistochemistry.
2.4.2 Androgen receptor & 5α-reductase antibodies.
Antibodies were specifically chosen against the androgen receptor and 5α-reductase to 
localise these molecules in the hair follicle by immunohistochemistry. The technique was 
initially repeated to establish optimum primary antibody concentrations, carefully avoiding 
excess that resulted in background staining, particularly with intermediate hair follicles. The 
concentration of blocking and diluting solutions of horse serum or mouse serum (Sigma-
Aldrich Ltd, Dorset, UK) were also optimised in the same manner, specific to each set of 
antibodies. Primary antibodies were incubated at 4oC and all other incubations were 
performed at room temperature (25oC), using a histology wet box to prevent evaporation.
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2.4.3 Localisation of androgen receptor expression by immunohistochemistry.
Human frozen pre-auricular facelift skin and rat prostate sections were immunostained for the 
androgen receptor. Slides were fixed in Zamboni’s fixative at room temperature (25oC) for 10 
minutes to fix proteins, washed in sterile PBS for 10 minutes and then dried. The histological 
sections were circled with a Vector ImmEdge Pen (Vector Laboratories, Peterborough, UK), 
producing an encircling hydrophobic ring to contain and thereby reduce the volumes of 
required antibody. Sections were incubated in 0.3% (v/v) hydrogen peroxide (Sigma-Aldrich 
Ltd, Dorset, UK) in methanol (Fisher Scientific, Loughborough, UK) for 30 minutes, blocking 
endogenous peroxidase activity, then washed in sterile PBS for 5 minutes. Permeabilisation 
was achieved using 0.1% Triton X100 at 4oC for 10 minutes, followed by a wash in sterile PBS 
for 5 minutes. 
Binding of non-specific protein was blocked by incubating the histological sections in 5% (v/v) 
horse serum in sterile PBS for 20 minutes. Two 5 minute washes in sterile PBS were then 
carried out to remove any remaining excess serum. The sections were incubated with the 
primary antibody, mouse monoclonal androgen receptor antibody (NCL-AR-318, Novocastra, 
Leica Biosystems Newcastle Ltd, UK), overnight at 4oC. Antibody dilution was 1:50 with 1.5% 
(v/v) horse serum in sterile PBS.
After overnight primary antibody incubation, the histological sections were washed twice in 
sterile PBS for 10 minutes each, to remove any excess primary antibody, in preparation for
secondary antibody incubation. The sections were incubated in 5μg/ml biotinylated anti-
mouse IgG secondary antibody (raised in horse) (Vector Laboratories BA-2001, Peterborough, 
UK) for 30 minutes, to detect the primary antibody, followed by 3 washes in sterile PBS for 5 
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minutes each. This was followed by incubation in ExtraAvidin® Peroxidase (Sigma-Aldrich Ltd, 
Dorset, UK) for 30 minutes and washing in PBS twice for 10 minutes. 
3-amino-9-ethylcarbazole (AEC) substrate (Vector Laboratories, Peterborough, UK) was applied 
as a chromogen to allow visualisation antibody binding locations. A positive result was 
indicated by a reddish-brown staining reaction, observed under a light microscope, which was 
interrupted by placing the slides in distilled water once sufficient colour had developed. The 
sections were then mounted with aqueous mountant, Aquamount (VWR International, 
Leicester, UK), and left to dry overnight before clear nail varnish (Laval, UK) was applied 
around the edges of the coverslips to prevent evaporation of the aquamount. 
Several control methods were utilised in order to exclude non-specific binding. Initially, the 
primary antibody was exchanged with 1.5% (v/v) mouse serum in sterile PBS to ensure that the 
secondary antibody was not binding non-specifically to tissue in the absence of the primary 
antibody. The rest of the procedure was then followed to detect the presence of any non-
specifically bound secondary antibody. Following this control, the secondary antibody was 
exchanged with PBS to ensure that the primary antibody or potential contaminants were not 
activating the AEC solution in the absence of secondary antibody. The final control exchanged 
both primary and secondary antibodies with 1.5% (v/v) mouse serum in sterile PBS and sterile 
PBS. This ensured that there was no endogenous peroxidase activity remaining in the tissue 
which could activate the AEC.
Histological sections were examined using a Nikon Eclipse 80i microscope; photographic 
documentation was obtained and electronically stored using ACT-2U software (Nikon, Surrey,
UK). 
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2.4.4 Localisation of 5α-reducatase expression by immunohistochemistry.
Immunostaining of human hair follicles for 5α-reductase was carried out using the 
methodology described in section 2.4.2, with two notable alterations. Firstly, the primary 
antibody used was goat IgG polyclonal 5α-reductase 2 (N-14) (SC-20400, Santa Cruz 
Biotechnology, Inc., Heidelberg, Germany).  To account for this, 5% (v/v) and 1.5% (v/v) mouse 
serum in sterile PBS were used in place of horse serum for blocking of non-specific protein 
binding and primary antibody preparation. The primary antibody was used at a 1:50 dilution 
with 1.5% (v/v) mouse serum in sterile PBS. Secondly, the biotinylated secondary antibody 
used was monoclonal anti-goat/sheep IgG-biotin antibody (raised in mouse) (Sigma-Aldrich 
Ltd, Dorset, UK). 
2.5 Reverse transcription polymerase chain reaction (RT-PCR).
2.5.1 Sample collection & processing.
In order to investigate the expression of the androgen receptor gene in matched terminal and 
intermediate hair follicles, RT-PCR was performed. Human facelift skin samples were collected 
from 5 healthy Caucasian females, aged (Mean ± SEM) 60 ± 3years, according to the 
methodology outlined in section 2.1.1, except that samples were transported in RNALater® 
(Sigma-Aldrich Ltd, Dorset, UK). Skin microdissection & matched hair follicle isolation was 
performed as outlined in section 2.3.2, except that only lower follicles (60 terminal and 80 
intermediate per matched sample) were microdissected and then stored in 100μl of 
RNALater® (Sigma-Aldrich Ltd, Dorset, UK) in a 1ml Eppendorf tube (Alpha Laboratories, Ltd, 
Eastleigh, UK) on ice. In addition, 3 male Wistar albino rat prostates of the species Rattus 
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norvegicus were dissected (40g per sample) and processed for use as positive controls for 
androgen receptor gene expression.
2.5.2 Total RNA extraction.
Matched terminal and intermediate hair follicle samples and rat prostate samples were initially 
drained of excess RNALater® in preparation for total RNA extraction using the GenElute 
Mammalian Total RNA kit (Sigma-Aldrich Ltd, Dorset, UK), in accordance with manufacturer’s 
instructions. All samples were separately transferred into glass homogenisers containing 500µl 
lysis solution and 5µl of 2-mercaptoethanol solution. Samples were vigorously homogenised 
for 15 minutes until no visible matter remained. The homogenate was then transferred to a 
GenElute filtration column and centrifuged (Eppendorf 5415 R) at 13000g centrifugal force for 
2 minutes, removing cellular debris and shearing DNA. Next, the filtration column was 
discarded, and an equal volume of 70% ethanol (made using 0.05% (v/v) DEPC treated water) 
was added to the filtered lysate for thorough mixing using a vortex. Following this, the 
lysate/ethanol mixture was transferred to a GenElute binding column and centrifuged for 15 
seconds at 13000g centrifugal force to bind the RNA to the column. After discarding the flow 
through, the binding column with bound total RNA was replaced back into the collection tube 
for repetition of this step with any remaining lysate/ethanol mixture. 
The binding column was then transferred to a new collection tube and washed by adding 500µl 
of wash solution 1 and centrifuging for 15 seconds at 13000g centrifugal force. The column 
was then transferred to another new collection tube. A second wash was carried out by adding 
500µl of wash solution 2 to the binding column, centrifuging for 15 seconds at 13000g 
centrifugal force and discarding the flow-through. After placing the binding column back into 
the same collection tube, ethanol was removed and the binding column dried by adding a 
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further 500µl volume of wash solution 2, centrifuging for 2 minutes and transferring the 
binding column to a new collection tube. 
To elute the total RNA from the binding column, 50µl of elution solution was added to the 
centre of the binding column and centrifuged for 1 minute, followed by repetition of this step 
to produce 100μl of flow through containing purified total RNA. This was collected and either 
used immediately for quality checking and poly(A)+RNA extraction or stored at -80°C until 
further required.
2.5.3 Agarose gel electrophoresis of total RNA.
To check the quality of total RNA, extracted total RNA samples were analysed by 1.5% agarose 
gel electrophoresis. Agarose (1.5 g) (Invitrogen Ltd, Paisley, UK) was completely dissolved in 
100mls of 1X tris-acetate-EDTA buffer (appendix) by using a 950W Proline Microchef ST44 
microwave on power 7 for 135. After cooling to around 50°C, 25µl ethidium bromide (1 mg/ml; 
Sigma-Aldrich Ltd, Dorset, UK) was added to the gel and gently mixed to avoid creating air 
bubbles. The gel was carefully poured into plastic gel trays containing well-forming gel combs, 
and left to set for 45 minutes. Once the mixture had set, gel combs were carefully removed 
and the gel (with gel-tray) submerged in an electrophoresis tank containing 300 µl 1X TAE 
buffer with 75µl 0.5 µg/ml ethidium bromide. A 10µl aliquot of total RNA from each sample 
was mixed with 2µl of blue/orange 6X loading dye (ratio 5:1) (Promega, Southampton, UK), to 
assist loading and monitoring of the migration of total RNA within the gel during 
electrophoresis, and then carefully loaded into the gel. 
The electrophoresis tank was set to 100 volts for approximately 30 minutes or until adequate 
migration through the gel had occurred. The UVItec gel documentation system (UVItec 
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Limited, Cambridge, UK) was used to visualise total RNA at 312nm wavelength and the images 
were captured and stored for further analysis.
2.5.4 Poly(A)+ RNA isolation.
The GenElute mRNA Miniprep kit (Sigma-Aldrich Ltd, Dorset, UK) was used in accordance with 
manufacturer’s instructions to isolate poly(A)+ RNA from total RNA samples. Total RNA samples 
were brought up to a volume of 250µl using RNase-free water, then mixed with 250µl 2X 
binding solution and 15µl oligo (dT) beads before mixing thoroughly using a vortex. The 
samples were then incubated at 70°C for 3 minutes to denature the total RNA, then left to cool 
at room temperature for 10 minutes. Samples were then centrifuged for 2 minutes at 13000 x 
g centrifugal force, forming pellets of oligo (dT) beads:poly(A)+ RNA complexes. The 
supernatant was discarded and the pellets resuspended in 500µl of wash solution using a 
vortex. The suspension was transferred to a spin filter/collection tube and centrifuged for 2 
minutes at 13000g and the flow through discarded. The column containing the oligo (dT) 
beads:poly (A)+ RNA complex was washed again by repeating this process. The column was 
then transferred into a fresh collection tube and 50µl pre-warmed elution solution (70°C) was 
added to the centre of the filter, incubated at 70°C for 5 minutes, followed by centrifugation 
for 1 minute. The elution procedure was repeated with an additional 50µl elution solution. The 
isolated poly(A)+ RNA was either used immediately for DNase treatment or stored at -80°C until 
further required.
2.5.5 DNase treatment of poly(A)+ RNA samples.
To remove any potential contaminating genomic DNA prior to cDNA synthesis by reverse 
transcription, all mRNA samples were treated with the dideoxynuclease I (DNase I) enzyme. A 
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0.5 ml eppendorf tube (Alpha Laboratories, Ltd, Eastleigh, UK) was used for each sample 
reaction mix. Mixtures consisted of 8µl poly(A)+ RNA, 1µl DNase I amplification grade and 1µl 
10X reaction buffer (Invitrogen Ltd). These were mixed thoroughly using a vortex mixer and 
incubated for 15 minutes at room temperature. To inactivate the DNase enzyme, 1µl EDTA 
(25mM; Invitrogen Ltd) was added followed by incubation at 65°C for 10 minutes. The DNase 
treated poly(A)+  RNA was stored on ice for immediate cDNA synthesis. 
2.5.6 Synthesis of cDNA by reverse transcription.
The DNase treated poly(A)+RNA samples were converted to cDNA using the Avian 
Myeloblastosis Virus (AMV) reverse transcription system (Promega, Southampton, UK). 
Reaction mixes were individually prepared in 0.5ml Eppendorf tubes (Alpha Laboratories) on 
ice, containing 1µl oligo (dT)15 primer (0.5µg/µl; Promega), 2µl dNTP mix (10mM; Promega), 
2µl 10X reaction buffer (Promega), 0.5µl recombinant RNasin® ribonuclease inhibitor 
(40units/µl; Promega) and 0.75µl AMV reverse transcriptase (high concentration 25units/µl, 
Promega). The mix was then brought up to a final volume of 10µl via the addition of 3.75µl 
nuclease-free water.  
After thorough mixing using a vortex mixer, the reaction mix was added to a 0.5ml Eppendorf 
tube containing 10µl of DNase treated poly(A)+RNA, and mixed again. The Eppendorf tubes 
were placed into a PCR Sprint thermal cycler (Thermo Hybaid, Ashford, UK) and set to run a 
reverse transcription program as follows: incubation for 1 hour at 42°C to allow cDNA 
synthesis from mRNA by reverse transcription, followed by 5 minutes incubation at 99°C to 
inhibit the action of reverse transcriptase with a final 5 minutes at 4°C to allow cooling. The 
cDNA was either used immediately for reverse transcription PCR, or stored at -80°C until 
further required.
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2.5.7 Primers for androgen receptor reverse transcription PCR.
The β-actin primer set used for positive control gene expression has previously been used for 
human hair follicle cDNA (Shorter et al., 2008) and was slightly modified from an existing 
established primer set (Merrick, 2000). The primer set used for detection of androgen receptor 
gene expression was used in previous PhD research (Croft, 2002). Prior to use, these primers 
were cross referenced with the programmes NCBI Primer Blast and Ensembl Genomic Browser, 
to confirm that they were appropriate for use in both rat and human samples, and to confirm 
exon location and specification (Tables 2.2 – 2.4). Only one gene product was found in each 
species of appropriate size. Primers were synthesised by Sigma Genosys Biotechnologies Ltd 
(Pampisford, UK).  
Table 2.2: NCBI Blast and Ensembl Genomic Browser results for androgen receptor primers.
AR PCR Primer 
(Homo Sapiens)
Primer Sequence (5'->3') Exon Length Tm GC%
Forward AAGAGGAACAGCAGCCTTCACA 1 22 56.15 50.00%
Reverse ATGGGGCAGCTGAGTCATCCT 1 21 57.28 57.14%
AR PCR Primer 
(Rattus norwegicus)
Primer Sequence (5'->3') Exon Length Tm GC%
Forward AAGAGGAACAGCAGCCTTCACA 1 22 56.15 50.00%
Reverse ATGGGGCAGCTGAGTCATCCT 1 21 57.28 57.14%
2.5.8 Reverse transcription polymerase chain reaction (RT-PCR) protocol & statistics.   
β-actin, was first used to ensure adequate cDNA quality of each sample, as well as to check the 
PCR system. All PCR reaction mixes were prepared in 0.5ml Eppendorf tubes (Alpha 
Laboratories) on ice. Reaction mixes consisted of 2.5µl forward and 2.5μl reverse target 
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primers (10µM), 5µl 10X reaction buffer (Invitrogen Ltd), 1µl of nucleotide mix containing 
equal volumes of ATP, CTP, GTP and TTP (10mM each; Promega), 1.5µl MgCl2 (50mM; 
Invitrogen Ltd), 5µl cDNA (β-actin) / 15µl cDNA (androgen receptor) and 0.5µl recombinant Taq 
DNA polymerase (5units/µl; Invitrogen Ltd). Nuclease free water was then added to increase 
the final mixture volume to 50µl, followed by thorough mixing using a vortex mixer. Negative 
controls were prepared by replacing cDNA with nuclease free water. 
The Eppendorf tubes were then placed into a PCR Sprint thermal cycler (Thermo Hybaid, 
Ashford, UK) and set to run reverse transcription PCR programmes according to the primers
(Table 2.5). To prevent evaporation of reaction components during PCR thermocycling, a drop 
of mineral oil (Sigma-Aldrich Ltd, Dorset, UK) was added to the surface of each reaction 
mixture prior to starting the thermal cycler. The PCR products were either analysed 
immediately by agarose gel electrophoresis, or stored at -80°C until further required.
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>NM_000044.2 Homo sapiens androgen receptor (AR), transcript variant 1, mRNA
product length = 153
Forward primer  1     AAGAGGAACAGCAGCCTTCACA  22
Template        1447  .T...........A........  1468
Reverse primer  1     ATGGGGCAGCTGAGTCATCCT  21
Template        1599  .....................  1579
>NM_175038.1 Homo sapiens contactin 1 (CNTN1), transcript variant 2, mRNA
product length = 1372
Forward primer  1     AAGAGGAACAGCAGCCTTCACA  22
Template        3165  G.TG...........TG.....  3144
Reverse primer  1     ATGGGGCAGCTGAGTCATCCT  21
Template        1794  .AT.C........AA...G..  1814
>NM_001843.2 Homo sapiens contactin 1 (CNTN1), transcript variant 1, mRNA
product length = 1372
Forward primer  1     AAGAGGAACAGCAGCCTTCACA  22
Template        3198  G.TG...........TG.....  3177
Reverse primer  1     ATGGGGCAGCTGAGTCATCCT  21
Template        1827  .AT.C........AA...G..  1847
>NM_001166693.1 Homo sapiens AF4/FMR2 family, member 1 (AFF1), transcript variant 1, mRNA
product length = 4690
Forward primer  1     AAGAGGAACAGCAGCCTTCACA  22
Template        6115  .TA.A.....CA.C........  6094
Reverse primer  1     ATGGGGCAGCTGAGTCATCCT  21
Template        1426  C.A.TA........C.....A  1446
>NM_005935.2 Homo sapiens AF4/FMR2 family, member 1 (AFF1), transcript variant 2, mRNA
product length = 4687
Forward primer  1     AAGAGGAACAGCAGCCTTCACA  22
Template        6223  .TA.A.....CA.C........  6202
Reverse primer  1     ATGGGGCAGCTGAGTCATCCT  21
Template        1537  C.A.TA........C.....A  1557
>NM_015082.1 Homo sapiens follistatin-like 4 (FSTL4), mRNA
product length = 3961
Forward primer  1    AAGAGGAACAGCAGCCTTCACA  22
Template        585  .......T..C.GT.A.C....  606
Reverse primer  1     ATGGGGCAGCTGAGTCATCCT  21
Template        4545  .G...TG..A..G.......A  4525
>NM_201431.1 Homo sapiens Ras association (RalGDS/AF-6) domain family member 6 (RASSF6), 
transcript variant 2, mRNA
product length = 557
Reverse primer  1    ATGGGGCAGCTGAGTCATCCT  21
Template        664  C.....AGT...GT.......  644
Reverse primer  1    ATGGGGCAGCTGAGTCATCCT  21
Template        108  .GC.CC........C...G..  128
Table 2.3: NCBI Primer Blast results for androgen receptor primers, compared against the 
human genome (Homo sapiens). 
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>NM_012502.1 Rattus norvegicus androgen receptor (Ar), mRNA 
product length = 153
Forward primer  1     AAGAGGAACAGCAGCCTTCACA  22
Template        1262  .G....................  1283
Reverse primer  1     ATGGGGCAGCTGAGTCATCCT  21
Template        1414  .....................  1394
>NR_027839.1 Rattus norvegicus ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 
(Atp2a2), transcript variant 1, non-coding RNA 
product length = 3105
Forward primer  1     AAGAGGAACAGCAGCCTTCACA  22
Template        5455  GT.T........T.G..G....  5434
Reverse primer  1     ATGGGGCAGCTGAGTCATCCT  21
Template        2351  .GC.....T.C........A.  2371
>NM_001110139.2 Rattus norvegicus ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 
(Atp2a2), transcript variant 2, mRNA 
product length = 1697
Forward primer  1     AAGAGGAACAGCAGCCTTCACA  22
Template        4047  GT.T........T.G..G....  4026
Reverse primer  1     ATGGGGCAGCTGAGTCATCCT  21
Template        2351  .GC.....T.C........A.  2371
>NM_053605.1 Rattus norvegicus sphingomyelin phosphodiesterase 3, neutral (Smpd3), mRNA 
product length = 1411
Forward primer  1     AAGAGGAACAGCAGCCTTCACA  22
Template        1918  .GCT...G.......A.....T  1939
Reverse primer  1     ATGGGGCAGCTGAGTCATCCT  21
Template        3328  T........GCA...GT....  3308
>NM_001037363.1 Rattus norvegicus leucine rich repeat neuronal 1 (Lrrn1), mRNA
product length = 1731
Forward primer  1    AAGAGGAACAGCAGCCTTCACA  22
Template        454  T.......A.T...AT....G.  475
Reverse primer  1     ATGGGGCAGCTGAGTCATCCT  21
Template        2184  TG.T.T........C....T.  2164
Table 2.4: NCBI Primer Blast results for androgen receptor primers, compared against the rat 
genome (Rattus norvegicus). 
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Table 2.5: Forward and reverse primers and thermal cycler program settings used in reverse 
transcription PCR analysis of β-actin and androgen receptor gene expression.
Gene Primer Sequence (5'->3') Thermal Cycler Settings Expected 
Amplicon 
Size
β-actin Forward:
ATCTGGCACCACACCTTCTACAATGAGCTGCG 
Reverse:
CTCATACTCCTGCTTGCTGATCCACATCTGC 
(Shorter et al., 2008)
94oC - 5 min
94oC - 1 min
56oC - 1 min
72oC - 1 min
72oC - 10 min
4oC (hold)
838bp
Androgen 
Receptor
Forward:
AAGAGGAACAGCAGCCTTCACA
Reverse:
ATGGGGCAGCTGAGTCATCCT
(Croft, 2002)
95oC - 5 min
95oC - 1 min
65oC - 1 min
72oC - 1 min
72oC - 11 min
4oC (hold)
153bp
2.5.9 Agarose gel electrophoresis of PCR products.
Agarose gel electrophoresis was performed to analyse the reverse transcription PCR products, 
by separating them using a 1.5% (w/v) agarose gel as previously described in section 2.5.3, 
with a few alterations. Firstly, 30μl aliquots from all PCR product samples were mixed with 
blue/orange 6X loading dye (Promega, Southampton, UK) (ratio 5:1) to assist loading and 
monitoring. An additional well was loaded with DNA ladder (10μl) (Promega, Southampton, 
UK), consisting of eleven DNA fragments that range in size from 100–1,500bp, mixed with 2µl 
of loading dye in order to allow estimation of product size. 
2.5.10 Sequencing of RT-PCR products.
The identity of androgen receptor PCR products, of expected amplicon size, were verified using 
a commercial company (Geneblitz, Sunderland, UK) for sequencing. The PCR products were 
run in an agarose gel, using the same methodology as outlined in section 2.5.9, except that low 
35
Cycles
35
Cycles
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melting point agarose gel (Invitrogen Ltd) was used to separate the PCR products. This was to 
allow for the use of a lower temperature when subsequently dissolving the gel after 
electrophoresis and purifying the extracted PCR products to prevent further DNA degradation. 
The MinElute Gel Extraction kit (Qiagen, Crawley, UK) was used, according to manufacturer’s 
instructions, to purify the androgen receptor PCR products prior to sending for sequencing. A 
UV-light source (UVitec) was used to visualise the separated product band within the gel size 
(153bp). The target DNA fragment was excised using a scalpel blade, and transferred to an 
empty pre-weighed 1.5ml Eppendorf tube. This was then re-weighed to obtain the net weight 
of the gel. To dissolve the gel slice, 3 volumes of Buffer QC was added per gel volume (e.g. 
150µl of Buffer QC to 50mg of gel).  The tube was incubated at 50°C for 10 minutes and mixed 
every 3 minutes during this time using a vortex. After the gel was fully dissolved, 1 volume of
isopropanol (Sigma-Aldrich Ltd) was added, and mixed by inversion. 
Next, the sample was added to a MinElute column and centrifuged at 13000g centrifugal force 
for 1 minute to bind the DNA to the column, discarding the flow-through.  A further 500µl of 
Buffer QC 500 were added to the column and the process repeated.  The column was placed 
back in the collection tube, incubated by adding 750µl of Buffer PE for 5 minutes at room 
temperature and washed by centrifuging for 1 minute at 13000g centrifugal force, discarding 
the flow-through. The column was centrifuged for another minute and the flow-through 
discarded again to remove any residual ethanol. The MinElute column was placed into a clean 
1.5ml Eppendorf tube, 10 µl of Buffer EB was added to the centre and then the column was 
incubated at room temperature for 1 minute prior to centrifuging at 13000g centrifugal force 
for 1 minute to elute the purified DNA from the column. The purified PCR product was sent 
with 20 µl of appropriate forward and reverse primers (10µM) for sequencing at Geneblitz 
(Sunderland, UK).
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To compare the homology of the sequencing result to the known published sequences, the 
NCBI BLAST program was used.  The chromatogram of the generated sequencing data was 
visualised using the software Chromas Lite v2, thus allowing further analysis of any non-
matching nucleotides between the sequenced and known data. In the chromatogram, each 
base was allocated a different colour, and the sequence determined by the highest peak. If 
more than one peak is of a similar height, without significant distance, then the base is 
reported as ‘N’. Hence, through visual analysis of the chromatogram, sequenced data could be 
more accurately interpreted.  
2.6 Quantitative real-time polymerase chain reaction (qPCR).
2.6.1 Sample collection, processing & total RNA extraction.
In order to quantify the expression of the androgen receptor and 5α-reductase type 2 genes in 
matched terminal and intermediate hair follicles, qPCR was performed. Human facelift skin 
samples were collected from 5 healthy Caucasian females, aged (Mean ± SEM) 60 ± 3years
(androgen receptor gene expression) and 60 ± 3years (5α-reductase type 2 gene expression). 
Collection, skin microdissection and hair follicle isolation were all performed according to the 
methodology outlined in section 2.5.1. 
2.6.2 Total RNA extraction, quality check, poly(A)+ RNA conversion & cDNA synthesis.
Total RNA extraction was carried out according to the methodology outlined in section 2.5.2, 
using the same number of follicles as previously described. The total RNA concentration and 
purity of all samples were checked using using a NanoDrop 2000 (Thermo Scientific, USA), 
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according to manufacturer’s instructions, prior to conversion to cDNA and analysis in triplicate 
by qPCR. Measurement of total RNA concentrations enabled standardisation of the amounts of 
total RNA used for conversion to cDNA. In all samples, total RNA 260:280nm wavelength 
absorbance ratios were checked to ensure adequate purity (normal = 2.0, according to 
manufacturer’s instructions). Poly(A)+ RNA conversion, DNase treatment of poly(A)+ RNA 
samples and synthesis of cDNA by reverse transcription were all performed according to the
methodology outlined in sections 2.5.4-2.5.6.
2.6.3 Primer choice & design for quantitative real time polymerase chain reaction (qPCR).
Androgen receptor primers were chosen from previously published literature (Bièche et al., 
2001). The primer set for detection of 5α-reductase type 2 (SRD5A2) gene expression was 
newly designed using the NCBI Primer Blast program, ensuring human specificity (Tables 2.6 & 
2.7). All primer sets were cross referenced with the human genome, using Ensembl Genomic 
Browser to establish their exon position (Table 2.8). Forward and reverse primers, for 
detection of 5α-reductase gene expression were selected within exons 2 (forward) and 5 
(reverse) (Table 2.6). Effort was made to ensure that G-C nucleotide percentages were kept to 
around 60% or below, and that the expected product length was suitable for qPCR (<200bp). 
Primers were synthesised by Sigma Genosys Biotechnologies Ltd (Pampisford, UK).  
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>NM_000044.2 Homo sapiens androgen receptor (AR), mRNA 
product length = 168
Forward primer  1     CCTGGCTTCCGCAACTTACAC  21
Template        3285  .....................  3305
Reverse primer  1     GGACTTGTGCATGCGGTACTCA  22
Template        3452  ......................  3431
>NM_000348.3 Homo sapiens steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid 
delta 4-dehydrogenase alpha 2) (SRD5A2), mRNA 
product length = 112
Forward primer  1    ACCCTGATGGGTGGTACACAGAC  23
Template        478  .......................  500
Reverse primer  1    GGCTTCCTGAGCTGGCGCAAT  21
Template        589  .....................  569
>NM_001145140.1 Homo sapiens chromosome X open reading frame 49 (CXorf49), mRNA 
product length = 698
Reverse primer  1    GGCTTCCTGAGCTGGCGCAAT  21
Template        813  ........TC.T..CG....A  793
Reverse primer  1    GGCTTCCTGAGCTGGCGCAAT  21
Template        116  ....G..C.GA.......C..  136
>NM_001145139.1 Homo sapiens chromosome X open reading frame 49B (CXorf49B), mRNA 
product length = 698
Reverse primer  1    GGCTTCCTGAGCTGGCGCAAT  21
Template        813  ........TC.T..CG....A  793
Reverse primer  1    GGCTTCCTGAGCTGGCGCAAT  21
Template        116  ....G..C.GA.......C..  136
Table 2.6: NCBI Primer Blast results for the androgen receptor gene qPCR primer set.
Table 2.7: NCBI Primer Blast results for the 5α-reductase type 2 gene qPCR primer set.
Table 2.8: Androgen receptor (AR) and 5α-reductase (SRD5A2) qPCR primer sets, including 
exon position. 
AR qPCR
Primer
Sequence (5'->3') Exon Length Tm GC%
Forward CCTGGCTTCCGCAACTTACAC 4 & 5 21 56.04 57.14%
Reverse GGACTTGTGCATGCGGTACTCA 6 22 57.27 54.55%
SRD5A2 qPCR
Primer
Sequence (5'->3') Exon Length Tm GC%
Forward ACCCTGATGGGTGGTACACAGAC 2 23 57.74 56.52%
Reverse GGCTTCCTGAGCTGGCGCAAT 5 21 60.05 61.90%
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2.6.4 Quantitative real time polymerase chain reaction (qPCR) protocol & statistics.   
Reaction mixtures were prepared in triplicate for terminal and intermediate hair follicles and 
rat prostate cDNA samples. Each reaction mix consisted of 12.5μl 1X iQ SYBR Green Supermix 
(Bio-Rad Laboratories, California, USA), 0.25μl forward and 0.25μl reverse primers, 11μl H2O 
and 1μl cDNA. β-actin primers were used as for control conditions. Amplification was 
performed using a Bio-Rad iCycler thermal cycler (Bio-Rad Laboratories, California, USA), for all 
samples in triplicate. Prior to recording and analysing output data, melt curves were examined, 
ensuring similar morphology within triplicate samples, indicating that contamination, 
mispriming or primer-dimer artefact was unlikely. Additionally, melt peaks were analysed, 
ensuring the presence of tall narrow peaks of similar morphology within triplicate samples, 
indicating that in each case, the gene of interest was amplified, rather than primer-dimers that 
produce broad low peaks. 
Thermal cycler program settings were optimised, by modifying a previously published set 
(Bièche et al., 2001). An initial denaturation step (95oC for 5 minutes) was programmed, 
followed by amplification consisting of 50 cycles of denaturation (95oC for 15 seconds), 
annealing (65oC for 1 minute) and elongation (72oC for 15 seconds). Following amplification, 
melt curves were generated by gradual heating of qPCR products from 60oC to 90oC. 
Expression of the control gene β-actin was used for normalisation of output data. 
Statistics
Relative differences in expression between samples were calculated using the program Gene 
Expression Macro (Bio-Rad Laboratories, California, USA) and ΔΔCt method.
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2.7 Comparison of intermediate and terminal hair follicles by gene microarray analysis.
2.7.1 Skin sample collection & processing.
In order to compare the differences in gene expression between matched terminal and 
intermediate hair follicles, preparation of total RNA for commercial gene microarray analysis 
(University of Sheffield Medical School Research Unit - Eu25) was performed. Human facelift 
skin samples were collected from 15 healthy Caucasian females, aged 54-86 years. Collection, 
skin microdissection and hair follicle isolation were all performed according to the 
methodology outlined in section 2.5.1, except that 30 intermediate and 20 terminal lower hair 
follicles were dissected per individual. Terminal and intermediate hair follicles were then 
pooled into 6 (3 terminal and 3 intermediate) matched samples, each from 5 subjects with the 
following ages (Mean ± SEM); sample 1 = 63 ± 3years, sample 2 = 67 ± 5years, Sample 3 = 58 ±
1 year. 
2.7.2 Total RNA extraction & preparation for gene microarray analysis.
Total RNA extraction was carried out according to the methodology outlined in section 2.5.2. 
The total RNA concentration and purity of all samples were checked using a NanoDrop 2000 
(Thermo Scientific, USA), according to the manufacturer’s instructions. All samples were 
required to have total RNA concentrations ≥35ng/μl for further processing and gene 
microarray analysis. In all samples, total RNA 260:280nm wavelength absorbance ratios were 
checked to ensure adequate purity (normal = 2.0, according to manufacturer’s instructions). 
Samples were then sent for commercial gene microarray analysis at the University of Sheffield
Medical School Research Unit (Eu25) and were re-checked for quantity, quality and purity 
using an Agilent 2100 Bioanalyzer (Agilent Technologies, USA). The Affymetrix GeneChip® 
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Human Exon 1.0 ST Array and GeneChip® WT Sense Target Labeling Assay (Affymetrix, 
California, USA) for genome-wide, exon-level expression were used for microarray analysis. 
The chips were hybridised in the Affymetrix GeneChip® Hybridisation Oven 640 with post-
hybridisation washing and staining performed using the Affymetrix GeneChip® Fluidics Station 
450 and scanning using the Affymetrix GeneChip® Scanner 3000 7G Upgrade.
Statistics
Results were all provided by the University of Sheffield Medical School Research Unit (Eu25) 
and were initially normalised using the manufacturer’s software (Affymetrix, California, USA), 
then analysed using the paired t-test analysis option in SPSS. Parametric statistical analyses 
were undertaken after confirming that data were normally distributed, using the Kolmogorov-
Smirnov test.
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SECTION 3
RESULTS
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3. RESULTS
3.1 Are there histological differences between intermediate and terminal hair follicles?
Histological staining of human pre-auricular facelift skin, illustrated the structure of a thin 
epidermis (dark blue stain), with a thick collagen dermis (blue stain), overlying a subcutaneous 
fat layer (grey) (Fig 3.1). With respect to the inner root sheath, Huxley’s layer (red stain) and 
Henley’s layer were both visualised (intermediate blue/green stain). The connective tissue 
sheath stained a brighter shade of blue than the outer root sheath (Fig 3.2). The dermal papilla 
was a lightly stained grey structure with few cells, surrounded by pale blue undifferentiated 
matrix cells (Fig 3.3). The differentiated, fully keratinised cells of the hair cortex were 
conspicuously yellow (Fig 3.2). Terminal and intermediate hair follicles, with their sebaceous 
glands (dark blue edges with clear centres), were also visualised within the skin, with terminal 
hair follicles appearing longer than intermediate hair follicles (Fig 3.4).
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Figure 3.1: SACPIC stained longitudinal frozen section of human pre-auricular facelift skin showing 
terminal hair follicles penetrating through dermis and subcutaneous fat. 
Taken at 4X magnification under a light microscope.
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Figure 3.2: SACPIC stained longitudinal frozen section of terminal hair from human pre-auricular 
facelift skin. 
Hux = Huxley’s Layer, Hen = Henle’s Layer, ORS = outer root sheath, CTS = connective tissue sheath. 
Taken at 400X magnification under a light microscope.
Figure 3.3: SACPIC stained frozen section of a terminal hair follicle bulb, from human pre-auricular 
facelift skin. 
Taken at 200X magnification under a light microscope.
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Figure 3.4: SACPIC stained longitudinal frozen sections of human pre-auricular facelift skin showing 
terminal (left) and intermediate (right) hair follicles. 
Taken at 20X magnification under a light microscope.
106
3.2 Are there morphological differences between intermediate and terminal hair 
follicles?
When regions of human pre-auricular facelift skin were examined prior to microdissection, 
terminal hair fibres appeared longer, thicker and more deeply pigmented than intermediate 
hair fibres (Fig 3.5). Matched terminal and intermediate hair follicles were successfully isolated 
by microdissection and cleaned (Fig 3.6), as described in section 2.3.1, enabling morphometric 
measurements to be made on matched groups of 25 terminal and 25 intermediate hair follicles 
from each of 5 healthy Caucasian females (Table 3.1). Furthermore, terminal hair follicle bulbs 
appeared more ‘bulbous’ than intermediate hair follicles.     
Figure 3.5: Photographs of dissected human pre-auricular skin from the same individual. 
Left = terminal hair follicles visible. Right = single intermediate hair follicle visible. Taken at 32X 
magnification under dissecting microscope.
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Figure 3.6: Photographs of dissected and partially cleaned, human pre-auricular terminal and 
intermediate hair follicles. 
Left taken at 32X magnification under dissecting microscope. Right taken at 125X magnification under 
inverted microscope. 
Table 3.1: Morphometric analysis of terminal (blue) and intermediate (green) hair follicles, all 
measurements given in µm. 
SEM = standard error of the mean.
Patient Age
Mean Follicle 
Length Below 
Skin Surface
(µm)
Mean Auber 
Line Bulb 
Diameter 
(µm)
Mean 
Auber Line 
Papilla 
Diameter
(µm)
Mean Hair 
Fibre 
Diameter at 
Epidermis
(µm)
Mean 
Connective 
Tissue Sheath 
Diameter at 
Dermis-Fat 
Junction (µm)
1 66 3822 2789 315 207 121 67 61 33 333 268
2 60 3222 2555 288 189 113 61 63 36 309 242
3 40 3602 2704 281 207 101 67 66 41 297 248
4 45 3454 2379 331 179 128 60 73 30 336 240
5 61 3492 2511 325 175 132 58 72 32 354 214
Mean 3518 2588 308 191 119 63 67 34 326 242
SEM 98 72 10 7 5 2 2 2 10 8
Range 2800-
4286
1914-
3171
229-
400
160-
257
69-
166
40-
94
51-
89
20-
51
237-
406
186-
343
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Intermediate hair follicles were smaller than their terminal counterparts when 25 terminal hair 
follicles were compared with 25 intermediate hair follicles from each of 5 healthy Caucasian 
females. The mean ± SEM values for intermediate hair follicle length below the skin surface, 
fibre diameter at the level of the epidermis, connective tissue sheath diameter at the dermis-
fat junction, bulb diameter at the level of Auber’s line and dermal papilla diameter at the level 
of Auber’s line, were 74 ± 0.02%, 51 ± 0.04%, 77 ± 0.04%, 65 ± 0.04% and 53 ± 0.04% of 
terminal hair follicles respectively (Fig 3.7).
Figure 3.7: Intermediate hair follicles (green) from the pre-auricular region were smaller, when 
expressed as a percentage of terminal hair follicles (blue), for hair follicle length below the skin 
surface (74 ± 0.02%,), fibre diameter at the level of the epidermis (51 ± 0.04%), connective tissue 
sheath diameter at the dermis-fat junction (77 ± 0.04%), bulb diameter at the level of Auber’s line (65 
± 0.04%) and dermal papilla diameter at the level of Auber’s line (53 ± 0.04%), for 5 individuals with 25 
follicle measurements from each hair follicle type.
Error bars for standard error of the mean are marked.
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Terminal hair follicles (3.518mm ± 0.098mm; Mean ± SEM) were significantly longer than 
intermediate follicles (2.588mm ± 0.072mm) (p=0.02), with a 95% confidence interval of 0.650-
1.210mm for the true difference between the means (Fig 3.8). They also had a significantly 
greater diameter (0.067mm ± 0.002mm) than intermediate fibres (0.034mm ± 0.002mm;
Mean ± SEM) at the level of the epidermis (p<0.001) (Fig 3.9). Terminal hair follicles (0.326mm 
± 0.008mm) had a significantly greater  connective tissue sheath diameter than intermediate 
follicles (0.242mm ± 0.007mm) at the level of the dermis-fat junction (p<0.001) (Fig 3.9). They 
also had significantly greater bulb diameters (0.308mm ± 0.010mm) than intermediate follicles 
(0.191mm ± 0.007mm) at the level of Auber’s line (p<0.001) (Fig 3.9). Terminal hair follicle 
dermal papillae (0.119mm ± 0.006mm) had a significantly greater diameter than intermediate 
follicles (0.063mm ± 0.002mm) at the level of Auber’s line (p<0.001), (Fig 3.9). 
Therefore, at the level of Auber’s line, the mean terminal hair follicle bulb diameter to dermal 
papilla diameter ratio was 2.6:1, which was significantly smaller than that of intermediate hair 
follicles, which was 3:1 (p<0.001) (Fig 3.18). The mean terminal hair follicle bulb diameter at 
the level of Auber’s line, was only 6% smaller than the corresponding mean hair follicle 
connective tissue sheath diameter at the level of the dermis-fat junction, while in intermediate 
hair follicles, the bulb diameter at the level of Auber’s line, was 21% smaller. The ratio of mean 
hair follicle dermal papilla diameter at the level of Auber’s line to mean hair fibre diameter at 
the level of the epidermis, were very similar at 1.8:1 and 1.9:1 in terminal and intermediate 
samples respectively (p=0.179).  
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Figure 3.8: Terminal hair follicles (blue) (3.518mm ± 0.098mm; Mean ± SEM) from the pre-auricular
region were significantly longer than intermediate hair follicles (green) (2.588mm ± 0.072mm) for 5 
individuals with 25 follicle measurements from each hair follicle type (p = 0.02). 
Error bars for standard error of the mean are marked.
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Figure 3.9: Terminal hair follicles (blue) from the pre-auricular region were significantly larger than 
intermediate hair follicles (green) with respect to fibre diameter at the epidermis (0.067mm ± 
0.002mm / 0.034 ± 0.002mm; Mean ± SEM : p<0.001), connective tissue sheath diameter  (0.326mm ± 
0.008mm / 0.242mm ± 0.007mm; p<0.001), hair follicle bulb diameter at the level of Auber's line 
(0.308mm ± 0.010mm / 0.191mm ± 0.007mm; p<0.001) and dermal papilla diameter at the level of 
Auber's line (0.119mm ± 0.006mm / 0.063mm ± 0.002mm; p<0.001) for 5 individuals with 25 follicle 
measurements from each hair follicle type. 
Error bars for standard error of the mean are marked.
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3.2.1 Correlations between hair follicle dermal papilla size and morphometry, for hair 
follicles from female Caucasian pre-auricular facelift skin. 
Initially, correlation analyses between dermal papilla size and other morphological parameters 
were carried out on all hair follicles. Significant positive correlations were found between hair 
follicle dermal papillae diameters at the level of Auber’s line and corresponding hair follicle 
lengths below the skin surface (r=0.72, p<0.001) (Fig 3.10), hair fibre diameters at the level of 
the epidermis (r=0.85, p<0.001) (Fig 3.11), connective tissue sheath diameters at the level of 
the dermis-fat junction (r=0.76, p<0.001) (Fig 3.12) and bulb diameters at the level of Auber’s 
line (r=0.90, p<0.001) (Figs 3.13). 
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Figure 3.10: Scatter graph showing significant correlations between dermal papilla diameter at the 
level of Auber’s line and hair follicle length below the skin surface (r=0.72, p<0.001), for 5 female 
Caucasian individuals, with 25 sets of measurements from both terminal and intermediate hair 
follicles, microdissected from pre-auricular facelift skin.
Figure 3.11: Scatter graph showing significant correlations between dermal papilla diameter at the 
level of Auber’s line and hair fibre diameter at the level of the epidermis (r=0.85, p<0.001), for 5 
female Caucasian individuals, with 25 sets of measurements from both terminal and intermediate hair 
follicles, microdissected from pre-auricular facelift skin.
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Figure 3.12: Scatter graph showing the relationship between dermal papilla diameter at the level of 
Auber’s line and connective tissue sheath diameter at the level of the dermis-fat junction (r=0.76, 
p<0.001), for 5 female Caucasian individuals, with 25 sets of measurements from both terminal and 
intermediate hair follicles, microdissected from pre-auricular facelift skin.
Figure 3.13: Scatter graph showing the relationship between dermal papilla diameter at the level of 
Auber’s line and hair follicle bulb diameter at the level of Auber’s line (r=0.90, p<0.001), for 5 female 
Caucasian individuals, with 25 sets of measurements from both terminal and intermediate hair 
follicles, microdissected from pre-auricular facelift skin.
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Since there appeared to be the possibility of 2 clear populations when these results were 
plotted as scatter graphs (Figs 3.10 - 3.13), data were stratified according to hair follicle type. 
There was no correlation between terminal hair follicle dermal papilla diameter at the level of 
Auber’s line and the length of the follicle below the skin surface (r=0.03, p=0.688) (Fig 3.14);
however there was a significant positive correlation between intermediate hair follicle dermal 
papilla diameter and follicle length (r=0.41, p<0.001) (Fig 3.14). In contrast, terminal hair 
follicle dermal papillae did have significant positive correlations with corresponding hair fibre 
diameters at the level of the epidermis (r=0.39, p<0.001) (Fig 3.15), connective tissue sheath 
diameters at the level of the dermis-fat junction (r=0.52, p<0.001) (Fig 3.16) and bulb 
diameters at the level of Auber’s line (r=0.53, p<0.001) (Fig 3.17). Significant positive 
correlations were also found for intermediate hair follicle dermal papillae and corresponding 
hair fibre diameters at the level of the epidermis (r=0.42, p<0.001) (Fig 3.15), connective tissue 
sheath diameters at the level of the dermis-fat junction (r=0.41, p<0.001) (Fig 3.16) and bulb 
diameters at the level of Auber’s line (r=0.69, p<0.001) (Fig 3.17). 
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Figure 3.14: Dermal papilla diameter at the level of Auber’s line and hair follicle length below the skin 
surface, were correlated for a: terminal (blue) (r=0.03, p=0.688) and b: intermediate (green) (r=0.41, 
p<0.001) hair follicles, for 5 female Caucasian individuals, with 25 sets of measurements from both 
terminal and intermediate hair follicles, microdissected from pre-auricular facelift skin.
a: Terminal Hair Follicles
b: Intermediate Hair Follicles 
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Figure 3.15: Dermal papilla diameter at the level of Auber’s line and hair fibre diameter at the level of 
the epidermis, were significantly correlated for both a: terminal (blue) (r=0.39, p<0.001) and b: 
intermediate (green) (r=0.42, p<0.001) hair follicles, for 5 female Caucasian individuals, with 25 sets of 
measurements from both terminal and intermediate hair follicles, microdissected from pre-auricular 
facelift skin. 
a: Terminal Hair Follicles
b: Intermediate Hair Follicles 
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Figure 3.16: Dermal papilla diameter at the level of Auber’s line and connective tissue sheath 
diameter at the level of the dermis-fat junction, were significantly correlated for both a: terminal 
(blue) (r=0.52, p<0.001) and b: intermediate (green) (r=0.41, p<0.001) hair follicles, for 5 female 
Caucasian individuals, with 25 sets of measurements from both terminal and intermediate hair 
follicles, microdissected from pre-auricular facelift skin. 
a: Terminal Hair Follicles
b: Intermediate Hair Follicles 
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Figure 3.17: Dermal papilla diameter at the level of Auber’s line and hair follicle bulb diameter at the 
level of Auber’s line, were significantly correlated for both a: terminal (blue) (r=0.53, p<0.001) and b: 
intermediate (green) (r=0.69, p<0.001) hair follicles, for 5 female Caucasian individuals, with 25 sets of 
measurements from both terminal and intermediate hair follicles, microdissected from pre-auricular 
facelift skin. 
a: Terminal Hair Follicles
b: Intermediate Hair Follicles 
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3.3 Do intermediate hair follicles exhibit differences to terminal hair follicles in organ 
culture?
Fifteen terminal and 20 intermediate hair follicles were successfully isolated for organ culture 
by microdissection (Fig 3.18) from each of 6 individuals (59 ± 3years; Mean ± SEM). Terminal 
hair follicles generally increased in length daily and maintained anagen morphology for 9 days 
in organ culture in normal culture medium. This involved growth of the hair fibre, inner root 
sheath and outer root sheath, but not the connective tissue sheath (Fig 3.19). Follicles which 
had not shown any increase in length in the first 3 days of the experiment were deemed 
damaged during isolation and not included in further experiments. Hair follicles that entered 
catagen, as indicated by separation of the dermal papilla from the hair matrix, were recorded 
and discounted from further growth measurements and excluded from cumulative and daily 
growth analyses, however they were included for percentage anagen and total hair fibre 
production analyses. 
3.3.1 Terminal and intermediate hair follicle growth in organ culture.
Intermediate hair follicles were much more difficult to isolate due to their small size and there 
were more which did not start to grow in culture (Section 3.3.2). However, those that did grow 
were able to grow similarly to terminal follicles, producing new hair fibre, inner and outer root
sheaths, but not connective tissue sheath (Fig 3.19). 
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Figure 3.18: Human terminal and intermediate hair follicles with Auber’s line marked through the 
widest diameter of the dermal papilla. 
The mean hair follicle bulb to dermal papilla ratio at this line was found to be 3:1 in terminal and 2.6:1 
in intermediate follicles. Intermediate hair follicle bulbs are seen to be more ‘tubular’ than terminal 
hair follicle bulbs, which are more ‘bulbous’. CT = connective tissue sheath, ORS = outer root sheath, 
IRS = inner root sheath. Taken at 50X magnification under a phase contrast microscope.
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Figure 3.19: Sequential photomicrographs of a terminal (upper) and an intermediate (lower hair 
follicle, over 9 days of incubation in normal culture conditions. 
CTS = connective tissue sheath, IRS = inner root sheath, ORS = outer root sheath. Taken at 50X 
magnification using an inverted microscope. 
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3.3.2 Differences between the percentage of terminal and intermediate hair follicle 
samples displaying growth within the first 3 days of culture.
Since fewer intermediate than terminal hair follicles appeared to be growing after 3 days (Fig 
3.20), this aspect was analysed. A significantly higher percentage of terminal hair follicles grew 
within the first 3 days of organ culture under normal conditions, versus intermediate hair 
follicles (86 ± 1.764% vs. 66 ± 1.764%; Mean ± SEM; p<0.001) (Fig 3.20).  
Figure 3.20: Histogram showing the mean percentage of anagen hair follicle samples that grew within 
the first 3 days of culture for 15 terminal (blue) and 20 intermediate (green) hair follicles in normal
culture conditions, from each of 6 female Caucasian individuals, microdissected from pre-auricular 
facelift skin. 
Significantly fewer microdissected intermediate hair follicles were able to grow in organ culture than 
terminal follicles isolated from the same skin samples (p<0.001). Bars for standard error of the mean 
are marked. 
***
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3.3.3 A comparison of terminal and intermediate hair follicles samples remaining in 
anagen over 9 days of organ culture under normal culture conditions.
   
A gradually decreasing proportion of both dissected anagen terminal and intermediate hair 
follicles, which actually started to grow, remained in anagen over 9 days under normal culture 
conditions i.e. a gradually increasing proportion, of terminal and intermediate hair follicles, 
entered catagen over 9 days (Fig 3.21). Interestingly, intermediate hair follicles remained in 
anagen for longer than terminal follicles, with significantly more follicles still growing at the 
end of 9 days under normal culture conditions (84 ± 0.03% vs. 74 ± 0.03%; p=0.012) (Fig 3.21).
Figure 3.21: Intermediate hair follicles (84 ± 0.03%; Mean ± SEM) remained in anagen for longer than 
terminal follicles (74 ± 0.03%), under normal culture conditions (p=0.012). 
Fifteen terminal and 20 intermediate hair follicles were cultured from each of 6 female Caucasian 
individuals, after microdissection from pre-auricular facelift skin for each sample (total 210 follicles). 
Black = terminal hair follicles. Red = intermediate hair follicles. Error bars for standard error of the 
mean are marked.
**
Terminal
Intermediate
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3.3.4 Cumulative and percentage growth of anagen terminal and intermediate hair 
follicles over 9 days under normal culture conditions.
Cumulative growth over 9 days, for both terminal and intermediate hair follicles, produced a 
sigmoid shaped curve under normal culture conditions (Fig 3.22). Terminal hair follicles grew 
significantly more (Mean ± SEM) (0.603 ± 0.025mm) than intermediate hair follicles (0.400 ± 
0.021mm) over 9 days under normal culture conditions (p<0.001) (Fig 3.22). When expressed 
as percentage growth of initial hair follicle length (Mean ± SEM), terminal hair follicles grew 
31.78 ± 0.01%, whilst intermediate hair follicles grew 22.28 ± 0.02%. 
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Figure 3.22: Terminal hair follicles (0.603 ± 0.025mm) grew more rapidly than intermediate hair 
follicles (0.400 ± 0.021mm), under normal culture conditions (p<0.001). 
Fifteen terminal and 20 intermediate hair follicles were cultured from each of 6 female Caucasian 
individuals, after microdissection from pre-auricular facelift skin (total 210 follicles). Black = terminal 
hair follicles under normal culture conditions. Red = intermediate hair follicles under normal culture 
conditions. Error bars for standard error of the mean are marked. 
***
Terminal
Intermediate
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3.3.5 Mean daily growth of terminal and intermediate hair follicle samples under normal 
culture conditions.
When cumulative growth over 9 days was plotted for both terminal and intermediate hair 
follicles, a sigmoid shaped curve was obtained under normal culture conditions (Fig 3.22). In 
contrast, when the results were plotted as mean daily growth over 9 days of culture, a
positively skewed histogram was obtained (Fig 3.23).
The pattern of growth variation was very similar between terminal and intermediate hair 
follicles with respect to mean daily growth under normal culture conditions, however terminal 
hair follicles grew faster, particularly during the early stages of culture (p=0.003) (Fig 3.23).
Mean daily growth was greatest over days 2-4 for both terminal and intermediate hair follicles 
(Figs 3.23). This supports the sigmoid nature of cumulative growth.
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Figure 3.23: Daily growth was significantly greater for human pre-auricular terminal hair follicles than 
intermediate follicles, particularly during the early stages of culture, under normal culture conditions 
(p=0.003). 
Fifteen terminal and 20 intermediate hair follicles were cultured from each of 6 female Caucasian 
individuals, after microdissection from pre-auricular facelift skin (total 210 follicles). Black = terminal 
hair follicles under normal culture conditions. Red = intermediate hair follicles under normal culture 
conditions. Error bars for standard error of the mean are marked.
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3.3.6 Mean total hair fibre production after 9 days of organ culture under normal culture 
conditions.
Total hair fibre production was significantly higher (Mean ± SEM) for terminal hair follicles 
(0.502 ± 0.028mm), than for intermediate follicles (0.357 ± 0.021mm), after 9 days under 
normal culture conditions (p<0.001) (Fig 3.24). This was calculated by including those follicles 
that had either continued to grow over the course of the experiment, or by taking the final 
length of follicles on the day that they underwent catagen-like changes.
Figure 3.24: Total hair fibre production was significantly higher for terminal follicles (0.502 ± 
0.028mm), than for intermediate follicles (0.357 ± 0.021mm), at 9 days under normal culture 
conditions (p<0.001). 
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals, after microdissection from pre-auricular facelift skin (total 210 follicles). 
Black = terminal hair follicles under normal culture conditions, Red = intermediate hair follicles under 
normal culture conditions. Error bars for standard error of the mean are marked.
***
Terminal
Intermediate
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3.4 Does testosterone stimulate intermediate or terminal hair follicle growth in organ 
culture at physiological levels?
Fifteen terminal and 20 intermediate hair follicles were successfully isolated by 
microdissection from each of 6 individuals (59 ± 3years; Mean ± SEM) for organ culture and 
growth in 0.0001% ethanol-control and 10nM testosterone-supplemented organ culture 
conditions. Follicles which had not shown any increase in length in the first 3 days of the 
experiment were deemed damaged during isolation and not included in the experiment. 
3.4.1 Testosterone effects on the percentage of terminal and intermediate hair follicle 
samples growing during the first 3 days of organ culture.
The difference between the percentage of terminal hair follicles that grew within the first 3 
days, under normal (86 ± 3.2%; Mean ± SEM) and 0.0001% ethanol control (79 ± 1.5%) culture 
conditions, was not significant (p=0.242) (Fig 3.25). Similarly, 10nM testosterone (89 ± 2.3%)
caused no significant difference (p=0.068). There were no differences in the percentage of
intermediate hair follicles that grew within the first 3 days, under normal (72 ± 2.4%) and 
ethanol control (63 ± 1.1%) culture conditions (p=0.062), nor under ethanol control and 
testosterone (74 ± 1.2%) culture conditions (p=0.158). Overall, significantly fewer intermediate 
hair follicles (70 ± 2.0%) grew within the first 3 days of organ culture compared to terminal hair 
follicles (84 ± 1.7%) (p=0.001).
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Figure 3.25: Histogram showing the mean percentage of anagen hair follicle samples that grew within 
the first 3 days of culture for 15 terminal (blue) and 20 intermediate (green) hair follicles per culture 
condition (total 210 follicles per culture condition), from each of 6 female Caucasian individuals, 
microdissected from pre-auricular facelift skin.
Significantly fewer microdissected intermediate hair follicles were able to grow in organ culture than 
terminal follicles isolated from the same skin samples (p<0.001). C = normal culture conditions, E = 
0.0001% ethanol culture conditions, T = 10nM testosterone culture conditions. Bars for standard error 
of the mean are marked. 
***
***
***
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3.4.2 Testosterone effects on the percentage of terminal & intermediate hair follicle 
samples remaining in anagen over 9 days of organ culture.
   
With respect to terminal hair follicles, there was no significant difference for the percentage 
remaining in anagen at the end of 9 days of organ culture when 0.0001% ethanol (75 ± 2.1% : 
Mean ± SEM) was added to normal culture media (74 ± 0.03%) (p=0.836). Similarly, the 
addition of 10nM testosterone had no effect (72 ± 2.0%) (p=0.977) (Fig 3.26). With respect to 
intermediate hair follicles, there was also no significant difference for the percentage 
remaining in anagen between normal culture (84 ± 0.03%) and ethanol control (81 ± 1.8%)
conditions (p=0.338) (Fig 3.27). However in marked contrast to terminal hair follicles, the 
addition of 10nM testosterone (87 ± 2.3%) resulted in a significant increase in the percentage 
of follicles remaining in anagen (p<0.001).
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Figure 3.26: Testosterone had no effect on the percentage of terminal hair follicles that remained in 
anagen. 
Fifteen terminal hair follicles, per culture condition, were cultured from each of 6 female Caucasian 
individuals (total 90 follicles per culture condition), after microdissection from pre-auricular facelift 
skin. 0.0001% ethanol control and 10nM testosterone culture conditions are shown. Error bars for 
standard error of the mean are marked.
Terminal Hair Follicles
134
Figure 3.27: Testosterone significantly increased the percentage of intermediate hair follicles that 
remained in anagen (81 ± 1.8% vs. 87 ± 2.3% : p<0.001).
Twenty intermediate hair follicles per culture condition, were cultured from each of 6 female 
Caucasian individuals (total 90 follicles per culture condition), after microdissection from pre-auricular 
facelift skin. 0.0001% ethanol control and 10nM testosterone culture conditions are shown. Error bars 
for standard error of the mean are marked.
Intermediate Hair Follicles
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3.4.3 Testosterone altered the cumulative growth of anagen intermediate, but not 
terminal, hair follicles over 9 days of organ culture. 
Cumulative growth over 9 days, for both terminal and intermediate hair follicles (Fig 3.28), 
produced a sigmoid shaped curve under both 0.0001% ethanol and 10nM testosterone culture 
conditions (Figs 3.29 - 3.30). 
There was no significant difference between mean cumulative terminal hair follicle growth at 9 
days in normal (0.603 ± 0.025mm) (Mean ± SEM) (Fig 3.22) and 0.0001% ethanol control (0.596 
± 0.023mm) (Fig 2.29) culture conditions (p=0.834). Similarly the presence of 10nM 
testosterone (0.589 ± 0.024mm) caused no difference in mean cumulative terminal hair follicle 
growth at 9 days (p=0.808) (Fig 3.29). 
In intermediate hair follicles, the mean cumulative hair follicle growth at 9 days in normal 
(0.400 ± 0.021mm) (Fig 3.22) and 0.0001% ethanol control (0.432 ± 0.022mm) (Fig 3.30) was 
also not significantly different (p=0.0.293). However, 10nM testosterone (0.589 ± 0.024mm) 
caused a highly significant increase in mean cumulative intermediate hair follicle growth at 9 
days (p<0.001) (Fig 3.30).
Interestingly, intermediate hair follicles, in the presence of 10nM testosterone, grew as fast as 
terminal follicles in 0.0001% ethanol or 10nM testosterone; the difference between mean 
cumulative terminal hair follicle growth at 9 days under 0.0001% ethanol culture conditions 
(0.596 ± 0.023mm) and mean intermediate hair follicle growth at 9 days under testosterone 
culture conditions (0.589 ± 0.024mm) was not significant (p=0.691) (Figs 3.29 & 3.30). 
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When growth was expressed as a percentage of initial hair follicle length, mean terminal hair 
follicle percentage growth was unaffected by the addition of 10nM testosterone (31.59 ± 
0.03%; Mean ± SEM), compared to 0.0001% ethanol control (29.42 ± 0.02%) culture conditions 
over 9 days of organ culture. Mean intermediate hair follicle percentage growth was 23.09 ± 
0.02% and 30.89 ± 0.01% over 9 days under 0.0001% ethanol control and 10nM testosterone 
culture conditions respectively. Hence, the addition of testosterone only had a significant 
effect on increasing the percentage growth of intermediate hair follicles in organ culture 
(p<0.001).   
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Figure 3.28: Sequential photomicrographs of a terminal (upper) and an intermediate (lower) 
hair follicle, over 9 days of incubation in 10nM testosterone culture conditions. 
CTS = connective tissue sheath, IRS = inner root sheath, ORS = outer root sheath. Taken at 
50X magnification using an inverted microscope. 
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Figure 3.29: Testosterone had no effect on the cumulative growth of human pre-auricular terminal 
hair follicles. 
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin.
0.0001% ethanol control and 10nM testosterone culture conditions are shown. Error bars for 
standard error of the mean are marked. 
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Figure 3.30: The difference between mean cumulative intermediate hair follicle growth at 9 days 
under 0.0001% ethanol (0.432 ± 0.022mm) and 10nM testosterone (0.589 ± 0.024mm) culture 
conditions was highly significant (p<0.001). 
Fifteen terminal and 20 intermediate hair follicles were cultured, per culture condition, from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. 0.0001% ethanol control and 10nM testosterone culture conditions are shown. 
Error bars for standard error of the mean are marked. 
***
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3.4.4 Testosterone altered daily growth of anagen intermediate, but not terminal, hair 
follicles over 9 days of organ culture. 
With respect to terminal pre-auricular hair follicles, there was no significant difference 
between mean daily growth, or the pattern of this growth, under normal and ethanol control 
culture conditions (p=0.833), nor did the addition of 10nM testosterone affect this (p=0.874) 
(Fig 3.31). Pre-auricular terminal hair follicle mean daily growth was also significantly affected 
by the day of culture for these conditions (p<0.001) (Fig 3.31).
With respect to intermediate pre-auricular hair follicles, there was no significant difference 
between mean daily absolute growth, or its pattern over the experiment, under normal and 
ethanol control culture conditions (p=0.145). When 10nM testosterone was added, the pattern 
remained unchanged, but there was a significant increase in intermediate hair follicle mean 
daily absolute growth (p=0.019) that was seen early over days 1-3 of organ culture (Fig 3.31). 
Pre-auricular intermediate hair follicle mean daily absolute growth was also significantly 
affected by the day of culture, for these conditions (p<0.001).
Interestingly, there was no significant difference between intermediate hair follicle mean daily 
absolute growth under testosterone culture conditions, and terminal hair follicle mean daily 
absolute growth under 0.0001% ethanol control culture conditions (p=0.858).
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Figure 3.31: Daily absolute growth on each culture day, for human pre-auricular terminal and 
intermediate hair follicles, under 0.0001% ethanol control and testosterone culture conditions. 
Fifteen terminal and 20 intermediate matched hair follicles, per culture condition, were cultured from
each of 6 female Caucasian individuals (total 210 follicles per culture condition), after 
microdissection from pre-auricular facelift skin. 0.0001% ethanol control and 10nM testosterone
culture conditions are shown. Error bars for standard error of the mean are marked.
Terminal Hair Follicles
Intermediate Hair Follicles
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3.4.5 Testosterone altered total hair fibre production of intermediate, but not terminal, 
hair follicles at 9 days of organ culture.
With respect to terminal hair follicles, there was neither a significant difference between mean 
total hair fibre production at 9 days in normal (0.502 ± 0.028mm) (Fig 3.24) and 0.0001% 
ethanol control (0.501 ± 0.028mm) (Fig 3.32) culture conditions (p=0.982), nor with the 
addition of 10nM testosterone (0.478 ± 0.026mm) (p=0.558) (Fig 3.32). With respect to 
intermediate hair follicles, there was again no significant difference between the mean total 
hair fibre production at 9 days in normal (0.357 ± 0.021mm) (Fig 3.24) and 0.0001% ethanol 
control (0.366 ± 0.024mm) (Fig 3.32) culture conditions (p=0.770). However, intermediate hair 
follicles produced significantly more hair fibre at 9 days of culture in 10nM testosterone (0.532 
± 0.027mm) culture conditions (p<0.001) (Fig 3.32).
Interestingly, hair fibre production was similar between terminal follicles under 0.0001% 
ethanol control (0.501 ± 0.028mm) culture conditions and intermediate hair follicles under 
10nM testosterone (0.532 ± 0.027mm) culture conditions (p=0.306).
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Fig 3.32: Testosterone had no effect on total hair fibre production by terminal hair follicle samples 
over 9 days of organ culture (0.478 ± 0.026mm) (p=0.558), however it increased total hair fibre 
production by intermediate hair follicle samples (0.532 ± 0.027mm) (p<0.001). 
Fifteen terminal and 20 intermediate matched hair follicles, per culture condition, were cultured from
each of 6 female Caucasian individuals (total 210 follicles per culture condition), after microdissection 
from pre-auricular facelift skin. 0.0001% ethanol control and 10nM testosterone culture conditions 
are shown. Bars for standard error of the mean are marked.
Terminal Hair Follicles
Intermediate Hair Follicles
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3.5 Do the effects of testosterone involve the androgen receptor?
3.5.1 Effects of cyproterone acetate on terminal and intermediate hair follicles in 
testosterone-supplemented culture conditions over 9 days of organ culture.   
Fifteen terminal and 20 intermediate hair follicles were successfully isolated, for each of 4 
organ culture conditions, by microdissection from each of 6 healthy female individuals (57 ± 
3years; Mean ± SEM) (total 840 follicles). Organ culture conditions were as follows: 0.0001% 
ethanol, 10nM testosterone, 1μM cyproterone acetate and 1μM cyproterone acetate + 10nM 
testosterone. Follicles which had not shown any increase in length in the first 3 days of the 
experiment were deemed damaged during isolation and not included in the experiment. 
With respect to terminal hair follicles, there was no significant difference for the percentage 
remaining in anagen between 1μM cyproterone acetate and 0.0001% ethanol culture 
conditions (82 ± 2.3% vs. 78± 2.0%; p=0.08) (Mean ± SEM) (Fig 3.33). This was also true for 
intermediate hair follicles (77 ± 2.0% vs. 80 ± 4.6%; p=0.27) (Fig 3.34). The addition of 1μM 
cyproterone acetate (81 ± 4.1%) to terminal hair follicles with 10nM testosterone (82 ± 2.3%) 
resulted in no significant difference in the percentage of follicles remaining in anagen over 9 
days of organ culture (p=0.30) (Fig 3.33). However, with respect to intermediate hair follicles 
and in marked contrast to terminal hair follicles, the addition of 10nM testosterone (88 ± 1.9%) 
to ethanol control culture conditions (78± 2.0%) caused a significant increase in the percentage 
of intermediate hair follicles remaining in anagen (p=0.04); furthermore cyproterone acetate, 
in combination with testosterone, significantly inhibited the stimulatory effects of 
testosterone culture conditions alone (74 ± 1.2% vs. 88 ± 1.9%; p<0.001) (Fig 3.34).
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Fig 3.33: Cyproterone acetate had no effect on the percentage of human pre-auricular terminal hair 
follicles remaining in anagen, versus both ethanol control and testosterone culture condition.
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for terminal hair follicles; 1µM 
cyproterone acetate, 0.0001% ethanol control (above), 10nM testosterone culture conditions, 1µM 
cyproterone acetate + 10nM testosterone (below). Error bars for standard error of the mean are 
marked.  
Terminal Hair Follicles
1µM Cyproterone Acetate
Control
10nM Testosterone
1µM Cyproterone Acetate
+ 10nM Testosterone
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Fig 3.34: Cyproterone acetate had no effect on the percentage of human pre-auricular intermediate 
hair follicles remaining in anagen, versus ethanol-supplemented culture conditions. However, when 
compared to testosterone culture conditions alone, cyproterone acetate in combination with 
testosterone blocked the testosterone-stimulated increase in the percentage of intermediate hair 
follicles remaining in anagen (88 ± 1.9% vs. 74 ± 1.2%; p<0.001). 
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for intermediate hair follicles; 1µM 
cyproterone acetate, 0.0001% ethanol control (above), 10nM testosterone culture conditions, 1µM 
cyproterone acetate + 10nM testosterone (below). Error bars for standard error of the mean are 
marked.  
Intermediate Hair Follicles
***
10nM Testosterone
1µM Cyproterone Acetate
+ 10nM Testosterone
1µM Cyproterone Acetate
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With respect to cumulative growth of anagen hair follicles (Fig 3.35), there was no significant 
difference between 1μM cyproterone acetate and 0.0001% ethanol culture conditions for 
either terminal (0.584 ± 0.02mm vs. 0.595 ± 0.04mm; p=0.28) (Mean ± SEM) (Fig 3.36) or 
intermediate hair follicles (0.395 ± 0.06mm vs. 0.400 ± 0.02mm; p=0.06) (Fig 3.37). The 
addition of 1μM cyproterone acetate (0.608 ± 0.03mm) to terminal hair follicles under 10nM 
testosterone (0.573 ± 0.01mm) culture conditions resulted in no significant difference in the 
cumulative growth over 9 days of organ culture (p=0.08) (Fig 3.36). In intermediate hair 
follicles however, the addition of 10nM testosterone (0.590 ± 0.04mm) to ethanol control 
(0.400 ± 0.02mm) culture conditions caused a significant increase in cumulative growth 
(p=0.004); furthermore cyproterone acetate, in combination with testosterone, significantly 
inhibited the stimulatory effects of testosterone culture conditions alone (0.391 ± 0.03mm vs. 
0.590 ± 0.04mm; p<0.001) (Figs 3.37).
When expressed as percentage growth of initial hair follicle length, mean terminal hair follicle 
percentage growth was, 29 ± 1.6% (Mean ± SEM) and 28 ± 1.3% over 9 days under 10nM 
testosterone and 1μM cyproterone acetate + 10nM testosterone organ culture conditions 
respectively. Mean intermediate hair follicle percentage growth was 22 ± 2.1% and 31 ± 2.4% 
over 9 days under 10nM testosterone and 1μM cyproterone acetate + 10nM testosterone 
organ culture conditions respectively. Hence, the addition of cyproterone acetate to 
testosterone culture conditions only had a significant effect on decreasing the percentage 
growth of intermediate hair follicles in organ culture (p<0.001).   
There was no significant difference between mean daily growth, or its pattern over the 
experiment, under normal and ethanol control culture conditions for both terminal (p=0.80) 
and intermediate (p=0.22) hair follicles (Figs 3.38 & 3.39). The addition of cyproterone acetate 
to terminal hair follicles in testosterone-supplemented culture media produced no effect 
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(p=0.45) (Fig 3.38). In intermediate hair follicles only, the addition of 10nM testosterone to 
ethanol control culture conditions caused a significant increase in daily growth (p=0.001); 
furthermore cyproterone acetate, in combination with testosterone, significantly inhibited the 
stimulatory effects of testosterone culture conditions alone (p=0.01) (Fig 3.39). Pre-auricular 
intermediate hair follicle mean daily absolute growth was also significantly affected by the day 
of culture, for all of these organ culture conditions (p<0.001).
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Fig 3.35: Sequential photomicrographs of an intermediate hair follicle, over 9 days of incubation in 
10nM testosterone (upper) and 10nM testosterone culture conditions supplemented with 1μM 
cyproterone acetate (lower). 
CTS = connective tissue sheath, IRS = inner root sheath, ORS = outer root sheath. Taken at 50X 
magnification using an inverted microscope. 
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Fig 3.36: Cyproterone acetate had no effect on the cumulative growth of human pre-auricular 
terminal hair follicles, compared to both ethanol control (a) and testosterone (b) culture conditions. 
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for terminal hair follicles; 1µM 
cyproterone acetate, 0.0001% ethanol control. Error bars for standard error of the mean are marked.  
3.36a: Terminal Hair Follicles.
1µM Cyproterone Acetate
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Fig 3.37: Cyproterone acetate had no effect on the cumulative growth of human pre-auricular 
intermediate hair follicles, compared to ethanol control culture conditions (a). However, when 
compared to testosterone culture conditions alone (b), cyproterone acetate in combination with 
testosterone blocked the testosterone-stimulated increase in cumulative growth of intermediate hair 
follicles (0.391 ± 0.03mm vs. 0.590 ± 0.04mm : p<0.001).
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for intermediate hair follicles; 1µM 
cyproterone acetate, 0.0001% ethanol control. Error bars for standard error of the mean are marked.  
Fig 3.37a: Intermediate Hair Follicles.
1µM Cyproterone Acetate
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Fig 3.37b: Intermediate Hair Follicles.
10nM Testosterone
1µM Cyproterone Acetate
+ 10nM Testosterone
***
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Fig 3.38: Cyproterone acetate had no effect on mean daily absolute growth of human pre-auricular 
terminal hair follicles, versus both ethanol control and testosterone culture condition.
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for terminal hair follicles; 1µM 
cyproterone acetate, 0.0001% ethanol control (above), 10nM testosterone culture conditions, 1µM 
cyproterone acetate + 10nM testosterone (below). Error bars for standard error of the mean are 
marked.
Terminal Hair Follicles
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Fig 3.39: Cyproterone acetate had no effect on mean daily absolute growth of human pre-auricular 
intermediate hair follicles, versus ethanol-supplemented culture conditions. However, when 
compared to testosterone culture conditions alone, cyproterone acetate in combination with 
testosterone blocked the testosterone-stimulated increase in daily absolute growth of intermediate 
hair follicles (p=0.001).
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition),, after microdissection from 
pre-auricular facelift skin. The following culture conditions are shown for intermediate hair follicles; 
1µM cyproterone acetate, 0.0001% ethanol control (above), 10nM testosterone culture conditions, 
1µM cyproterone acetate + 10nM testosterone (below). Error bars for standard error of the mean are 
marked.  
Intermediate Hair Follicles
*
*
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When mean total hair fibre production was measured, there was neither a significant 
difference between 1μM cyproterone acetate and 0.0001% ethanol culture conditions (Mean ± 
SEM) (0.505 ± 0.03mm vs. 0.486 ± 0.004mm; p=0.25) in terminal hair follicles, nor with the 
addition of cyproterone acetate to testosterone-supplemented culture conditions (0.502 ± 
0.01mm vs. 0.472 ± 0.01mm; p=0.11) (Fig 3.40). With respect to intermediate hair follicles, 
there was no significant difference between mean total hair fibre production at 9 days under 
1μM cyproterone acetate and 0.0001% ethanol culture conditions (0.300 ± 0.02mm vs. 0.324 ± 
0.02mm; p=0.24) (Fig 3.41). Again in marked contrast to terminal hair follicles, the addition of 
10nM testosterone (0.530 ± 0.03) to ethanol control (0.324 ± 0.02mm) culture conditions 
caused a significant increase in mean total hair fibre production of intermediate hair follicles
(p=0.001); furthermore cyproterone acetate, in combination with testosterone, significantly 
inhibited the stimulatory effects of testosterone on mean total hair fibre production (0.313 ± 
0.02mm vs. 0.530 ± 0.03; p<0.0001) (Fig 3.41).
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Fig 3.40: Mean total hair fibre production of human pre-auricular terminal hair follicles was 
unchanged between both ethanol and cyproterone acetate culture conditions, and testosterone and 
cyproterone + testosterone culture conditions. 
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. Control = terminal hair follicles under 0.0001% ethanol control culture 
conditions, TCPA = terminal hair follicles under 1µM cyproterone acetate culture conditions, TT = 
terminal hair follicles under 10nM testosterone culture conditions, TCPA+T = terminal hair follicles 
under 1µM cyproterone acetate & 10nM testosterone culture conditions. Error bars for standard error 
of the mean are marked.  
Terminal Hair Follicles
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Fig 3.41: Cyproterone acetate had no effect on mean total hair fibre production of human pre-
auricular intermediate hair follicles, versus ethanol-supplemented culture conditions. 
Testosterone significantly stimulated intermediate hair follicle growth (0.53 ± 0.03mm; p=0.001), 
however when added to testosterone-supplemented culture conditions, cyproterone acetate 
significantly inhibited mean total hair fibre production of human pre-auricular intermediate hair 
follicles under testosterone culture conditions (0.31 ± 0.02mm; p<0.0001). Fifteen terminal and 20 
intermediate hair follicles, per culture condition, were cultured from each of 6 female Caucasian 
individuals (total 210 follicles per culture condition), after microdissection from pre-auricular facelift 
skin. Control = intermediate hair follicles under 0.0001% ethanol control culture conditions, ICPA = 
intermediate hair follicles under 1µM cyproterone acetate culture conditions, IT = intermediate hair 
follicles under 10nM testosterone culture conditions, ICPA+T = intermediate hair follicles under 1µM 
cyproterone acetate & 10nM testosterone culture conditions. Error bars for standard error of the 
mean are marked.
Intermediate Hair Follicles
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3.5.2 Comparison of the location of the androgen receptor in terminal and intermediate
pre-auricular hair follicles, by immunohistochemistry.   
Initially, rat prostate was used as a positive control for androgen receptor localisation by 
immunohistochemistry in 3 male Wistar albino rats of the species Rattus norvegicus. As 
expected, positive staining was nuclear and localised within epithelial cells located around the 
periphery of the secretory ducts of the prostate gland (Figs 3.42). No similar staining was seen 
in any of the prepared control sections where antibody was replaced with PBS according to the 
methodology outlined in 2.4.3. 
Androgen receptor localisation was investigated in cryosections of matched terminal and 
intermediate hair follicles that were microdissected from human female pre-auricular facelift 
skin from 5 different healthy patients. Again, nuclear staining patterns were found in both
terminal (Fig 3.43) and intermediate hair follicles (Fig 3.44), within the dermal papilla, inner 
and outer root sheaths and connective tissue sheath, however staining was stronger and more 
widespread throughout intermediate hair follicles. Terminal hair follicles exhibited clear red 
staining for the androgen receptor within particular nuclei of the dermal papilla and its stalk, 
with further red nuclei occasionally seen interspersed with brown nuclei throughout the
previously mentioned components of the hair follicle. In intermediate hair follicles however, 
clear red staining was observed not only within the dermal papilla and its stalk, but also 
throughout all previously mentioned components of the hair follicle, against a generalised 
brown effect on all cells compared to the negative control. 
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Fig 3.42: Rat prostate androgen receptor immunohistochemistry. 
There is positive intra-nuclear staining of cells around the periphery of the secretory subunits of the 
prostate gland but none in the negative control without primary antibody. The primary antibody used 
was a mouse monoclonal androgen receptor antibody (dilution 1:50) (NCL-AR-318, Novocastra, Leica
Biosystems Newcastle Ltd, UK). The secondary antibody was biotinylated anti-mouse IgG antibody 
(raised in horse) (Vector Laboratories BA-2001, Peterborough, UK). Taken at 100X magnification.
Negative Control
Androgen Receptor Staining
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Fig 3.43: Terminal hair follicle androgen receptor immunohistochemistry. 
There is positive intra-nuclear staining within the dermal papilla, inner and outer root sheaths and 
connective tissue sheath (right). There is no staining of the negative control (left). IRS = inner root 
sheath, ORS = outer root sheath, CTS = connective tissue sheath. Taken at 200X magnification.
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Fig 3.44: Intermediate hair follicle androgen receptor immunohistochemistry. 
There is positive intra-nuclear staining within the dermal papilla, inner and outer root sheaths and 
connective tissue sheath (right). There is no staining of the negative control (left). IRS = inner root 
sheath, ORS = outer root sheath, CTS = connective tissue sheath. Taken at 200X magnification.
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3.5.3 Expression of the androgen receptor gene by reverse transcription polymerase chain 
reaction (RT-PCR).   
Total RNA was extracted from the prostates of 3 male Wistar albino rats of the species Rattus 
norvegicus to learn the techniques and as a positive control, and from matched terminal (60) 
and intermediate (90) hair follicles, microdissected from the human female pre-auricular 
facelift skin of each of 5 healthy Caucasian individuals (60 ± 3years; Mean ± SEM) (total 750 
follicles). Total RNA was extracted for each sample and checked for quality and purity by 1.5% 
agarose gel electrophoresis separation and visualisation by ethidium bromide staining. Sharp 
28S and 18S ribosomal RNA bands were visualised, with the 28S band being of a higher 
intensity, approximately twice that of the 18S band in all samples (Fig 3.45). These data 
confirmed good quality RNA for each sample as intact RNA generates bands with a 2:1 ratio 
(28S:18S), as paritally-degraded RNA does not generate a 2:1 ratio and completely degraded 
RNA appears as a very low molecular weight smear (Skrypina et al., 2003).
After reverse transcription to cDNA, quality was checked in all samples using primers that were 
specific to the house-keeping gene β-actin. Agarose gel (1.5%) electrophoresis separation and 
visualisation with ethidium bromide staining amplified bands which corresponded to the 
expected amplicon size for β-actin (838 base pairs) in all samples (Fig 3.46). As no bands were 
observed in the negative control, where template cDNA was omitted from the RT-PCR reaction 
mix and replaced with nuclease-free water, these data indicated that the products resulted 
from direct amplification of cDNA synthesised from mRNA (not contaminants), and that the 
reagents used in the RT-PCR reaction mixture were also free from DNA contamination. 
Once cDNA quality had been established for all samples, androgen receptor gene expression 
was investigated using previously-designed primers (Croft, 2002). When the resulting RT-PCR 
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products were separated by 1.5% agarose gel electrophoresis, the amplified bands in all 
samples of both terminal and intermediate hair follicles corresponded to the expected 
amplicon size for the androgen receptor (153 base pairs) (Fig 3.47). No bands were observed in 
the negative control, in which cDNA was replaced with nuclease-free water, indicating that the 
products resulted from direct amplification of cDNA synthesised from mRNA (not 
contaminants), and that the reagents used in the RT-PCR reaction mixture were also free from 
DNA contamination. The bands for the androgen receptor were stronger for intermediate hair 
follicles compared to terminal hair follicles, even though the same amounts of cDNA were used 
as for β-actin RT-PCR where no major differences were seen between terminal and 
intermediate hair follicle expression.
To confirm the identity of the RT-PCR products, further separation by agarose gel 
electrophoresis was carried out, using low melting point agarose (Invitrogen Ltd) according to 
the methodology outlined in section 2.5.10. The amplified band of the expected amplicon size 
(153 base pairs) was excised from the gel, purified and sent for sequencing analysis. The BLAST 
program (www.enseble.org) was used to compare the homology of the sequenced product 
with the known human androgen receptor gene sequence. Initially the automatically-
generated query sequence was utilised for these purposes, exhibiting 94% homology (Fig 
3.48). However, automated analysis of the chromatogram that allows identification of relevant 
nucleotides is often not as sensitive as human analysis. The reasons for this include the 
generation of non-specific peaks (N) on the chromatogram, and the generation of different 
peaks with similar amplitudes. After further scrutinisation of the chromatogram (Fig 3.49) and 
reanalysis of the homology of the revised sequenced product with the known human androgen 
receptor gene sequence, 100% homology was exhibited (Fig 3.50).
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Fig 3.45: Agarose gel electrophoresis of human hair follicle total RNA. 
Matched human terminal and intermediate hair follicles, were taken from the pre-auricular facelift 
skin of 5 female Caucasian subjects. Total RNA (10µl) was loaded into each well for 1.5% agarose gel 
electrophoresis. RP = rat prostate positive control, HI = human intermediate ha, HT = human terminal 
hair follicles. 28s and 18s bands are labelled.   
Subject 1 Subject 2
Subject 3 Subject 4
Subject 5
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Fig 3.46: Agarose gel electrophoresis of human hair follicle β-actin RT-PCR products. 
Matched human terminal and intermediate hair follicles, were taken from the pre-auricular facelift 
skin of 5 female Caucasian subjects. β-actin RT-PCR amplification was achieved using 5µl cDNA and 
30µl of PCR products were loaded into each well for 1.5% agarose gel electrophoresis. Lad = DNA 
ladder, RP = rat prostate positive control, HI = human intermediate hair follicle cDNA, HT = human 
terminal hair follicle cDNA, -ve = negative control. The expected base pair size of 838bp was found.   
Subject 1 Subject 2
Subject 3 Subject 4
Subject 5
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Fig 3.47: Agarose gel electrophoresis of human hair follicle androgen receptor RT-PCR products.
Matched human terminal and intermediate hair follicles, were taken from the pre-auricular facelift 
skin of 5 female Caucasian subjects. Androgen receptor RT-PCR amplification was achieved using 15µl 
cDNA and 30µl of PCR products were was loaded into each well for 1.5% agarose gel electrophoresis. 
Lad = DNA ladder, RP = rat prostate positive control, HI = human intermediate hair follicle cDNA, HT = 
human terminal hair follicle cDNA, -ve = negative control. The expected base pair size of 153bp was 
found.   
Subject 1 Subject 2
Subject 3 Subject 4
Subject 5
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Query = Int_F (121 letters)
Database: Homo_sapiens.
       
                                                                     Smallest
                                                                       Sum
                                                              High  Probability
Sequences producing High-scoring Segment Pairs:              Score  P(N)      N
X dna:chromosome chromosome:NCBI36:X:1:154913754:1             95  1.2e-46   1
17 dna:chromosome chromosome:NCBI36:17:1:78774742:1             18  0.997     2
5 dna:chromosome chromosome:NCBI36:5:1:180857866:1              19  0.99992   2
c6_COX dna:chromosome chromosome:NCBI36:c6_COX:28688544:3...    18  0.99995   1
c6_QBL dna:chromosome chromosome:NCBI36:c6_QBL:28885510:3...    18  0.99995   1
6 dna:chromosome chromosome:NCBI36:6:1:170899992:1              18  0.99995   1
Score = 95 (189.4 bits), Expect = 1.2e-46, P = 1.2e-46
Identities = 112/119 (94%), Positives = 112/119 (94%), Strand = Plus / Plus
Query:        2 CCTGGAGTGCCACCCTGAGAGAGGTTGCGTCCCAGAGCCTGGAGCNGCCGTGGCNGCNGG 61
                ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct: 66682079 CCTGGAGTGCCACCCCGAGAGAGGTTGCGTCCCAGAGCCTGGAGCCGCCGTGGCCGCCAG 66682138
Query:       62 CAAGGGGCTGCCGCAGCAGCTGCCAGCTCCTCCGGANGAGGATGACTCAGCTGCCCCAT 120
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct: 66682139 CAAGGGGCTGCCGCAGCAGCTGCCAGCACCTCCGGACGAGGATGACTCAGCTGCCCCAT 66682197
Fig 3.48: Sequencing data for androgen receptor RT-PCR products, amplified from human 
intermediate hair follicle cDNA. 
The BLAST program (www.enseble.org) was used to compare the homology of the sequenced product 
(query / blue) with the known human androgen receptor (sbjct / green). Relying on automated 
laboratory analysis, 94% homology was exhibited. Mismatched and unidentified nucleotides have 
been highlighted. 
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Fig 3.49: Chromatogram of sequencing data for androgen receptor RT-PCR products, amplified from human intermediate hair follicle cDNA.
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Query = Int_F_Adjusted_Chromatogram (119 letters)
Database: Homo_sapiens.
                                                                     Smallest
                                                                       Sum
                                                              High  Probability
Sequences producing High-scoring Segment Pairs:              Score  P(N)      N
X dna:chromosome chromosome:NCBI36:X:1:154913754:1             119  7.3e-62   1
11 dna:chromosome chromosome:NCBI36:11:1:134452384:1            21  0.93      2
7 dna:chromosome chromosome:NCBI36:7:1:158821424:1              19  0.95      2
8 dna:chromosome chromosome:NCBI36:8:1:146274826:1              20  0.9998    2
Score = 119 (236.9 bits), Expect = 7.3e-62, P = 7.3e-62
Identities = 119/119 (100%), Positives = 119/119 (100%), Strand = Plus / Plus
Query:        1 CCTGGAGTGCCACCCCGAGAGAGGTTGCGTCCCAGAGCCTGGAGCCGCCGTGGCCGCCAG 60
                ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct: 66682079 CCTGGAGTGCCACCCCGAGAGAGGTTGCGTCCCAGAGCCTGGAGCCGCCGTGGCCGCCAG 66682138
Query:       61 CAAGGGGCTGCCGCAGCAGCTGCCAGCACCTCCGGACGAGGATGACTCAGCTGCCCCAT 119
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct: 66682139 CAAGGGGCTGCCGCAGCAGCTGCCAGCACCTCCGGACGAGGATGACTCAGCTGCCCCAT 66682197
Fig 3.50: Sequencing data for androgen receptor RT-PCR products, amplified from human intermediate 
hair follicle cDNA. 
The BLAST program (www.enseble.org) was used to compare the homology of the sequenced product 
(query / blue) with the known human androgen receptor (sbjct / green). After adjusting the 
automated nucleotide sequencing data using the chromatogram, 100% homology was exhibited.
171
3.5.4: Expression of the androgen receptor gene by quantitative real-time polymerase chain 
reaction (qPCR).
To further investigate the differences in androgen receptor gene expression seen between 
terminal and intermediate hair follicles by reverse transcription polymerase chain reaction (RT-
PCR), their expression was compared by qPCR. Matched terminal (60) and intermediate (90)
hair follicles were microdissected from the human female pre-auricular facelift skin of each of 
6 healthy Caucasian individuals (60 ± 3years; Mean ± SEM) (total 900 hair follicles). Total RNA 
was extracted individually from each matched sample and checked for adequate purity and 
quantity, using a NanoDrop 2000 (Thermo Scientific, USA), prior to conversion to cDNA and
analysis in triplicate by qPCR. In all samples, total RNA 260:280nm wavelength absorbance 
ratios indicated adequate purity (1.97 ± 0.12). Using the generated total RNA quantity data, 
1µg of total RNA was used in the conversion mix to cDNA for each sample in order to achieve 
standardisation for qPCR. 
Prior to statistical analysis, melt curves were generated and analysed for both the androgen 
receptor (AR) gene and β-actin housekeeping gene, revealing similar morphology within 
triplicate samples. This indicated that contamination, mispriming or primer-dimer artefact was 
unlikely. Additionally, melt peaks were generated and analysed, revealing tall narrow peaks of 
similar morphology within triplicate samples. This indicated that in each case, the gene of 
interest was amplified, rather than primer-dimers that would produce broad low peaks. Using 
β-actin as a housekeeping gene, the delta delta threshold cycle (ΔΔCt) method was used to 
generate ΔΔCt values for each matched triplicate sample and then analysed over the 6 samples
of each hair follicle type, producing mean ΔΔCt values that indicated significantly higher (3.52 
fold change) expression of the AR gene in intermediate hair follicles versus terminal hair 
follicles (4.10 ± 0.16 vs. 1.17 ± 0.47; p=0.04) (Fig 3.51). 
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Fig 3.51: Intermediate hair follicles expressed the androgen receptor at higher levels than terminal 
hair follicles. 
Mean ΔΔCt values, for androgen receptor gene expression, were significantly higher for intermediate 
(green) (4.10 ± 0.16) versus terminal (blue) (1.17 ± 0.47) hair follicles (3.52 fold change; p=0.04). cDNA 
synthesised from 60 terminal and 90 intermediate matched hair follicles, was analysed from each of 6 
female Caucasian individuals (total 900 hair follicles), after microdissection from pre-auricular facelift 
skin. Error bars for standard error of the mean are marked.
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3.6 Do the effects of testosterone require metabolism of testosterone by 5α-reductase?
3.6.1 Effects of the 5α-reductase (type 2) inhibitor, finasteride, on terminal and 
intermediate hair follicles in testosterone-supplemented culture conditions over 9 days of 
organ culture.   
Fifteen terminal and 20 intermediate hair follicles were successfully isolated, for each of 4 
organ culture conditions, by microdissection from each of 6 individuals (65 ± 2years; Mean ± 
SEM). Organ culture conditions were as follows: 0.0001% ethanol, 10nM testosterone, 
40ng/ml finasteride and 40ng/ml finasteride + 10nM testosterone. Follicles which had not 
shown any increase in length in the first 3 days of the experiment were deemed damaged 
during isolation and not included in the experiment. 
There was no significant difference in the percentage of hair follicles remaining in anagen with 
the addition of 40ng/ml finasteride for either terminal (80 ± 1.8% vs. 78 ± 1.5%; p=0.81) (Mean 
± SEM) (Fig 3.52) or intermediate (79 ± 2.8% vs. 77 ± 3.3%; p=0.18) (Fig 3.53) hair follicles. The 
combination of 40ng/ml finasteride + 10nM testosterone (81 ± 1.9%) did not alter the 
percentage of terminal hair follicles remaining in anagen, compared to testosterone alone (78 
± 1.9%) (Fig 3.52). This was also true for intermediate hair follicles (87 ± 1.2% vs. 86 ± 2.1%;
p=0.40) (Fig 3.53).
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Fig 3.52: Finasteride had no effect on the percentage of human pre-auricular terminal hair follicles 
remaining in anagen, versus both ethanol control and testosterone culture condition.
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for terminal hair follicles; 0.0001% 
ethanol control, 40ng/ml finasteride (above), 10nM testosterone, 40ng/ml finasteride + 10nM 
testosterone (below). Error bars for standard error of the mean are marked.
Terminal Hair Follicles
10nM Testosterone
40ng/ml Finasteride
+ 10nM Testosterone
Control
40ng/ml Finasteride
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Fig 3.53: Finasteride acetate had no effect on the percentage of human pre-auricular intermediate 
hair follicles remaining in anagen, versus both ethanol control and testosterone culture conditions.
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for intermediate hair follicles; 
0.0001% ethanol control, 40ng/ml finasteride (above), 10nM testosterone, 40ng/ml finasteride + 
10nM testosterone (below). Error bars for standard error of the mean are marked.
Intermediate Hair Follicles
Control
40ng/ml Finasteride
10nM Testosterone
40ng/ml Finasteride
+ 10nM Testosterone
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With respect to cumulative growth of anagen hair follicles, there was no significant difference 
between 40ng/ml finasteride and 0.0001% ethanol culture conditions for either terminal 
(0.598 ± 0.01mm vs. 0.576 ± 0.01mm; p=0.12) (Mean ± SEM) (Fig 3.54) or intermediate hair 
follicles (0.388 ± 0.02mm vs. 0.398 ± 0.03mm; p=0.32) (Fig 3.55). The addition of 40ng/ml 
finasteride (0.588 ± 0.02mm) to terminal hair follicles under 10nM testosterone (0.596 ± 
0.01mm) culture conditions resulted in no significant difference in the cumulative growth over 
9 days of organ culture (p=0.33) (Fig 3.54). This was also true for intermediate hair follicles 
(0.530 ± 0.02mm vs. 0.580 ± 0.03mm; p=0.07) (Figs 3.55).
Terminal hair follicle growth, expressed as a percentage of initial hair follicle length, was also 
unaffected by the addition of either 10nM testosterone or 40ng/ml finasteride + 10nM 
testosterone (Mean ± SEM), 31 ± 0.7% and 32 ± 0.6% over 9 days of organ culture. Mean 
intermediate hair follicle percentage growth was 34 ± 1.8% and 32 ± 0.8% over 9 days under 
10nM testosterone and 40ng/ml finasteride + 10nM testosterone organ culture conditions 
respectively. Hence, the addition of finasteride to testosterone culture conditions did not alter
the percentage growth of intermediate hair follicles in organ culture (p=0.20).   
There was no significant difference between mean daily growth, or its pattern over the 
experiment, under ethanol control and 40ng/ml finasteride culture conditions for both 
terminal (p=0.74) and intermediate (p=0.40) hair follicles (Figs 3.56 & 3.57). The combination 
of 40ng/ml finasteride + 10nM testosterone also produced no effect on both terminal (p=0.88) 
and intermediate (p=0.17) hair follicles, compared to testosterone alone (Figs 3.56 & 3.57).
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Fig 3.54: Finasteride had no effect on the cumulative growth of human pre-auricular terminal hair 
follicles, compared to both ethanol control (a) and testosterone (b) culture conditions.
Finasteride had no effect on the cumulative growth of human pre-auricular terminal hair follicles, 
versus ethanol-supplemented culture conditions. Fifteen terminal and 20 intermediate hair follicles, 
per culture condition, were cultured from each of 6 female Caucasian individuals (total 210 follicles 
per culture condition), after microdissection from pre-auricular facelift skin. The following culture 
conditions are shown for terminal hair follicles; 0.0001% ethanol control, 40ng/ml finasteride. Error 
bars for standard error of the mean are marked.  
Fig 3.54a: Terminal Hair Follicles
Control
40ng/ml Finasteride
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Fig 3.54b: Terminal Hair Follicles.
10nM Testosterone
40ng/ml Finasteride
+ 10nM Testosterone
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Fig 3.55: Finasteride had no effect on the cumulative growth of human pre-auricular intermediate hair 
follicles, compared to both ethanol control (a) and testosterone (b) culture conditions.
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for intermediate hair follicles; 
0.0001% ethanol control, 40ng/ml finasteride. Error bars for standard error of the mean are marked.  
Fig 3.55a: Intermediate Hair Follicles.
Control
40ng/ml Finasteride
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Fig 3.55b: Intermediate Hair Follicles.
10nM Testosterone
40ng/ml Finasteride
+ 10nM Testosterone
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Fig 3.56: Finasteride had no effect on mean daily growth of human pre-auricular terminal hair follicles,
versus both ethanol control and testosterone culture condition.
Fifteen terminal and 20 terminal hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for terminal hair follicles; 0.0001% 
ethanol control, 40ng/ml finasteride (above), 10nM testosterone, 40ng/ml finasteride + 10nM 
testosterone (below). Error bars for standard error of the mean are marked.
Terminal Hair Follicles  
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Fig 3.57: Finasteride had no effect on mean daily growth of human pre-auricular intermediate hair 
follicles, versus both ethanol control and testosterone culture condition.
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for intermediate hair follicles; 
0.0001% ethanol control, 40ng/ml finasteride (above), 10nM testosterone, 40ng/ml finasteride + 
10nM testosterone (below). Error bars for standard error of the mean are marked.
Intermediate Hair Follicles
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Similarly when total hair fibre production, of terminal hair follicles, at 9 days was examined, 
there was neither a significant difference between 40ng/ml finasteride (0.482 ± 0.005mm;
Mean ± SEM) and 0.0001% ethanol (0.478 ± 0.005mm) culture conditions (p=0.35) (Fig 3.58), 
nor with the combination of 40ng/ml finasteride + 10nM testosterone (0.489 ± 0.01mm), 
compared to testosterone (0.497 ± 0.01mm) culture conditions (p=0.33) (Fig 3.58). With 
respect to intermediate hair follicles, there was no significant difference in mean total hair 
fibre production at 9 days between 40ng/ml finasteride (0.316 ± 0.01mm) and 0.0001% 
ethanol (0.324 ± 0.02mm) culture conditions (p=0.34) (Fig 3.59). Although the addition of 
testosterone (0.520 ± 0.03) significantly stimulated intermediate total hair fibre production 
(p=0.001), the addition of 40ng/ml finasteride to 10nM testosterone culture conditions (0.471 
± 0.01mm) had no effect on this (p=0.2) (Fig 3.59).
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Fig 3.58: Mean total hair fibre production of human pre-auricular terminal hair follicles was 
unchanged between both ethanol and cyproterone acetate culture conditions, and testosterone and 
cyproterone + testosterone culture conditions. 
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for terminal hair follicles; Control = 
intermediate hair follicles in 0.0001% ethanol control culture conditions, IF = intermediate hair 
follicles in 40ng/ml finasteride culture conditions, IT = intermediate hair follicles in 10nM testosterone 
culture conditions, IF+T = intermediate hair follicles in 40ng/ml finasteride + 10nM testosterone 
culture conditions. Error bars for standard error of the mean are marked.  
Terminal Hair Follicles
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Fig 3.59: Mean total hair fibre production of human pre-auricular intermediate hair follicles was 
unchanged between both ethanol and cyproterone acetate culture conditions, and testosterone and 
cyproterone + testosterone culture conditions. 
Testosterone significantly stimulated intermediate hair follicle growth (0.53 ± 0.03mm; p=0.001), 
however when added to testosterone-supplemented culture conditions, finasteride had no effect. 
Fifteen terminal and 20 intermediate hair follicles, per culture condition, were cultured from each of 6 
female Caucasian individuals (total 210 follicles per culture condition), after microdissection from pre-
auricular facelift skin. The following culture conditions are shown for intermediate hair follicles; 
Control = intermediate hair follicles in 0.0001% ethanol control culture conditions, IF = intermediate 
hair follicles in 40ng/ml finasteride culture conditions, IT = intermediate hair follicles in 10nM 
testosterone culture conditions, IF+T = intermediate hair follicles in 40ng/ml finasteride + 10nM 
testosterone culture conditions. Error bars for standard error of the mean are marked.  
Intermediate Hair Follicles
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3.6.2 Localisation of 5α-reductase, in terminal and intermediate hair follicles, by 
immunohistochemistry.   
5α-reductase localisation was investigated in matched terminal and intermediate hair follicles 
that were microdissected from human female pre-auricular facelift skin from 5 different 
healthy patients (53 ± 3 years; Mean ± SEM). Positive staining was only observed in small areas
within the outer root sheath across the isthmus, well above the top of the hair bulbs of both 
hair follicle types (Fig 3.60 8 & 3.61). No staining was seen in the dermal papilla or other areas 
of the hair bulb.
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Fig 3.60: Terminal hair follicle 5α-reductase immunohistochemistry. 
There is positive staining within the outer root sheath of the hair follicle isthmus well above 
the top of the hair bulb (middle) and no staining of the negative control (left) (taken at 100X 
magnification). Positive staining is more clearly seen at 200X magnification (right). DP = 
dermal papilla, ORS = outer root sheath.
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Fig 3.61: Intermediate hair follicle 5α-reductase immunohistochemistry (taken at 200X 
magnification). 
There is positive staining within the outer root sheath of the hair follicle isthmus well above 
the top of the hair bulb (right). There is no staining of the negative control (left). DP = dermal 
papilla, ORS = outer root sheath. 
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3.6.3: Expression of 5α-reductase by quantitative real-time polymerase chain reaction 
(qPCR).
Matched terminal (60) and intermediate (90) hair follicles were microdissected from the 
human female pre-auricular facelift skin of each of 6 healthy Caucasian individuals (60 ± 
3years; Mean ± SEM) (total 900 hair follicles). Total RNA was extracted from each matched 
sample and individually checked for adequate purity and quantity, as outlined in section 3.5.4,
prior to conversion to cDNA and analysis in triplicate by qPCR. In all samples, total RNA
260:280nm wavelength absorbance ratios indicated adequate purity (1.96 ± 0.04) and 1µg of 
total RNA was used in the conversion mix to cDNA for each sample in order to achieve 
standardisation for qPCR. 
Prior to statistical analysis, melt curves and melt peaks were generated and analysed for both 
the 5α-reductase (type 2) gene (SRD5A2) and β-actin housekeeping gene, revealing similar 
morphology within triplicate samples. This indicated that contamination, mispriming or 
primer-dimer artefact was unlikely and that the gene of interest was amplified, rather than 
primer-dimers that would produce broad low peaks. Using β-actin as a housekeeping gene, the 
delta delta threshold cycle (ΔΔCt) method was used to generate ΔΔCt values for each matched 
triplicate sample and then analysed over 6 samples, producing mean ΔΔsCt values that 
indicated significantly higher (2.58 fold change) expression of the SRD5A2 gene in intermediate 
hair follicles versus terminal hair follicles (4.70 ± 1.06 vs. 1.82 ± 0.73; p=0.03) (Fig 3.62).
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Fig 3.62: Mean ΔΔCt values for 5α-reductase type 2 gene (SRD5A2) expression, were significantly 
higher for intermediate (4.70 ± 1.06) versus terminal (1.82 ± 0.73) hair follicles (2.58 fold change; 
p=0.03). 
Sixty terminal and 90 intermediate hair follicles were taken from each of 6 female Caucasian 
individuals (total 900 hair follicles), after microdissection from pre-auricular facelift skin. Error bars for 
standard error of the mean are marked. 
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3.7 Are there differences between intermediate and terminal hair follicles at gene 
microarray analysis?
Matched terminal (20) and intermediate (30) hair follicles were microdissected from the 
human pre-auricular facelift skin of 15 healthy Caucasian individuals. These hair follicles were 
pooled into 3 matched samples (T1-T3 and I1-I3), with each matched sample comprising 100 
terminal or 150 intermediate hair follicles from 5 individuals. Total RNA was extracted from 
each of the 6 samples and taken for microarray analysis to the University of Sheffield Medical 
School Research Unit (Eu25). Initial quantity, purity and quality checks, using an Agilent 2100 
Bioanalyzer (Agilent Technologies, USA), indicated good results in all samples (Table 3.2 & Fig 
3.63) and microarray analysis was then performed using the Human Exon 1.0 ST system 
(Affymetrix, USA) (Fig 3.64). Age values (Mean ± SEM) were as follows for each matched 
sample; sample 1 = 63 ± 3 years, sample 2 = 67 ± 5 years, Sample 3 = 58 ± 1 year. Hierarchical 
clustering diagrams illustrated similar gene expression profiles between samples from the 
same hair follicle type, with clear differences between terminal and intermediate hair follicle 
samples (Fig 3.64).  
Table 3.2: Total RNA concentrations used for gene microarray analysis. Each sample of total RNA was 
generated from either 100 terminal (20 per individual) or 150 intermediate (30 per individual) hair 
follicles, microdissected from the pre-auricular facelift skin of 5 healthy Caucasian females.
Total RNA Sample Total RNA Concentration
(ng/μl)
Total RNA Sample Total RNA Concentration
(ng/μl)
Terminal 1 (T1) 53 Intermediate 1 (I1) 292
Terminal 2 (T2) 91 Intermediate 2 (I2) 302
Terminal 3 (T3) 282 Intermediate 3 (I3) 243
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Prior to comparative analysis of intermediate versus terminal hair follicle samples, further 
quality checks were performed with respect to sample processing, using the software 
Expression Console (Affymetrix, USA). As expected, principle component analysis revealed 6 
distinct samples (Fig 3.65) represented as blue dots (intermediate hair follicle samples) and red 
dots (terminal hair follicle samples). The three dimensional nature of the axes here results in 
dots of differing sizes. Further analysis of fluorescence signals by Pearson's correlation 
coefficient (Fig 3.66) indicated that all samples were extracted from cells belonging to the 
same organ type (hair follicles). Furthermore when fluorescence data for each sample over the 
experiment were further analysed, signal histograms (Fig 3.67) and normalised relative log 
expression signals (Fig 3.68) were consistent between samples, hence minimising the 
possibility that any potential differences between microarray analysis results were artefacts
due to experimental error. 
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Fig 3.63: Example electropherogram summary of quantity, purity and quality for matched terminal 
and intermediate hair follicles (sample 2). 
Each sample of total RNA was generated from either 100 terminal (20 per individual) or 150 
intermediate (30 per individual) hair follicles, microdissected from the pre-auricular facelift skin of 5 
healthy Caucasian females.
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Fig 3.64: Example gene microarray chip fluorescence data of terminal (upper) and intermediate 
(lower) hair follicle samples (a) and hierarchical clustering diagrams for terminal (T) and intermediate 
(I) hair follicle samples 1-3 (b).   
Gene expression profiles were similar between samples from each hair follicle type, however there 
were distinct differences between terminal and intermediate hair follicle samples. Each sample was 
generated from either 100 terminal (20 per individual) or 150 intermediate (30 per individual) hair 
follicles, microdissected from the pre-auricular facelift skin of 5 healthy Caucasian females. Key for (b)
heat signature expression profiles: Blue = low, yellow = medium, red = high. 
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Fig 3.65: Principle component analysis indicated 6 distinct gene microarray samples. 
These comprised 3 terminal (red) and 3 intermediate (blue) matched sets of pooled hair follicle cDNA. 
Each sample was generated from either 100 terminal (20 per individual) or 150 intermediate (30 per 
individual) hair follicles, microdissected from the pre-auricular facelift skin of 5 healthy Caucasian 
females. 
Fig 3.66: Pearson's correlation coefficient fluorescence signals indicated that all samples were 
extracted from cells belonging to the same organ type (hair follicles).
These comprised of 3 terminal (BMt1-t3) and 3 intermediate (BMi1-i3) matched sets of pooled hair 
follicle cDNA. Each sample was generated from either 100 terminal (20 per individual) or 150 
intermediate (30 per individual) hair follicles, microdissected from the pre-auricular facelift skin of 5 
healthy Caucasian females. 
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Fig 3.67: Signal histograms of fluorescence signals for terminal and intermediate hair follicle samples 
were consistent between samples as the proportion of probe sets sharing alike signal intensities were 
similar across all samples.
These comprised of 3 terminal (BMt1-t3) and 3 intermediate (BMi1-i3) matched sets of pooled hair 
follicle cDNA. Each sample was generated from either 100 terminal (20 per individual) or 150 
intermediate (30 per individual) hair follicles, microdissected from the pre-auricular facelift skin of 5 
healthy Caucasian females.
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Fig 3.68: Box and whisker plots of normalised relative log expression signals for terminal and 
intermediate hair follicle samples were consistent between samples.
These comprised of 3 terminal (BMt1-t3) and 3 intermediate (BMi1-i3) matched sets of pooled hair 
follicle cDNA. Each sample was generated from either 100 terminal (20 per individual) or 150 
intermediate (30 per individual) hair follicles, microdissected from the pre-auricular facelift skin of 5 
healthy Caucasian females. Error bars for standard error of the mean are marked.
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Gene microarray analysis revealed marked differences in gene expression of many genes 
involved in the coding of the structural intermediate filaments present in hair follicles, the 
keratins. Unsurprisingly, intermediate hair follicle gene expression of these structural genes 
was significantly less than terminal hair follicles. Twenty keratin (KRT) and keratin associated 
protein (KRTAP) genes, with significant fold changes of ≥2, were significantly less expressed in 
intermediate hair follicles versus terminal hair follicles, whereas only 1 keratin gene (KRT79) 
was expressed significantly more (fold change = 2.95) (Fig 3.69). This supports the concept that 
intermediate hair follicles are structurally smaller than terminal hair follicles. The KRT79 gene
is known to encode an epithelial keratin (keratin 79) that is expressed in scalp tissue, skin and 
skeletal muscle (Entrez Gene Summary). 
There was no overall significant difference in fluorescence (expressed as log2 fluorescence 
units) between intermediate and terminal hair follicles with respect to gene expression for the 
androgen receptor (6.08 ± 0.36 vs. 5.88 ± 0.39; Mean ± SEM; p=0.06), 5α-reductase type 1 
(7.49 ± 0.25 vs. 7.39 ± 0.10; p=0.39) and 5α-reductase type 2 (5.40 ± 0.10 vs. 5.36 ± 0.15;
p=0.43) (Fig 3.70). However on closer inspection of individual probe sets, significant 
differences in gene expression were seen for the androgen receptor and 5α-reductase type 2 
genes (Fig 3.71 & 3.72), however none were found for 5α-reductase type 1. With the androgen 
receptor gene, intermediate hair follicles exhibited significantly more fluorescence over probe 
sets 3979925 (4.3 ± 0.1 vs. 3.9 ± 0.07; p=0.03), 3979956 (4.8 ± 0.4 vs. 4.0 ± 0.2; p=0.03), 
3979972 (5.9 ± 0.03 vs. 5.7 ± 0.08; p=0.01) and 3979975 (4.9 ± 0.4 vs. 4.2 ± 0.1; p=0.04), than 
terminal hair follicles (Fig 3.71 & Table 3.3). With respect to 5α-reductase type 2, significant 
differences were also noted at two probe sets; intermediate hair follicles exhibited significantly 
less fluorescence at probe set 2547248 (6.5 ± 0.2 vs. 7.2 ± 0.2; p<0.01), however there was a 
significant increase in fluorescence at probe set 2547240 (3.9 ± 0.1 vs. 2.2 ± 0.1; p<0.01) (Fig 
3.72 & Table 3.3).  
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Fig 3.69: Gene microarray analysis, for significant fold change differences (≥2) in keratin (KRT) and 
keratin associated protein (KRTAP) gene expression, revealed that 20 keratin and keratin associated 
protein genes were significantly less expressed in intermediate hair follicles, versus terminal hair 
follicles. 
KRT79 was the only gene that was expressed significantly more in intermediate hair follicles (fold 
change = 2.95).
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Fig 3.70: Microarray data comparing terminal and intermediate hair follicle overall gene expression 
for the androgen receptor (AR), 5α-reductase type 1 (SRD5A1) and 5α-reductase type 2 (SRD5A2).
There were no significant differences in overall gene expression between terminal and intermediate 
hair follicles with respect to the androgen receptor (6.08 ± 0.36 vs. 5.88 ± 0.39; Mean ± SEM; p=0.06), 
5α-reductase type 1 (7.49 ± 0.25 vs. 7.39 ± 0.10; p=0.39) and 5α-reductase type 2 (5.40 ± 0.10 vs. 5.36 
± 0.15; p=0.43). 
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Fig 3.71: Androgen receptor gene microarray data for each probe set (x-axis), expressed as 
fluorescence units (log2) (y-axis). 
There was a significant increase in fluorescence for intermediate hair follicles versus terminal hair 
follicles over probe sets 3979925 (4.3 ± 0.1 vs. 3.9 ± 0.07; p=0.03), 3979956 (4.8 ± 0.4 vs. 4.0 ± 0.2;
p=0.03), 3979972 (5.9 ± 0.03 vs. 5.7 ± 0.08; p=0.01) and 3979975 (4.9 ± 0.4 vs. 4.2 ± 0.1; p=0.04). Thirty 
intermediate and 20 terminal hair follicles were taken from each of 15 female Caucasian individuals 
(total 750 hair follicles), after microdissection from pre-auricular facelift skin. Error bars for standard 
error of the mean are marked.  
Androgen Receptor
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Fig 3.72: 5α-reductase type 2 gene microarray data for each probe set (x-axis), expressed as 
fluorescence units (log2) (y-axis). 
There was a significant increase in fluorescence for intermediate hair follicles versus terminal hair 
follicles at probe set 2547240 (3.9 ± 0.1 vs. 2.2 ± 0.1; p<0.01), and a significant decrease at probe set 
2547248 (6.5 ± 0.2 vs. 7.2 ± 0.2; p<0.01). Thirty intermediate and 20 terminal hair follicles were taken 
from each of 15 female Caucasian individuals (total 750 hair follicles), after microdissection from pre-
auricular facelift skin. Error bars for standard error of the mean are marked.   
5α-Reductase Type 2
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Table 3.3: Probe set ID – exon relationship for significant differences in splice-variant SRD5A2 and AR 
gene expression between intermediate (I) and terminal (T) hair follicles, including fold change 
differences and relevant p-values. 
Thirty intermediate and 20 terminal hair follicles were taken from each of 15 female Caucasian 
individuals (total 750 hair follicles), after microdissection from pre-auricular facelift skin.  
INTERMEDIATE (I) TERMINAL (T)
Probe 
Set ID
Gene Exon Mean 
Fluorescence
(log2)
SEM Mean 
Fluorescence
(log2)
SEM Fold 
Change
(I vs.T)
P-Value
3979925 AR 1 4.3 0.1 3.9 0.1 1.4 0.03
3979956 AR 2 4.8 0.4 4.0 0.2 1.6 0.04
3979972 AR 5 5.9 0.03 5.7 0.1 1.2 0.01
3979975 AR 7 4.9 0.4 4.2 0.1 1.7 0.04
2547240 SRD5A2 5 3.9 0.2 2.2 0.1 3.2 <0.01
2547248 SRD5A2 1 6.5 0.2 7.2 0.2 0.6 <0.01
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SECTION 4
DISCUSSION
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4. DISCUSSION
The overall aim of this research was to develop a novel model system for investigating human 
hair follicles, which was more clinically relevant than the existing models, based on 
intermediate hair follicles. The hypothesis behind this was that such intermediate follicles 
which in vivo should transform to larger, even terminal follicles if they encountered normal 
male androgen levels to form part of the beard, would also respond to androgens or other 
growth-promoting factors in vitro. This was to be achieved initially by characterising the 
differences between matched human female Caucasian pre-auricular terminal and 
intermediate hair follicles using histological, morphometric and organ culture techniques.
Histological SACPIC stained sections of Caucasian female human pre-auricular facelift skin 
demonstrated that intermediate hair follicles were much smaller, and penetrated less deeply 
into the subcutaneous tissues, than their terminal counterparts (Fig 3.4) (Miranda et al., 2010)
(appendix). This and other important differences were later confirmed by morphometric 
analysis (Section 4.2). Although overall staining patterns of the various hair follicle structural 
components were similar, intermediate hair follicles retained less yellow stain within their 
keratinised cortex. This suggested that intermediate hair follicles have less fully keratinised 
cells at this location. Later comparison by gene microarray analysis (Section 4.7) further 
demonstrated a broad range of keratin-related genes that were significantly less expressed in 
intermediate, versus terminal hair follicles.  
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4.1 Are there morphological differences between intermediate & terminal hair follicles?
In a recent histological study of terminal and vellus scalp hair follicles, morphological 
differences were measured that showed distinct differences (Vogt et al., 2007). Terminal hair 
follicles penetrated significantly further below the skin surface (3865µm) than vellus hair 
follicles (580µm). Mean terminal hair follicle (172µm) infundibulum diameter at the skin 
surface was also significantly greater than that of vellus hair follicles (86µm). Other statistically 
significant differences in morphometry between terminal and intermediate hairs included 
infundibulum length, depth and length of the bulge region, all of which were greater in 
terminal hair follicles. 
In this thesis, significant differences were also demonstrated, between terminal and 
intermediate hair follicles from Caucasian female pre-auricular facelift skin (Section 3.4.2) 
(Miranda et al., 2010) (appendix). These differences were apparent from the initial point of 
hair follicle isolation, as intermediate hair follicles were smaller, thinner and less pigmented 
than terminal follicles, making them difficult to visualise and microdissect. Terminal hair 
follicles (3.518mm ± 0.098mm; Mean ± SEM) penetrated deeper below the skin surface than 
intermediate hair follicles (2.588mm ± 0.072mm) (p=0.02). These values are in keeping with 
those outlined by Vogt et al. (2007) as the terminal hair follicle depths were similar, with 
intermediate hair follicle depths lying between their reported terminal and vellus hair follicle 
depths. Terminal hair follicles were also larger than intermediate hair follicles with respect to 
fibre diameter at the level of the epidermis (0.067mm ± 0.002mm / 0.034mm ± 0.002mm;
p<0.001), connective tissue sheath diameter at the level of the dermis-fat junction (0.326mm ± 
0.008mm / 0.242mm ± 0.007mm; p<0.001), dermal papilla (0.119mm ± 0.006mm / 0.063mm ± 
0.002mm; p<0.001) and bulb diameter (0.308mm ± 0.010mm / 0.191mm ± 0.007mm;
p<0.001), at the level of Auber’s line.
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Of particular interest in this thesis, was the overall shape difference found between terminal 
and intermediate hair follicles. Intermediate hair follicles had a mean bulb diameter that was 
21% smaller than the mean connective tissue sheath diameter at the level of the dermis-fat 
junction, whilst mean terminal hair follicle bulb diameter was only 6% smaller. This difference 
is compatible with the observation that intermediate hair follicle bulbs were more ‘tubular’ in 
morphology than terminal hair follicle bulbs that are more ‘bulbous’ (Fig 3.18). 
4.2 Is dermal papilla size important to terminal and intermediate hair follicle 
morphometry?
The relationships between dermal papilla size and hair follicle dimensions have been a topic of 
interest for some time (Elliott et al., 1999; Tobin et al., 2003; Van Scott and Ekel, 1958). In a 
histological geometric analysis of hair follicles taken from normal and alopecic scalp, evidence 
was put forward in support of the theory that hair follicle size and hair fibre volume are 
governed by the volume of the dermal papilla (Van Scott and Ekel, 1958). Various correlations 
between dermal papilla size and other hair follicle parameters have been demonstrated in the 
literature. These include correlations between the dermal papilla and hair cortex area (Elliott 
et al., 1999), hair bulb size and hair follicle size (Van Scott et al., 1963). Furthermore, a 
relationship between dermal papilla size and the volume of cells within the hair matrix has also 
been demonstrated, with greater mitotic activity of matrix cells below the level of Auber’s line
(Auber, 1952; Lorenz et al., 2007; Van Scott et al., 1963). Such findings strongly support the 
theory that dermal papilla size governs, and therefore should correlate with, other hair follicle 
dimensions.
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The hair follicle bulb to dermal papilla diameter ratios at the level of Auber's line found in this 
study (Figs 3.10 - 3.13 & 3.18) support the rationale that dermal papilla size influences the 
shape of the hair follicle bulb. At the level of Auber’s line, mean terminal hair follicle dermal 
papilla diameter was 5/13 of the bulb diameter (bulb to dermal papilla ratio = 2.6:1). This was 
significantly larger than for intermediate follicles, which had dermal papillae that were 1/3 of 
the bulb diameter (bulb to dermal papilla ratio = 3:1) (p<0.001). This implies that wider dermal 
papillae, as seen in terminal hair follicles, induce a 'bulbous' follicle bulb morphology, but that 
narrower dermal papillae, as seen in intermediate hair follicles, induce a 'tubular' follicle bulb 
morphology. Also of interest is the similar ratio of dermal papilla diameter at the level of 
Auber’s line to hair fibre diameter at the level of the epidermis in terminal (1.8:1) and 
intermediate (1.9:1) hair follicles (p=0.179). This implies that that the generated hair fibre size 
is proportionate to the size of the dermal papilla. 
This thesis demonstrates significant correlations between the dermal papilla diameter at the 
level of Auber’s line and hair follicle length below the skin surface, fibre diameter at the level 
of the epidermis, connective tissue sheath diameter at the dermis-fat junction and bulb 
diameter at the level of Auber’s line, in pre-auricular hair follicles (Figs 3.10 - 3.13). When 
subcategorised according to hair follicle type, terminal hair follicles retained these significant 
correlations for all categories except for hair follicle length below the skin surface (Figs 3.14 -
3.17). Intermediate hair follicles retained these significant correlations for all categories (Figs 
3.14 - 3.17). This generally corresponds well with data presented in earlier studies.
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4.3 Do intermediate pre-auricular hair follicles exhibit differences to terminal hair 
follicles in organ culture?
The first publication of human anagen hair follicle organ culture demonstrated a significant 
increase in length over 4 days of organ culture (Philpott et al., 1990). In a later study, human 
hair follicles were successfully maintained in organ culture over 10 days (Philpott et al., 1994a). 
Various organ culture studies have demonstrated hair follicle growth rates ranging from 
0.13mm/day - 0.35mm/day, across various body sites and culture media (Kwon et al., 2006; 
Magerl et al., 2004; Myers and Hamilton, 1951; Shorter et al., 2008). In this study, terminal 
pre-auricular hair follicles reached a peak growth rate of 0.12mm/day, in keeping with these 
reports. 
Intermediate hair follicles displayed behavioural differences to terminal hair follicles,
displaying significantly less daily absolute growth, cumulative growth and total hair fibre
production over the course of 9 days of organ culture under normal culture conditions (Section 
2.3) (Miranda et al., 2010) (appendix). Overall, 86% of terminal and 66% of intermediate hair 
follicles successfully began to grow within the first 3 days of organ culture, under normal 
culture conditions (Fig 3.20). This difference probably reflects the delicate nature of 
intermediate hair follicles over terminal hair follicles. During dissection, intermediate hair 
follicles were visibly inadvertently damaged in greater numbers than terminal hair follicles. 
With this in mind, it is likely that damage to the microstructure of intermediate hair follicles, to 
an extent incompatible with growth in culture media, also occurred in greater numbers than 
with terminal hair follicles. 
A gradually decreasing proportion of dissected anagen terminal and intermediate hair follicles 
remained in anagen over 9 days under normal culture conditions (Fig 3.21), a pattern in 
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keeping with other studies. For example, in a 9 day organ culture experiment of human anagen 
human hair follicles, taken from the scalps of healthy patients, 65% remained in anagen at the 
end of 9 days (Shorter et al., 2008). This study has demonstrated a similar figure for terminal 
hair follicles from the pre-auricular region, of which 74% were still in anagen at the end of 9 
days of organ culture under normal culture conditions. By contrast, a significantly higher 
proportion (84%) of intermediate hair follicles remained in anagen at the end of 9 days under 
the same culture conditions (p=0.012). This difference could be explained by a number of 
theories. Firstly, intermediate hair follicles may spend more time in anagen than terminal hair 
follicles, in organ culture, under normal culture conditions. Furthermore, it is possible that 
trauma has an effect on the hair follicle growth cycle, increasing the probability of entering 
catagen over 9 days of organ culture. In the case of delicate intermediate hair follicles, it is 
conceivable that even the smallest trauma is enough to prevent growth. When growth does 
occur however, it is possible that intermediate hair follicles are completely intact and 
therefore less likely to enter catagen over the course of 9 days of organ culture. Finally, it is 
possible that this difference was an anomaly. Interestingly, these differences were not 
observed during later experiments involving testosterone (Fig 3.27), cyproterone acetate (Fig 
3.34) or finasteride (Fig 3.53). This suggests that the most likely reason for the observed 
differences between the percentage of terminal and intermediate hair follicles remaining in 
anagen was due to intermediate hair follicle trauma during the microdissection process, 
something that was improved upon with practice.
Cumulative terminal (0.603 ± 0.025mm; Mean ± SEM) hair follicle growth over 9 days under 
normal culture conditions was significantly higher than for intermediate follicles (0.400 ± 
0.021mm) (p<0.001) (Fig 3.22). This implies that intermediate hair follicles behave differently 
to terminal hair follicles under normal culture conditions. These findings confirm that hair 
follicles follow a particular pattern of growth in culture. Furthermore, a significant difference 
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was demonstrated between terminal and intermediate hair follicle daily growth (p=0.003) (Fig 
3.23), providing further evidence for terminal hair follicle growth being greater than 
intermediate hair follicles, at organ culture, under normal culture conditions.
In order to account for the possibility that longer dissected hair follicles grow more than 
shorter dissected hair follicles, hair follicle growth at 9 days expressed as a percentage of initial 
length was also calculated. Percentage hair follicle growth was higher for terminal (31.78 ± 
0.01%; Mean ± SEM) than for intermediate (22.28 ± 0.02%) hair follicles (p<0.001). This is an 
interesting observation, as it further suggests that intermediate hair follicles grow less than 
terminal hair follicles in organ culture, under normal culture conditions. 
In this study, the day of culture had a significant effect on daily absolute growth for both 
terminal and intermediate hair follicle samples, across all culture conditions, with most growth 
occurring between days 2-4. Graph shapes were all sigmoid for cumulative growth (Figs 3.22 & 
3.29 - 3.30 & 3.36 - 3.37 & 3.54 - 3.55) and positively skewed for absolute daily growth (Figs
3.23 & 3.31 & 3.38 - 3.39 & 3.56 - 3.57). The sigmoid cumulative growth pattern implies a short 
lasting, initial slow growth phase, followed by an accelerated growth phase between days 2-4, 
completed by a final slow growth phase tending towards cessation of growth. This may have 
occurred as hair follicles initially recovered from any trauma and adjusted to their new culture 
conditions (initial slow growth phase), followed by a stable optimal growth period (accelerated 
growth phase), with gradual cessation of growth occurring as something crucial for hair follicle 
growth was used up, for example something that was not present in the culture media (final 
slow growth phase).      
Total hair fibre production at 9 days of organ culture was significantly higher for terminal 
(0.502 ± 0.028mm; Mean ± SEM) than for intermediate (0.357 ± 0.021mm) hair follicles, under 
212
normal culture conditions (p<0.001%) (Fig 3.24), providing further evidence that terminal hair 
follicles display more growth in organ culture, than intermediate hair follicles, under normal 
culture conditions.
4.4 Does testosterone stimulate intermediate or terminal pre-auricular hair follicle 
growth in organ culture at physiological levels?
Since there were significant differences between the intermediate and terminal hair follicles in 
vivo and also in organ culture, the next aim was to determine whether the intermediate 
follicles from the pre-auricular region would respond to androgens by increased growth in vitro
as they would in vivo to form terminal beard follicles if exposed to male levels of androgens. 
This involved investigating the action of physiological levels of testosterone on these follicles 
and whether any effects involved action on the androgen receptor or metabolism to 5α-
dihydrotestosterone. 
Any effect of the small quantity of ethanol used to dilute the testosterone was initially studied 
carefully in both terminal and intermediate hair follicles over 9 days of organ culture. This was 
in order to exclude the possibility that any observed differences in organ culture with 
testosterone were due to the vehicle itself. Adding 0.0001% ethanol to the culture media had 
no effect on the following: mean percentage hair follicle growth within the first 3 days of 
culture (Fig 3.25), the percentage of hair follicle samples that remained in anagen (Figs 3.21 & 
3.26 - 3.27), cumulative hair follicle growth (Figs 3.22 & 3.29 - 3.30), daily absolute growth (Figs 
3.23 & 3.31) and total hair fibre production (Figs 3.24 & 3.32). Therefore any changes detected 
with the addition of 10nM testosterone should not have been caused by the vehicle.
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Androgens exert paradoxical effects on hair growth (Randall, 2008). At puberty, an increase in 
circulating androgens results in vellus follicles being replaced by terminal follicles on areas 
such as the beard, pubic diamond, chest and limbs of males (Hamilton, 1958). In contrast, the 
same individual may have the exact opposite response to androgens in later life during the 
male scalp balding process (Hamilton, 1951). What is interesting, in male pattern baldness, is 
the frontal-temporal recession leading to hair loss from the scalp vertex. The pre-auricular and 
occipital regions are notably spared in such cases, supporting the concept that terminal hair 
follicles in these regions behave somewhat differently and are androgen insensitive (Fig 1.9). 
The terminal hair follicles used here did not display any changes in growth after 9 days of 
organ culture, when stimulated with physiologically relevant levels of testosterone (10nM). 
This finding is unsurprising as all hair follicles were dissected from the pre-auricular region of 
the scalp. In contrast, in an organ culture study of terminal scalp hair follicles, culture media 
supplementation with 17-433nM testosterone resulted in suppression of growth (Kondo et al., 
1990). It is difficult to comment on the effects of the very high concentrations of testosterone 
as these are well outside the physiological, receptor-mediated response range. Again this is 
unsurprising as scalp hair follicles, particularly from the frontal and parietal regions, are 
affected by androgenetic alopecia, whereas those from the pre-auricular region are not (Fig 
1.9). 
With respect to both terminal and intermediate hair follicles, there were no significant 
differences between the numbers that grew within the first 3 days under 0.0001% ethanol 
control and 10nM testosterone culture conditions. This suggests that the addition of 10nM 
testosterone did not alter the initial ability for either types of follicle to grow in organ culture. 
Testosterone did not have a significant effect on the proportion of terminal hair follicles 
remaining in anagen over 9 days of organ culture (Fig 3.26). The duration in which the hair 
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follicle remains in anagen, particularly in anagen stage VI, is traditionally thought to determine 
the length of the resulting hair fibre (Saitoh et al., 1970; Trotter, 1924; Whiting, 2001). There 
are approximately 100,000 hairs present on normal adult scalp, of which 90% are in anagen 
and 10% in telogen (Braun-Falco and Heilgemeir, 1985; Pecoraro and Astore, 1990). A decrease 
in the percentage of anagen (80%) and an increase in the percentage of telogen (20%) hairs 
are a notable feature of androgenetic alopecia in men (Whiting, 1998). It therefore follows 
that in androgenetic alopecia, androgens such as testosterone decrease the duration of 
anagen, thereby accelerating the balding process (Olsen et al., 2005).
There was no significant difference between cumulative terminal hair follicle growth under 
0.0001% ethanol control and 10nM testosterone culture conditions (Fig 3.25). Terminal hair 
follicle percentage growth was similar across all culture conditions, further confirming the lack 
of effect on growth. These observations suggest that testosterone has neither a stimulatory 
nor inhibitory effect on female, pre-auricular terminal hair follicle cumulative growth over 9 
days of organ culture. This concurs with the observation in vivo that this area is unaffected in 
male and female pattern baldness (Hamilton, 1951; Ludwig, 1977) (Figs 1.9 & 1.10); it can be 
considered unresponsive to androgens and a non-balding region of the scalp.    
With respect to intermediate hair follicles, the addition of testosterone significantly increased 
the percentage of hair follicles remaining in anagen (81 ± 1.8% vs. 87 ± 2.3%; p<0.001). This 
suggests that testosterone has a significant effect in maintaining intermediate hair follicles in 
anagen in organ culture. There was also a significant increase in cumulative intermediate hair 
follicle growth with the addition of 10nM testosterone (Fig 3.30). This implies that 
testosterone has a stimulatory effect on cumulative intermediate hair follicle growth over 9 
days of organ culture. What is even more interesting is that intermediate hair follicle growth, 
as a percentage of initial length, was also affected. Intermediate hair follicles grew 23.09 ± 
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0.02% (Mean ± SEM) under 0.0001% ethanol control conditions during organ culture over 9 
days, but their percentage growth significantly increased with the addition of 10nM 
testosterone (30.89 ± 0.01%) (p<0.001) (Section 3.4.3), further confirming the stimulatory 
effect of testosterone. Furthermore, 10nM testosterone induced cumulative growth / 
percentage growth in intermediate hair follicles (0.589 ± 0.024mm / 30.89 ± 0.01%; Mean ± 
SEM) that was similar to terminal hair follicles (0.596 ± 0.023mm / 31.59 ± 0.03%) under 
0.0001% ethanol control culture conditions. These observations suggest that when female 
human pre-auricular anagen intermediate hair follicles are stimulated with testosterone, they 
behave in a similar manner to anagen terminal pre-auricular hair follicles in control medium
with respect to cumulative growth, under these organ culture conditions. 
The addition of 10nM testosterone did not have a significant effect on terminal hair follicle 
daily absolute growth (Fig 3.31). There was a significant stimulatory effect however, with 
intermediate hair follicles (p=0.019) (Fig 3.31), suggesting that testosterone does have a 
stimulatory effect on human pre-auricular intermediate hair follicle daily absolute growth. 
There was no significant difference between intermediate hair follicle daily absolute growth 
under testosterone culture conditions and terminal hair follicle daily absolute growth under 
normal culture conditions (p=0.858). This provides further evidence for the similar behaviour 
of intermediate hair follicles, when stimulated by testosterone, to terminal hair follicles
without testosterone in organ culture. 
With respect to terminal hair follicles, there was no significant effect on mean total hair fibre
production after 9 days in the presence of 10nM testosterone (Fig 3.32). However, there was a 
significant stimulatory effect in intermediate hair follicles (p<0.001) (Fig 3.32). This further 
confirms the stimulatory effect of testosterone on human pre-auricular intermediate hair 
follicle growth at organ culture. No significant difference was found between terminal hair 
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follicles under ethanol control culture conditions and intermediate hair follicles under 
testosterone culture conditions. This confirms that intermediate hair follicles behave in a 
similar manner to terminal hair follicles with respect to growth in organ culture, when 
stimulated by testosterone.
Nothing was known previously about the response of intermediate hair follicles to 
testosterone stimulation in organ culture. In this study, human pre-auricular terminal hair 
follicles did not respond to testosterone, however intermediate hair follicles displayed 
significantly greater daily absolute growth, cumulative growth and total hair fibre production 
over the course of 9 days of organ culture, when supplemented with 10nM testosterone. 
Testosterone, near the physiological concentration, had a stimulatory effect on the growth of 
human pre-auricular intermediate hair follicles in vitro. Furthermore, this stimulated growth 
reflected that of terminal hair follicles under ethanol control culture conditions. Overall these 
results are very exciting as the behaviours of the two types of follicles in vitro mirrors that of 
both types of follicles in vivo. 
4.5 Do the effects of testosterone involve the androgen receptor?
In order to confirm that this was a biologically relevant response by establishing the 
involvement of the androgen receptor in the growth stimulation responses of intermediate 
pre-auricular hair follicles, organ culture using the androgen receptor blocker (anti-androgen)
cyproterone acetate (Fiet et al., 2000; Honer et al., 2003), androgen receptor 
immunohistochemistry and polymerase chain reaction techniques were employed.
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There were no significant differences between the numbers of terminal or intermediate hair 
follicles that grew within the first 3 days under 0.0001% ethanol control and 1μM cyproterone 
acetate. This suggests that the addition of 1μM cyproterone acetate did not alter the initial 
ability for either types of follicle to grow in organ culture, such that any further observations of 
growth inhibition with the addition of cyproterone acetate to testosterone could be attributed 
to androgen receptor blockade rather than drug toxicity. 
Cyproterone acetate (1μM) alone had no effect on any of the growth conditions in either 
terminal of intermediate hair follicles. When added to 10nM testosterone culture conditions, 
1μM cyproterone acetate did not alter the proportion of terminal hair follicles remaining in 
anagen, their cumulative growth, absolute daily growth or total hair fibre production over 9 
days of organ culture (Figs 3.33 & 3.36 & 3.38 & 3.40). However, interesting effects were 
observed for intermediate hair follicles as the duration of anagen (p<0.001) (Fig 3.34), 
cumulative growth (p<0.001) (Fig 3.37), absolute daily growth (p<0.001) (Fig 3.39) and total 
hair fibre production (p<0.0001) (Fig 3.41) were all decreased. This confirms that the 
stimulation of their growth by testosterone was an action via the androgen receptor. The 
blocking action of cyproterone acetate (Fiet et al., 2000; Honer et al., 2003) on the androgen 
receptors of human female Caucasian pre-auricular intermediate hair follicles prevented 
testosterone binding, presumably decreasing subsequent dimerisation of androgen-receptor 
complexes and binding to the hormone response element (Handelsman, 2001), so that there 
was no increased DNA transcription and subsequent growth stimulation. 
To locate androgen receptor protein in the hair follicles in vivo, immunohistochemistry using a 
monoclonal antibody to the androgen receptor was carried out on frozen sections of terminal 
and intermediate ehair follicles. The androgen receptor was detected in both terminal and 
intermediate hair follicles (Figs 3.43 & 3.44), from human female Caucasian pre-auricular 
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facelift skin, with intra-nuclear staining located primarily within the cells of the dermal papilla.
In terminal hair follicles, minimal staining was found within the cells of the inner and outer 
root sheaths and the connective tissue sheath; this staining pattern was even more noticeable 
within intermediate hair follicles. These data confirm the presence of the androgen receptor in 
terminal hair follicles, and highlights a more widespread presence within intermediate hair 
follicles. These findings are in keeping with the concept that the effects of both testosterone 
stimulation and cyproterone acetate inhibition, on intermediate hair follicle growth 
parameters over 9 days of organ culture, were mediated via action on the androgen receptor.
The androgen receptor has previously been observed within pilosebaceous units, primarily 
within the cells of the hair follicle dermal papilla, differentiated and basal cells of sebaceous 
glands and eccrine sweat glands (Itami et al., 1994; Kariya et al., 2005; Thornton et al., 2003). 
Furthermore, an immunofluorescence study of human hair follicles illustrated the presence of 
the androgen receptor within the cells of the dermal papilla and connective tissue sheath of 
beard, but not occipital scalp hair follicles (Rutberg et al., 2006). However, in an interesting 
immunohistochemical study of human frontal and occipital scalp anagen hair follicles from 
patients with androgenetic alopecia, positive androgen receptor staining was observed in both 
the outer root sheath and dermal papilla of frontal follicles more than occipital follicles, with 
most staining appearing in the outer root sheath (Sawaya and Price, 1997). 
To complement the immunolocalisation of androgen receptor protein in the intermediate 
follicles, the expression of the androgen receptor gene was investigated using reverse 
transcription polymerase chain reaction methodology (RT-PCR). In this study, RT-PCR 
confirmed the presence of the androgen receptor gene in both terminal and intermediate hair 
follicles, however this expression was weak (Fig 3.47). Real time quantitative real time 
polymerase chain reaction (qPCR), which requires less cDNA, further confirmed the presence 
of the androgen receptor in both terminal and intermediate hair follicles (Fig 3.51). The 
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relative gene expression was 3.52 fold greater in pre-auricular intermediate hair follicles than 
terminal ones (p=0.04). Androgen receptor gene expression has previously been shown in hair 
follicle components and in cultured cells (Asada et al., 2001; Kwon et al., 2004; Yoo et al., 
2007). These studies examined various cells and locations within human hair follicles and 
together demonstrated gene expression of the androgen receptor within the dermal papilla, 
connective tissue sheath, matrix, inner and outer root sheaths and within dermal fibroblasts. 
Overall, the blocking of testosterone-stimulated growth in pre-auricular intermediate hair 
follicles by the anti-androgen, cyproterone acetate, in organ culture and the confirmation of 
androgen receptor protein and gene expression within them strongly supports the hypothesis 
that androgen effects are via the androgen receptor. Since androgen receptors were also 
detected in terminal hair follicles, albeit at a lower level, the lack of response of terminal pre-
auricular follicles to androgens in organ culture is unlikely to be due to a lack of the androgen 
receptor. It is more likely that within the terminal follicles the target genes available within 
intermediate follicles, or some necessary cofactors, are not available, or the relevant genes are 
switched off in their cells. There are clearly differences between follicles in different areas in 
this regard as testosterone has such different effects on hair growth in different sites, such as 
transforming vellus hair follicles to terminal ones on the beard during puberty, or inhibiting 
and reversing follicular growth in certain body areas such as the scalp later in life, resulting in 
the replacement of terminal follicles with vellus follicles (Randall, 2008) (Fig 1.4). Androgen 
receptors have been shown to be present in dermal papilla cells cultured from terminal 
follicles from non-androgen dependent occipital scalp as well as androgen-dependent beard 
cells (Randall et al., 1992), even though scalp cells have been shown not to alter their 
production of paracrine factors in response to testosterone as beard cells have (Thornton et 
al., 1998).  
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4.6 Do the effects of testosterone require metabolism of testosterone by 5α-reductase?
The presence of 5α-reductase type 2 within some hair follicles is important as it converts 
testosterone to the more potent androgen 5α-dihydrotestosterone (Hoffmann et al., 2001; 
Randall, 1994a). The enzyme 5α-reductase type 2 has previously been observed by 
semiquantitative immunohistochemistry in numerous human tissues, however strong 
immunoreactivity was only observed within the prostate, epididymis and within hair follicles 
(Eicheler et al., 1994). In order to investigate the involvement of 5α-reductase type 2 in the
testosterone-stimulated growth of intermediate hair follicles in organ culture finasteride, a 
type 2 5α-reductase inhibitor (Thiboutot et al., 2000), was added to terminal and intermediate 
hair follicles from human female Caucasian pre-auricular facelift skin in testosterone 
supplemented culture conditions. This was followed by investigations into localisation by 
immunohistochemistry and gene expression by quantitative real time polymerase chain 
reaction (qPCR) methods.
Again, there were no significant differences between the numbers that grew within the first 3 
days under 0.0001% ethanol control and 40ng/ml finasteride in either terminal or intermediate 
hair follicles. This suggests that the addition of 40ng/ml finasteride did not alter the initial 
ability for either types of follicle to grow in organ culture. 
The addition of 40ng/ml finasteride to either control medium or 10nM testosterone culture 
conditions did not affect the proportion of terminal or intermediate hair follicles remaining in 
anagen, cumulative growth, absolute daily growth or mean total hair fibre production over 9 
days of organ culture in either terminal (Figs 3.52 & 3.54 & 3.56 & 3.58) or intermediate (Figs 
3.53 & 3.55 & 3.57 & 3.59) hair follicles. These findings could suggest that the action of 
testosterone on human female Caucasian pre-auricular intermediate hair follicles did not 
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involve the metabolism of testosterone to the more potent androgen, 5α-dihydrotestosterone, 
by 5α-reductase type 2. However, it is also possible that there was not enough finasteride used 
in the culture medium in order to produce an effect, although the concentration of finasteride 
was chosen in relation to peak plasma concentrations achieved after ingestion of a 5mg tablet 
of finasteride (average=37ng/ml; range=27-49ng/ml) (www.merck.com). Other reasons might 
include that finasteride was not stable in the culture medium, in contrast to testosterone that 
is naturally present within the body, or that 5α-reductase type 1 is involved in addition to, or 
instead of type 2. Therefore, immunohistochemical and molecular biology methodologies were 
utilised in order to investigate the presence of 5α-reductase type 2. 
In this study, immunohistochemistry demonstrated the presence of 5α-reductase type 2 in 
both terminal and intermediate hair follicles (Figs 3.60 & 3.61) from human female Caucasian 
pre-auricular facelift skin. Staining patterns were similar for both terminal and intermediate 
hair follicles. Positive staining was observed within the outer root sheath of the isthmus of 
both hair follicle types (Figs 3.60 & 3.61). These data indicated the presence of the enzyme 5α-
reductase in both hair follicle types, suggesting that it is the outer root sheath that is more 
important with respect to expression. However, the similarity between the terminal and 
intermediate hair follicles was surprising.
Immunohistochemistry has previously localised 5α-reductase type 2 within the outer root
sheath and dermal papilla of human frontal and occipital scalp anagen hair follicles, with most 
staining appearing in the outer root sheath (Sawaya and Price, 1997) and within the 
companion (innermost) layer of the outer root sheath of terminal hair follicles from back 
biopsies (Thiboutot et al., 2000). As androgens are believed to primarily act within the dermal 
papilla, it is interesting that 5α-reductase type 2 was not localised to these cells in this thesis, 
in contrast to data published in an earlier study of terminal hair follicles (Asada et al., 2001). 
222
However, immunohistochemistry results strongly depend on the specificity of the antibody. 
Asada et al. (2001) utilised semi-quantitative reverse transcription polymerase chain reaction 
methodology (RT-PCR) and found that 5α-reducatase type 2 gene expression was primarily 
located within the mesenchymal portions of the hair follicle such as the dermal papilla, upper 
and lower connective tissue sheaths, while hardly any was expressed in the epithelial portions 
such as the matrix, inner and outer root sheaths. 
When the expression of 5α-reductase genes was examined by quantitative real time 
polymerase chain reaction (qPCR) methodology in this thesis, the presence of the 5α-
reducatase type 2 gene in both terminal and intermediate pre-auricular hair follicles was 
confirmed, concurring with the immunohistochemistry results. Relative gene expression was 
2.58 fold greater in the intermediate hair follicles than the terminal ones (p=0.03) (Fig 3.62). In 
another study, this methodology demonstrated that 5α-reductase type 2 relative gene 
expression was similar within dermal papilla cells harvested from beard and a non-specified 
region of scalp terminal hair follicles (Liu and Yamauchi, 2008). This contrasts with studies 
examining the actual metabolism of testosterone in cultured dermal papilla cells which found 
that testosterone was primarily metabolised to 5α-dihydrotestosterone in beard cells, but not
in ambisexual areas like non-balding scalp, axilla and pubis (Hamada et al., 1996; Itami et al., 
1994; Thornton et al., 1993), reflecting hair growth in 5α-reductase deficiency patients.
Although no biological response was observed with the addition of finasteride (5α-reductase 
type 2 inhibitor) to testosterone supplemented culture conditions in intermediate or terminal 
hair follicle growth over 9 days of organ culture, the concentrated location is interesting. The 
expression of 5α-reductase type 2 was not widespread throughout these hair follicles and not 
found in the dermal papilla, such that any metabolism of testosterone could be marginal, 
hence not significantly contributing to any growth effects. This is a slightly different concept to 
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that outlined in section 3.6.1, where growth effects were not attributed at all to the action of 
5α-reductase type 2. The presence of this enzyme within the hair follicle in vivo may have 
different effects to those observed in vitro. Early studies investigating the ability of plucked 
human hair follicles from various sites to metabolise testosterone to 5α-dihydrotestosterone 
in vitro was limited and unaffected by the secondary sexual characteristics of the follicles
(Randall, 1994b) in contrast to what would be expected after examining the hair growth 
patterns in men with 5α-reductase deficiency. Such plucked follicles do not include the dermal 
papilla indicating that the 5α-reductase was located elsewhere in the follicle in line with the 
observations in this thesis.
The inability to detect 5α-reductase in the dermal papilla of intermediate hair follicles (Fig 
3.61) does concur with the absence of any effect of finasteride on the testosterone-stimulated 
growth in intermediate follicles in organ culture (Fig 3.55). However, it contrasts with the 
importance of 5α-reductase type 2 in beard hair growth in 5α-reductase deficiency (Fig 1.6)
(Wilson et al., 1993) and the pronounced metabolism to 5α-dihydrotestosterone in cultured 
dermal papilla cells from beard follicles (Hamada et al., 1996; Itami et al., 1994; Thornton et 
al., 1993). It is possible that exposure to androgens in vivo induces the expression of 5α-
reductase type 2 in the dermal papilla cells of facial hair follicles, like the beard. 
Overall, the results from this thesis indicate that 5α-reductase type 2 is present, but further 
studies will be necessary to determine whether it is essential for androgen stimulation to occur
in intermediate hair follicles.
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4.7 Are there differences between intermediate and terminal hair follicles at gene 
microarray analysis?
As expected, comparative gene microarray analysis of terminal and intermediate hair follicles 
from female human Caucasian pre-auricular facelift skin revealed some interesting differences. 
With respect to keratin and keratin associated protein related genes, intermediate hair follicle
expression was significantly less than terminal hair follicles (Fig 3.69). Keratins are the major 
structural proteins of the vertebrate epidermis and its appendages, comprising 85% of fully 
differentiated keratinocytes (Fuchs, 1995) and the hair follicle itself is dedicated to producing 
the structural hair fibre that is also largely composed of hair keratin proteins (Gilon et al., 
2008), with keratin-associated proteins involved in the formation of cross-linking networks 
that provide further support (Shimomura et al., 2003). The microarray data presented in this 
thesis are therefore in keeping with the hypotheses that intermediate hair follicles are 
structurally smaller than terminal hair follicles, and that they also possess a different gene 
expression profile. For example, keratin genes KRT14, KRT16 and KRT17 were all significantly 
less expressed in intermediate follicles versus terminal ones (Fig 3.69) and these genes have all 
been identified in hair follicles (Entrez Gene Summary). Only one keratin gene, KRT79, was 
expressed more in intermediate follicles and this gene is known to encode an epithelial keratin 
(keratin 79) that is expressed in scalp tissue, skin and skeletal muscle (Entrez Gene Summary).
The overall absence of differences in androgen receptor gene expression between the follicle 
types during gene microarray analysis contrasted with both RT-PCR (Fig 3.47) and qPCR (Fig 
3.51) analyses which detected significantly more androgen receptor gene expression in 
intermediate hair follicles compared to terminal ones. Intermediate hair follicles, unlike 
terminal ones, did respond to androgens in organ culture. Furthermore, on closer inspection of 
the microarray data 4 individual probe sets, located at exons 1, 2, 5 and 7, exhibited 
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significantly more fluorescence in intermediate versus terminal hair follicles. These data imply 
the identification of splice variants for the androgen receptor, with the potential for increased 
expression in intermediate hair follicles.
The androgen receptor protein comprises 919 amino acid residues, encoded by 8 exons (Fig 
4.1) (Brinkmann, 2009). The primers designed for androgen receptor RT-PCR were in exon 1,
and those designed for qPCR were in exons 4, 5 and 6. This confirms the gene microarray 
observation that exons 1 and 5 were more highly expressed in intermediate hair follicles. 
Taking into account that the overall expression of all androgen receptor genes did not differ in 
the microarray analysis, this suggests that intermediate follicle androgen receptors may 
contain different splice variants to terminal hair follicles. The N-terminal domain, involved in 
transcriptional regulation of the androgen receptor, is encoded by exon 1 (Brüggenwirth et al., 
1997; Faber et al., 1989), therefore splice variants could affect the final sensitivity of the
androgen receptor, or affect transcription with a subsequent knock-on effect on translation 
and androgen receptor protein synthesis. For example, exon 1 contains CAG repeats that when 
present in fewer numbers have been well associated with the development of precocious 
puberty due to increased androgen receptor sensitivity (Ibáñez et al., 2003; Vottero et al., 
2006). Exon 6 encodes for the ligand-binding domain that is distributed over exons 4-8
(Brüggenwirth et al., 1997; Chang et al., 1988; Trapman et al., 1988). This is another potentially 
interesting splice variant as binding of androgens to the ligand-binding domain of the 
androgen receptor, allows entry of the ligand-bound receptor into the nucleus and subsequent 
transcriptional regulation of androgen-responsive genes (Hu et al., 2009; Shang et al., 2002). 
Although not investigated by the qPCR methods used here, the involvement of a potential 
splice variant at exon 2, as outlined by gene microarray analysis, is of potential interest since 
exons 2-3 separately encode 2 zinc fingers that represent the DNA-binding domain of the 
androgen receptor.
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Fig 4.1: The human androgen receptor gene is located on the long arm of the X-chromosome. 
The human androgen receptor protein (919 amino acid residues) is encoded by 8 exons and 
consists of several distinct functional domains: the NH2-terminal domain containing two 
polymorphic stretches, the DNA-binding domain, the hinge region and the ligand binding 
domain. 
From Brinkmann A 2009.
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When 5α-reductase type 2 gene expression was examined by microarray analysis, no 
significant differences were noted in overall gene expression. However on closer inspection, 2 
individual probe sets exhibited significant differences in fluorescence in intermediate hair 
follicles versus terminal ones. The 5α-reductase type 2 gene is composed of 5 exons, separated 
by 4 introns (Labrie et al., 1992) and is illustrated in Fig 4.2 (Brinkmann, 2009). In this thesis,
expression of exon 5 was found to be significantly higher in intermediate hair follicles, whereas 
expression of exon 1 was significantly lower. These data imply the possible identification of 
splice variants for the enzyme 5α-reductase type 2. The primers designed for 5α-reductase
type 2 qPCR, where gene expression was also higher for intermediate hair follicles, were in 
exons 2 and 5. Exon 5 was therefore confirmed to obtain a potential splice variant for 5α-
reductase type 2 gene expression, with the potential for increased expression in intermediate 
hair follicles.
Fig 4.2: The 5α-reductase type 2 gene consists of 5 exons, separated by 4 introns.
Adapted from Brinkmann A 2009.
Although not confirmed in experiments presented in this thesis, the lower expression of exon 1 
is interesting as the most frequent polymorphism (V89L) of the 5α-reductase type 2 gene, 
located at exon 1, results in a 30% decrease in 5α-reductase type 2 activity, possibly reducing 
susceptibility to androgen-dependent prostate cancer (Lunn et al., 1999; Makridakis et al., 
2000; Makridakis et al., 1997), although a recent systematic review and meta-analysis has 
disputed the association of both V89L and A49T mutations with prostate cancer development 
228
(Li et al., 2010). Makridakis et al (2000) examined the effects of certain gene mutations on the 
kinetic properties of 5α-reductase type 2 and identified mutations, present in exons 1 (the 
location of the initiator codon) and 5 (the location of the translation stop codon) respectively.
Mutations within exon 1 included V89L, A49T, and C5R, both of which resulted in an increase 
in the kinetic activity of 5α-reductase type 2, whereas P30L, A51T and P48R mutations resulted 
in a decrease. The F234L mutation present in exon 5 also resulted in a decrease in the kinetic
activity of 5α-reductase type 2. These observations confirm the potential impact that splice 
variants of exons of the 5α-reductase type 2 gene may have on its function. Although 
interesting observations have been presented in this thesis, further investigations into the role 
of 5α-reductase, and potential splice variants, are required in order to attribute or rule out any 
involvement in the phenotypic differences between human terminal and intermediate hair 
follicles. 
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5. CONCLUSION
The overall aim of this research was to develop a novel, clinically-relevant model system based 
on intermediate hair follicles. In males, hair from the pre-auricular region becomes thicker 
during puberty, particularly in the inferior part of this region, as the hair turns into the beard. 
In females however, this does not occur, such that much of this hair is intermediate. Therefore, 
female pre-auricular facelift skin was chosen for use in these experiments. Intermediate and 
terminal hair follicles from human female Caucasian pre-auricular facelift skin showed distinct 
morphology with intermediate hair follicles being thinner, less pigmented and extending less 
below the skin surface than terminal hair follicles. Gene microarray analysis demonstrated 
reductions in the expression of many keratin and keratin associated protein genes, in keeping 
with these observations. Furthermore, the bulb region of intermediate hair follicles tends to 
have a more 'tubular' morphology, rather than the 'bulbous' morphology generally seen in 
their terminal counterparts. At the level of Auber’s line, the 'tubular' intermediate hair follicle 
bulb morphology houses a dermal papilla that is relatively narrower than in terminal hair 
follicles with a bulb to dermal papilla ratio of 2.6:1 and 3:1 respectively. Despite this, fibres 
produced by both hair follicle types, had similarly proportionate dermal papilla (at Auber’s 
line) to hair fibre diameter (at the dermis-fat junction) ratios of 1.8:1 for terminal and 1.9:1 for 
intermediate hair follicles. This study also demonstrated significant correlations between 
dermal papilla diameter at the level of Auber’s line and other morphometric characteristics of 
both terminal and intermediate hair follicles, further supporting the idea that the dermal 
papilla plays an important role with respect to the morphometry of the hair follicle.
To determine whether the intermediate hair follicles could be used as a model system to 
investigate factors which promote hair growth and to establish whether they retained in vivo 
differences to terminal hair follicles in vitro, both types of follicles were grown in organ culture. 
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Intermediate hair follicles proved very hard to isolate by microdissection, but were cultured 
successfully. Pre-auricular terminal and intermediate hair follicles did show differences, with 
intermediate follicles growing more slowly than terminal follicles. Most interestingly, terminal 
follicles did not alter their growth in response to 10nM testosterone, unlike intermediate 
follicles which grew more, increasing daily absolute growth, percentage growth, cumulative 
growth and hair fibre production. Furthermore, the growth pattern behaviours of intermediate 
hair follicles in 10nM testosterone were statistically indistinct from terminal hair follicle 
behaviours under normal culture conditions. 
The absence of any effect of testosterone on female pre-auricular terminal hair follicles in 
organ culture is consistent with the lack of response of pre-auricular terminal hair follicles in 
men in vivo during androgenetic alopecia. The growth stimulation of female intermediate 
follicles from pre-auricular regions by testosterone in vitro organ culture, is particularly 
exciting, because testosterone, in male levels in vivo, stimulates the transformation of follicles 
in this area into the terminal hair follicles of the beard. This may also be seen in hirsutism, 
where androgens, either due to raised circulating levels or idiopathic reasons (generally 
believed to be related to follicular hypersensitivity) stimulate follicles to enlarge and produce 
darker, thicker, longer hairs (Simpson and Barth, 1997).
Such a response to testosterone in organ culture is important because it suggests that 
intermediate hair follicles, in organ culture, offer a complex biological organ involving 
epithelial and mesenchymal interactions which can respond to androgens in vitro. Involvement 
of the androgen receptor in this response was demonstrated in several ways. Firstly, organ 
culture in the presence of the androgen receptor blocker, cyproterone acetate, antagonised 
the effects of testosterone on intermediate hair follicles. This only occurred in intermediate 
hair follicles, providing further evidence for the differential responses of intermediate and 
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terminal hair follicles, seen in the androgen supplemented organ culture experiment.
Secondly, androgen receptor protein expression was successfully demonstrated in both 
terminal and intermediate hair follicles using immunohistochemistry, though its presence 
appeared more widespread throughout intermediate hair follicles. Thirdly, mRNA analysis via
reverse transcription polymerase chain reaction (RT-PCR), quantitative real time polymerase 
chain reaction (qPCR) and gene microarray experiments, detected androgen receptor gene 
expression in both terminal and intermediate hair follicles, with greater expression in 
intermediate hair follicles (3.52 fold change difference) by qPCR. 
Androgen action frequently involves a further stage prior to binding of testosterone to the 
androgen receptor, the metabolism of testosterone to the more active androgen 5α-
dihydrotestosterone (Randall, 2008). In addition, given that the active androgen involved in 
beard growth and hair follicle miniaturisation is 5α-dihydrotestosterone, terminal and 
intermediate hair follicles were investigated for 5α-reductase type 2 gene (SRD5A2) expression 
via qPCR. Intermediate hair follicles appeared to express more SRD5A2 than terminal hair 
follicles (2.58 fold change) and enzyme (protein) expression, as detected by 
immunohistochemistry, was also demonstrated in both hair follicles types though not in the 
classical androgen target, the dermal papilla. However, when added to both terminal and 
intermediate hair follicles in organ culture, the 5α-reductase type 2 inhibitor finasteride did 
not affect growth of either hair follicle type, including intermediate hair follicles cultured in the 
presence of testosterone. At this stage, it is unclear whether in female Caucasian pre-auricular 
intermediate hair follicles, the stimulatory effects of testosterone on growth in organ culture 
are mediated by testosterone, or 5α-dihydrotestosterone. 
Although no overall expression differences were found between these hair follicle types with 
respect to the androgen receptor (AR), 5α-reductase type 1 (SRD5A1) and SRD5A2 genes
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during gene microarray analysis, further individual probe set analysis revealed interesting data. 
Intermediate hair follicle gene expression was significantly higher than terminal hair follicles in 
probe sets that were within exons 1, 2, 5 and 7 for the AR gene, and exon 5 for the SRD5A2 
gene. These data suggest the presence of splice variants that were confirmed by PCR methods 
for exons 1 and 5 for the AR gene, and exon 5 for the SRD5A2 gene.
The most exciting result obtained in the research for this thesis is the accelerated growth of 
intermediate hair follicles in response to exogenous testosterone, a process that was inhibited 
by exogenous cyproterone acetate. The ability to elicit such responses in whole intermediate 
hair follicles in organ culture is important, as it provides a novel, more clinically-relevant model 
for developing new drugs for use in conditions such as alopecia, as well as for increasing hair 
growth after hair transplant surgery or full thickness skin grafting surgery from donor sites 
bearing a higher proportion of intermediate or vellus hair follicles, rather than terminal ones.
This body of work also provides the first data of how intermediate hair follicles respond to
androgens in isolated organ culture. The suggested model is that human female Caucasian pre-
auricular intermediate hair follicles possess a functional androgen receptor, responsive to 
testosterone, which can interact with the appropriate genes in organ culture, to stimulate 
gene expression of appropriate growth factors and/or extracellular matrix factors to increase
hair follicle growth. Therefore, intermediate hair follicles offer a novel, exciting, more clinically 
relevant, albeit technically difficult, model for future investigations into hair growth (Miranda 
et al., 2010) (appendix). Further investigation into the genes whose expression may be altered 
by testosterone in organ culture should provide important information with potentially 
significant relevance for further clinical treatments. 
At the current time this is a unique phenomenon, a hormonally sensitive organ responding 
physiologically to a hormone in organ culture, and could have useful implications outside of 
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the hair follicle biology field in the future. Understanding steroid hormone action is important, 
not only for hormonal responses such as those in the prostate leading to prostate cancer, or 
the breast leading to breast cancer, but also in transcription regulation, as androgens bind to 
their specific receptors and form transcription regulator complexes to stimulate the regulation 
of specific genes (Handelsman, 2001). Changes in gene expression under androgen-stimulation 
in intermediate hair follicles may well be important for these fields too.
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7. APPENDICES
7.1 SACPIC Staining
These solutions required preparation as follows:
Celestine Blue: Five hundred mls of 5% ferric ammonium sulphate aqueous solution were 
added to 2.5g celestine blue (C1 51050). This was then boiled for 3 minutes, then allowed to 
cool to room temperature, before filtering using grade 595 filter paper, (Schleicher and 
Schuell, supplied by SLS, Nottingham, UK). Finally, 70mls of glycerol was added.
Picric Acid: A saturated alcoholic solution of picric acid (5ml) was mixed with 300mls of
absolute ethanol.
Picro-Indigo Carmine: Three hundred mls of saturated picric acid aqueous solution 
was mixed with 1 g of indigo carmine (C1 73015). This solution was then filtered prior to use.
Safranin: Six grams of safranin (C1 50240) was dissolved in 300mls of a 1:1 
ethanol:distilled water solution. This solution was then filtered prior to use.
Scott’s Tap Water: Two grams of sodium hydrogen carbonate and 20g magnesium 
sulphate, were dissolved in 1L of distilled water. This was then filtered prior to use and stored 
at 4°C between uses. 
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7.2 Phosphate Buffered Saline (1X) (PBS)
Eight grams of sodium chloride, 0.2g of potassium chloride, 1.44g of sodium phosphate and 
0.24g of monopotassium phosphate, were dissolved in 800mls of distilled water, with a 
maintained pH of 7.4.     
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